Sentence	entity_1	entity_2	entity_3	entity_4	json	split
The present study was undertaken to investigate the effects of TET and FAN on the experimental thrombosis induced by collagen plus epinephrine ( EP) in mice, and platelet aggregation and blood coagulation in vitro.	TET,63,66,Chemical/Drug	FAN,71,74,Chemical/Drug	epinephrine,131,142,Chemical/Drug	EP,145,147,Chemical/Drug	"[{""token"": ""TET"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""FAN"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Chemical/Drug""}, {""token"": ""EP"", ""start_span"": 145, ""end_span"": 147, ""type"": ""Chemical/Drug""}]"	train
In the in vivo study, the administration ( 50 mg / kg, i. p.) of TET and FAN in mice showed the inhibition of thrombosis by 55% and 35%, respectively, while acetylsalicylic acid ( ASA, 50 mg / kg, i. p.), a positive control, showed only 30% inhibition.	TET,65,68,Chemical/Drug	FAN,73,76,Chemical/Drug	acetylsalicylic acid,157,177,Chemical/Drug	ASA,180,183,Chemical/Drug	"[{""token"": ""TET"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""FAN"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""acetylsalicylic acid"", ""start_span"": 157, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""ASA"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Chemical/Drug""}]"	train
Recent reports indicate that single agent therapy with vinorelbine ( VNB) or gemcitabine ( GEM) may obtain a response rate of 20 - 30% in elderly patients, with acceptable toxicity and improvement in symptoms and quality of life.	vinorelbine,55,66,Chemical/Drug	VNB,69,72,Chemical/Drug	gemcitabine,77,88,Chemical/Drug	GEM,91,94,Chemical/Drug	"[{""token"": ""vinorelbine"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""VNB"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""gemcitabine"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""GEM"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Chemical/Drug""}]"	train
NRA0160 has negligible affinity for the human cloned dopamine D3 receptor ( Ki = 39 nM), rat serotonin ( 5 - HT) 2A receptors ( Ki = 180 nM) and rat alpha1 adrenoceptor ( Ki = 237 nM).	NRA0160,0,7,Chemical/Drug	dopamine,53,61,Chemical/Drug	serotonin,93,102,Chemical/Drug	5 - HT,105,111,Chemical/Drug	"[{""token"": ""NRA0160"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 53, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Chemical/Drug""}]"	train
NRA0160 and clozapine antagonized locomotor hyperactivity induced by methamphetamine ( MAP) in mice.	NRA0160,0,7,Chemical/Drug	clozapine,12,21,Chemical/Drug	methamphetamine,69,84,Chemical/Drug	MAP,87,90,Chemical/Drug	"[{""token"": ""NRA0160"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""clozapine"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 69, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""MAP"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Chemical/Drug""}]"	train
NRA0160 and clozapine significantly shortened the phencyclidine ( PCP) - induced prolonged swimming latency in rats in a water maze task.	NRA0160,0,7,Chemical/Drug	clozapine,12,21,Chemical/Drug	phencyclidine,50,63,Chemical/Drug	PCP,66,69,Chemical/Drug	"[{""token"": ""NRA0160"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""clozapine"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""phencyclidine"", ""start_span"": 50, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""PCP"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Chemical/Drug""}]"	train
When activating the ( Na, K) - ATPase with its substrate ATP, no changes in Km and Vmax values were observed in NO - deficient rats.	Na,22,24,Chemical/Drug	K,26,27,Chemical/Drug	ATP,31,34,Chemical/Drug	NO,112,114,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 22, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 26, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 112, ""end_span"": 114, ""type"": ""Chemical/Drug""}]"	train
After recovery from hypertension, the activity of ( Na, K) - ATPase increased, due to higher affinity of the ATP - binding site, as revealed from the lowered Km value for ATP.	Na,52,54,Chemical/Drug	K,56,57,Chemical/Drug	ATP,61,64,Chemical/Drug	ATP,109,112,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 52, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 56, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Chemical/Drug""}]"	train
In the present paper the authors describe 2 female patients who developed incontinence secondary to the selective serotonin reuptake inhibitors paroxetine and sertraline, as well as a third who developed this side effect on venlafaxine.	serotonin,114,123,Chemical/Drug	paroxetine,144,154,Chemical/Drug	sertraline,159,169,Chemical/Drug	venlafaxine,224,235,Chemical/Drug	"[{""token"": ""serotonin"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""paroxetine"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""sertraline"", ""start_span"": 159, ""end_span"": 169, ""type"": ""Chemical/Drug""}, {""token"": ""venlafaxine"", ""start_span"": 224, ""end_span"": 235, ""type"": ""Chemical/Drug""}]"	train
Two mouse lines were selectively bred according to their sensitivity ( BS line) or resistance ( BR line) to seizures induced by a single i. p. injection of methyl beta - carboline - 3 - carboxylate ( beta - CCM), an inverse agonist of the GABA ( A) receptor benzodiazepine site.	methyl beta - carboline - 3 - carboxylate,156,197,Chemical/Drug	beta - CCM,200,210,Chemical/Drug	GABA,239,243,Chemical/Drug	benzodiazepine,258,272,Chemical/Drug	"[{""token"": ""methyl beta - carboline - 3 - carboxylate"", ""start_span"": 156, ""end_span"": 197, ""type"": ""Chemical/Drug""}, {""token"": ""beta - CCM"", ""start_span"": 200, ""end_span"": 210, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Chemical/Drug""}, {""token"": ""benzodiazepine"", ""start_span"": 258, ""end_span"": 272, ""type"": ""Chemical/Drug""}]"	train
We measured diazepam - induced anxiolysis with the elevated plus - maze test, diazepam - induced sedation by recording the vigilance states, and picrotoxin - and pentylenetetrazol - induced seizures after i. p. injections.	diazepam,12,20,Chemical/Drug	diazepam,78,86,Chemical/Drug	picrotoxin,145,155,Chemical/Drug	pentylenetetrazol,162,179,Chemical/Drug	"[{""token"": ""diazepam"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""picrotoxin"", ""start_span"": 145, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""pentylenetetrazol"", ""start_span"": 162, ""end_span"": 179, ""type"": ""Chemical/Drug""}]"	train
In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen - induced nephrotoxicity, amiodarone - induced lung toxicity and doxorubicin - induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract.	acetaminophen,86,99,Chemical/Drug	amiodarone,126,136,Chemical/Drug	doxorubicin,165,176,Chemical/Drug	IH636 grape seed proanthocyanidin extract,213,254,Chemical/Drug	"[{""token"": ""acetaminophen"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""amiodarone"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""IH636 grape seed proanthocyanidin extract"", ""start_span"": 213, ""end_span"": 254, ""type"": ""Chemical/Drug""}]"	train
For the cytoprotection study, animals were orally gavaged 100 mg / Kg GSPE for 7 - 10 days followed by i. p. injections of organ specific three drugs ( AAP: 500 mg / Kg for 24 h; AMI: 50 mg / Kg / day for four days; DOX: 20 mg / Kg for 48 h).	GSPE,70,74,Chemical/Drug	AAP,152,155,Chemical/Drug	AMI,179,182,Chemical/Drug	DOX,216,219,Chemical/Drug	"[{""token"": ""GSPE"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""AAP"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""AMI"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Chemical/Drug""}]"	train
Results indicate that GSPE preexposure prior to AAP, AMI and DOX, provided near complete protection in terms of serum chemistry changes ( ALT, BUN and CPK), and significantly reduced DNA fragmentation.	GSPE,22,26,Chemical/Drug	AAP,48,51,Chemical/Drug	AMI,53,56,Chemical/Drug	DOX,61,64,Chemical/Drug	"[{""token"": ""GSPE"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""AAP"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""AMI"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Chemical/Drug""}]"	train
Interestingly, all the drugs, such as, AAP, AMI and DOX induced apoptotic death in addition to necrosis in the respective organs which was very effectively blocked by GSPE.	AAP,39,42,Chemical/Drug	AMI,44,47,Chemical/Drug	DOX,52,55,Chemical/Drug	GSPE,167,171,Chemical/Drug	"[{""token"": ""AAP"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""AMI"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""GSPE"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Chemical/Drug""}]"	train
Since AAP, AMI and DOX undergo biotransformation and are known to produce damaging radicals in vivo, the protection by GSPE may be linked to both inhibition of metabolism and / or detoxification of cytotoxic radicals.	AAP,6,9,Chemical/Drug	AMI,11,14,Chemical/Drug	DOX,19,22,Chemical/Drug	GSPE,119,123,Chemical/Drug	"[{""token"": ""AAP"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""AMI"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""GSPE"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Chemical/Drug""}]"	train
In behavioral studies, pre - treatment of mice with BD1018, BD1063, or LR132 significantly attenuated cocaine - induced convulsions and lethality.	BD1018,52,58,Chemical/Drug	BD1063,60,66,Chemical/Drug	LR132,71,76,Chemical/Drug	cocaine,102,109,Chemical/Drug	"[{""token"": ""BD1018"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""BD1063"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""LR132"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Chemical/Drug""}]"	train
In contrast to the protection provided by the putative antagonists, the well - characterized sigma receptor agonist di - o - tolylguanidine ( DTG) and the novel sigma receptor agonist BD1031 ( 3R - 1 - [ 2 - ( 3, 4 - dichlorophenyl) ethyl] - 1, 4 - diazabicyclo [ 4. 3. 0] nonane) each worsened the behavioral toxicity of cocaine.	di - o - tolylguanidine,116,139,Chemical/Drug	DTG,142,145,Chemical/Drug	BD1031,184,190,Chemical/Drug	cocaine,322,329,Chemical/Drug	"[{""token"": ""di - o - tolylguanidine"", ""start_span"": 116, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""DTG"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""BD1031"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 322, ""end_span"": 329, ""type"": ""Chemical/Drug""}]"	train
At doses where alone, they produced no significant effects on locomotion, BD1018, BD1063 and LR132 significantly attenuated the locomotor stimulatory effects of cocaine.	BD1018,74,80,Chemical/Drug	BD1063,82,88,Chemical/Drug	LR132,93,98,Chemical/Drug	cocaine,161,168,Chemical/Drug	"[{""token"": ""BD1018"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""BD1063"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""LR132"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Chemical/Drug""}]"	train
The underlying mechanism of withdrawal - emergent RS in the present case may have been related to the pharmacological profile of risperidone, a serotonin - dopamine antagonist, suggesting the pathophysiologic influence of the serotonin system in the development of RS.	risperidone,129,140,Chemical/Drug	serotonin,144,153,Chemical/Drug	dopamine,156,164,Chemical/Drug	serotonin,226,235,Chemical/Drug	"[{""token"": ""risperidone"", ""start_span"": 129, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 144, ""end_span"": 153, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 156, ""end_span"": 164, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 226, ""end_span"": 235, ""type"": ""Chemical/Drug""}]"	train
Pharmacokinetic / pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog.	E4031,63,68,Chemical/Drug	cisapride,70,79,Chemical/Drug	terfenadine,81,92,Chemical/Drug	terodiline,97,107,Chemical/Drug	"[{""token"": ""E4031"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""terfenadine"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""terodiline"", ""start_span"": 97, ""end_span"": 107, ""type"": ""Chemical/Drug""}]"	train
Four compounds known to increase QT interval and cause TDP were investigated: terfenadine, terodiline, cisapride and E4031.	terfenadine,78,89,Chemical/Drug	terodiline,91,101,Chemical/Drug	cisapride,103,112,Chemical/Drug	E4031,117,122,Chemical/Drug	"[{""token"": ""terfenadine"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""terodiline"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""E4031"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Chemical/Drug""}]"	train
These data indicate that the free ED50 in plasma for terfenadine ( 1. 9 nM), terodiline ( 76 nM), cisapride ( 11 nM) and E4031 ( 1. 9 nM) closely correlate with the free concentration in man causing QT effects.	terfenadine,53,64,Chemical/Drug	terodiline,77,87,Chemical/Drug	cisapride,98,107,Chemical/Drug	E4031,121,126,Chemical/Drug	"[{""token"": ""terfenadine"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""terodiline"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""E4031"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Chemical/Drug""}]"	train
Forty - nine percent of patients were pain free 2 h after rizatriptan, compared with 24. 3% treated with ergotamine / caffeine ( p < or = 0. 001), rizatriptan being superior within 1 h of treatment.	rizatriptan,58,69,Chemical/Drug	ergotamine,105,115,Chemical/Drug	caffeine,118,126,Chemical/Drug	rizatriptan,147,158,Chemical/Drug	"[{""token"": ""rizatriptan"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""ergotamine"", ""start_span"": 105, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""caffeine"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""rizatriptan"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Chemical/Drug""}]"	train
CONCLUSION: This rat study demonstrated a synergistic nephrotoxic effect of CsA plus SRL, whereas FK506 plus SRL was better tolerated.	CsA,76,79,Chemical/Drug	SRL,85,88,Chemical/Drug	FK506,98,103,Chemical/Drug	SRL,109,112,Chemical/Drug	"[{""token"": ""CsA"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""FK506"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Chemical/Drug""}]"	train
BACKGROUND: Cyproterone acetate combined with ethinyl estradiol ( CPA / EE) is licensed in the UK for the treatment of women with acne and hirsutism and is also a treatment option for polycystic ovary syndrome ( PCOS).	Cyproterone acetate,12,31,Chemical/Drug	ethinyl estradiol,46,63,Chemical/Drug	CPA,66,69,Chemical/Drug	EE,72,74,Chemical/Drug	"[{""token"": ""Cyproterone acetate"", ""start_span"": 12, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""ethinyl estradiol"", ""start_span"": 46, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""CPA"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""EE"", ""start_span"": 72, ""end_span"": 74, ""type"": ""Chemical/Drug""}]"	train
Rats were treated with the vehicle ( 2 mL / kg of distilled water and 5% w / v cellulose, 10 days), gum Arabic ( 2 mL / kg of a 10% w / v aqueous suspension of gum Arabic powder, orally for 10 days), or gum Arabic concomitantly with GM ( 80mg / kg / day intramuscularly, during the last six days of the treatment period).	gum Arabic,100,110,Chemical/Drug	gum Arabic,160,170,Chemical/Drug	gum Arabic,203,213,Chemical/Drug	GM,233,235,Chemical/Drug	"[{""token"": ""gum Arabic"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Chemical/Drug""}, {""token"": ""gum Arabic"", ""start_span"": 160, ""end_span"": 170, ""type"": ""Chemical/Drug""}, {""token"": ""gum Arabic"", ""start_span"": 203, ""end_span"": 213, ""type"": ""Chemical/Drug""}, {""token"": ""GM"", ""start_span"": 233, ""end_span"": 235, ""type"": ""Chemical/Drug""}]"	train
Nephrotoxicity was assessed by measuring the concentrations of creatinine and urea in the plasma and reduced glutathione ( GSH) in the kidney cortex, and by light microscopic examination of kidney sections.	creatinine,63,73,Chemical/Drug	urea,78,82,Chemical/Drug	glutathione,109,120,Chemical/Drug	GSH,123,126,Chemical/Drug	"[{""token"": ""creatinine"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""glutathione"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Chemical/Drug""}, {""token"": ""GSH"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Chemical/Drug""}]"	train
Sub - chronic low dose gamma - vinyl GABA ( vigabatrin) inhibits cocaine - induced increases in nucleus accumbens dopamine.	gamma - vinyl GABA,23,41,Chemical/Drug	vigabatrin,44,54,Chemical/Drug	cocaine,65,72,Chemical/Drug	dopamine,114,122,Chemical/Drug	"[{""token"": ""gamma - vinyl GABA"", ""start_span"": 23, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""vigabatrin"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Chemical/Drug""}]"	train
OBJECTIVES: Given its preclinical success for treating substance abuse and the increased risk of visual field defects ( VFD) associated with cumulative lifetime exposure, we explored the effects of sub - chronic low dose GVG on cocaine - induced increases in nucleus accumbens ( NAcc) dopamine ( DA).	GVG,221,224,Chemical/Drug	cocaine,228,235,Chemical/Drug	dopamine,285,293,Chemical/Drug	DA,296,298,Chemical/Drug	"[{""token"": ""GVG"", ""start_span"": 221, ""end_span"": 224, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 285, ""end_span"": 293, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 296, ""end_span"": 298, ""type"": ""Chemical/Drug""}]"	train
When comparing all lithium treated versus non - lithium - treated groups, lithium caused a reduction in glomerular filtration rate ( GFR) without significant changes in effective renal plasma flow ( as determined by a marker secreted into the proximal tubules) or lithium clearance.	lithium,19,26,Chemical/Drug	lithium,48,55,Chemical/Drug	lithium,74,81,Chemical/Drug	lithium,264,271,Chemical/Drug	"[{""token"": ""lithium"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 264, ""end_span"": 271, ""type"": ""Chemical/Drug""}]"	train
Protection against amphetamine - induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist.	amphetamine,19,30,Chemical/Drug	dopamine,71,79,Chemical/Drug	LY274614,102,110,Chemical/Drug	amino acid,126,136,Chemical/Drug	"[{""token"": ""amphetamine"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""LY274614"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Chemical/Drug""}, {""token"": ""amino acid"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Chemical/Drug""}]"	train
LY274614, 3SR, 4aRS, 6SR, 8aRS - 6 - [ phosphonomethyl] decahydr oisoquinoline - 3 - carboxylic acid, has been described as a potent antagonist of the N - methyl - D - aspartate ( NMDA) subtype of glutamate receptor.	LY274614,0,8,Chemical/Drug	N - methyl - D - aspartate,151,177,Chemical/Drug	NMDA,180,184,Chemical/Drug	glutamate,197,206,Chemical/Drug	"[{""token"": ""LY274614"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""N - methyl - D - aspartate"", ""start_span"": 151, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Chemical/Drug""}]"	train
A 10 mg / kg dose of LY274614 was effective in antagonizing the depletion of dopamine in the striatum, when given as long as 8 hr prior to amphetamine but not when given 24 hr prior to amphetamine.	LY274614,21,29,Chemical/Drug	dopamine,77,85,Chemical/Drug	amphetamine,139,150,Chemical/Drug	amphetamine,185,196,Chemical/Drug	"[{""token"": ""LY274614"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 185, ""end_span"": 196, ""type"": ""Chemical/Drug""}]"	train
NO - induced migraine attack: strong increase in plasma calcitonin gene - related peptide ( CGRP) concentration and negative correlation with platelet serotonin release.	NO,0,2,Chemical/Drug	calcitonin gene - related peptide,56,89,Chemical/Drug	CGRP,92,96,Chemical/Drug	serotonin,151,160,Chemical/Drug	"[{""token"": ""NO"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Chemical/Drug""}, {""token"": ""calcitonin gene - related peptide"", ""start_span"": 56, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""CGRP"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Chemical/Drug""}]"	train
Tincture of Crataegus ( TCR), an alcoholic extract of the berries of hawthorn ( Crataegus oxycantha), is used in herbal and homeopathic medicine.	Tincture of Crataegus,0,21,Chemical/Drug	TCR,24,27,Chemical/Drug	alcoholic extract of the berries of hawthorn,33,77,Chemical/Drug	Crataegus oxycantha,80,99,Chemical/Drug	"[{""token"": ""Tincture of Crataegus"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""TCR"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""alcoholic extract of the berries of hawthorn"", ""start_span"": 33, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""Crataegus oxycantha"", ""start_span"": 80, ""end_span"": 99, ""type"": ""Chemical/Drug""}]"	train
TCR prevented the isoproterenol - induced decrease in antioxidant enzymes in the heart and increased the rate of ADP - stimulated oxygen uptake and respiratory coupling ratio.	TCR,0,3,Chemical/Drug	isoproterenol,18,31,Chemical/Drug	ADP,113,116,Chemical/Drug	oxygen,130,136,Chemical/Drug	"[{""token"": ""TCR"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical/Drug""}, {""token"": ""isoproterenol"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""ADP"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""oxygen"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Chemical/Drug""}]"	train
The rise in blood pressure became less marked when higher concentrations of sevoflurane or enflurane were administered and the blood pressure at convulsions decreased significantly in 1. 6% sevoflurane, and in 0. 8% and 1. 6% enflurane.	sevoflurane,76,87,Chemical/Drug	enflurane,91,100,Chemical/Drug	sevoflurane,190,201,Chemical/Drug	enflurane,226,235,Chemical/Drug	"[{""token"": ""sevoflurane"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""enflurane"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""sevoflurane"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Chemical/Drug""}, {""token"": ""enflurane"", ""start_span"": 226, ""end_span"": 235, ""type"": ""Chemical/Drug""}]"	train
Apamin, a selective blocker of calcium - dependent potassium channels, was administered intracerebroventricularly in rats anesthetized with 0. 8% sevoflurane to investigate the mechanism of the anticonvulsive effects.	Apamin,0,6,Chemical/Drug	calcium,31,38,Chemical/Drug	potassium,51,60,Chemical/Drug	sevoflurane,146,157,Chemical/Drug	"[{""token"": ""Apamin"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""sevoflurane"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Chemical/Drug""}]"	train
Both, Ro4368554 ( 3 and 10 mg / kg, intraperitoneally ( i. p.)) and metrifonate ( 10 mg / kg, p. o., respectively) reversed memory deficits induced by scopolamine and TRP depletion ( 10 mg / kg, i. p., and 3 mg / kg, p. o., respectively).	Ro4368554,6,15,Chemical/Drug	metrifonate,68,79,Chemical/Drug	scopolamine,151,162,Chemical/Drug	TRP,167,170,Chemical/Drug	"[{""token"": ""Ro4368554"", ""start_span"": 6, ""end_span"": 15, ""type"": ""Chemical/Drug""}, {""token"": ""metrifonate"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Chemical/Drug""}, {""token"": ""TRP"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Chemical/Drug""}]"	train
The effect of a 6 - week treatment with the calcium channel blocker nitrendipine or the angiotensin converting enzyme inhibitor enalapril on blood pressure, albuminuria, renal hemodynamics, and morphology of the nonclipped kidney was studied in rats with two - kidney, one clip renovascular hypertension.	calcium,44,51,Chemical/Drug	nitrendipine,68,80,Chemical/Drug	angiotensin,88,99,Chemical/Drug	enalapril,128,137,Chemical/Drug	"[{""token"": ""calcium"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""nitrendipine"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""angiotensin"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""enalapril"", ""start_span"": 128, ""end_span"": 137, ""type"": ""Chemical/Drug""}]"	train
Initial cardiopulmonary resuscitation and immediate treatment with adrenaline ( epinephrine), atropine and furosemide was successful.	adrenaline,67,77,Chemical/Drug	epinephrine,80,91,Chemical/Drug	atropine,94,102,Chemical/Drug	furosemide,107,117,Chemical/Drug	"[{""token"": ""adrenaline"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""atropine"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""furosemide"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Chemical/Drug""}]"	train
THP exhibited an antipsychotic - like profile by potentiating haloperidol - induced catalepsy, reducing amphetamine - induced hyperactivity and reducing apomorphine - induced climbing in mice.	THP,0,3,Chemical/Drug	haloperidol,62,73,Chemical/Drug	amphetamine,104,115,Chemical/Drug	apomorphine,153,164,Chemical/Drug	"[{""token"": ""THP"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 104, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""apomorphine"", ""start_span"": 153, ""end_span"": 164, ""type"": ""Chemical/Drug""}]"	train
Atorvastatin ( Ato) possesses pleiotropic properties that have been reported to improve endothelial function through increased availability of NO and reduced O2 - production in various forms of hypertension.	Atorvastatin,0,12,Chemical/Drug	Ato,15,18,Chemical/Drug	NO,143,145,Chemical/Drug	O2 -,158,162,Chemical/Drug	"[{""token"": ""Atorvastatin"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""Ato"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 143, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""O2 -"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	train
Aortic superoxide production was lower in the Dex + Ato group compared with the group treated with Dex alone ( P < 0. 0001).	superoxide,7,17,Chemical/Drug	Dex,46,49,Chemical/Drug	Ato,52,55,Chemical/Drug	Dex,99,102,Chemical/Drug	"[{""token"": ""superoxide"", ""start_span"": 7, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""Dex"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""Ato"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""Dex"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Chemical/Drug""}]"	train
Although these adverse effects occur in some patients, their occurrence could be minimised by knowledge of the molecular effects of sirolimus on the kidney, the use of sirolimus in appropriate patient populations, close monitoring of proteinuria and renal function, use of angiotensin - converting enzyme inhibitors or angiotensin II receptor blockers if proteinuria occurs and withdrawal if needed.	sirolimus,132,141,Chemical/Drug	sirolimus,168,177,Chemical/Drug	angiotensin,273,284,Chemical/Drug	angiotensin II,319,333,Chemical/Drug	"[{""token"": ""sirolimus"", ""start_span"": 132, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""sirolimus"", ""start_span"": 168, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""angiotensin"", ""start_span"": 273, ""end_span"": 284, ""type"": ""Chemical/Drug""}, {""token"": ""angiotensin II"", ""start_span"": 319, ""end_span"": 333, ""type"": ""Chemical/Drug""}]"	train
While contractions to carbachol and ATP were the same in inflamed and in control strips when related to a reference potassium response, isoprenaline - induced relaxations were smaller in inflamed strips.	carbachol,22,31,Chemical/Drug	ATP,36,39,Chemical/Drug	potassium,116,125,Chemical/Drug	isoprenaline,136,148,Chemical/Drug	"[{""token"": ""carbachol"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""isoprenaline"", ""start_span"": 136, ""end_span"": 148, ""type"": ""Chemical/Drug""}]"	train
As penicillin derivatives and amoxicillin alone are known to induce such types of lesions, the amoxicillin component, with or without a potentiating effect of clavulanic acid, might have a major role.	penicillin,3,13,Chemical/Drug	amoxicillin,30,41,Chemical/Drug	amoxicillin,95,106,Chemical/Drug	clavulanic acid,159,174,Chemical/Drug	"[{""token"": ""penicillin"", ""start_span"": 3, ""end_span"": 13, ""type"": ""Chemical/Drug""}, {""token"": ""amoxicillin"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""amoxicillin"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""clavulanic acid"", ""start_span"": 159, ""end_span"": 174, ""type"": ""Chemical/Drug""}]"	train
BACKGROUND: No direct comparisons exist of the renal tolerability of the low - osmolality contrast medium iopamidol with that of the iso - osmolality contrast medium iodixanol in high - risk patients.	contrast medium,90,105,Chemical/Drug	iopamidol,106,115,Chemical/Drug	contrast medium,150,165,Chemical/Drug	iodixanol,166,175,Chemical/Drug	"[{""token"": ""contrast medium"", ""start_span"": 90, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""iopamidol"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""contrast medium"", ""start_span"": 150, ""end_span"": 165, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 166, ""end_span"": 175, ""type"": ""Chemical/Drug""}]"	train
As the most potent dose ( 1 mg / kg) of lipopolysaccharide was administered two weeks, one day before or after the methamphetamine dosing regimen, methamphetamine - induced striatal dopamine and 3, 4 - dihydroxyphenylacetic acid depletions remained unaltered.	lipopolysaccharide,40,58,Chemical/Drug	methamphetamine,115,130,Chemical/Drug	methamphetamine,147,162,Chemical/Drug	dopamine,182,190,Chemical/Drug	"[{""token"": ""lipopolysaccharide"", ""start_span"": 40, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 147, ""end_span"": 162, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Chemical/Drug""}]"	train
While small prospective studies have not revealed any significant drug - drug interaction between warfarin and levofloxacin, several case reports have indicated that levofloxacin may significantly potentiate the anticoagulation effect of warfarin.	warfarin,98,106,Chemical/Drug	levofloxacin,111,123,Chemical/Drug	levofloxacin,166,178,Chemical/Drug	warfarin,238,246,Chemical/Drug	"[{""token"": ""warfarin"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""levofloxacin"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""levofloxacin"", ""start_span"": 166, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""warfarin"", ""start_span"": 238, ""end_span"": 246, ""type"": ""Chemical/Drug""}]"	train
Serum samples were PCR amplified with HBV reverse transcriptase ( RT) primers, followed by direct sequencing across the tyrosine - methionine - aspartate - aspartate ( YMDD) motif of the major catalytic region in the C domain of the HBV RT enzyme.	tyrosine,120,128,Chemical/Drug	methionine,131,141,Chemical/Drug	aspartate,144,153,Chemical/Drug	aspartate,156,165,Chemical/Drug	"[{""token"": ""tyrosine"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""methionine"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 144, ""end_span"": 153, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 156, ""end_span"": 165, ""type"": ""Chemical/Drug""}]"	train
Briefly, cells were differentiated for 72 h with 100 nM PMA to obtain a macrophage - like phenotype in the presence or absence of 1 nM 17beta - estradiol ( E2), 100 nM progesterone or vehicle ( 0. 01% ethanol).	17beta - estradiol,135,153,Chemical/Drug	E2,156,158,Chemical/Drug	progesterone,168,180,Chemical/Drug	ethanol,201,208,Chemical/Drug	"[{""token"": ""17beta - estradiol"", ""start_span"": 135, ""end_span"": 153, ""type"": ""Chemical/Drug""}, {""token"": ""E2"", ""start_span"": 156, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""progesterone"", ""start_span"": 168, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""ethanol"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Chemical/Drug""}]"	train
Admission laboratory tests were as follows: alanine aminotransferase, 67 U / L ( reference range, 10 - 37 U / L); aspartate aminotransferase, 98 U / L ( 10 - 40 U / L); alkaline phosphatase, 513 U / L ( 0 - 270 U / L); gamma - glutamyltransferase, 32 U / L ( 7 - 49 U / L); amylase, 46 U / L ( 0 - 220 U / L); total bilirubin, 20. 1 mg / dL ( 0. 2 - 1. 0 mg / dL); direct bilirubin, 14. 8 mg / dL ( 0 - 0. 3 mg / dL); and albumin, 4. 7 mg / dL ( 3. 5 - 5. 4 mg / dL).	alanine,44,51,Chemical/Drug	aspartate,114,123,Chemical/Drug	bilirubin,316,325,Chemical/Drug	bilirubin,372,381,Chemical/Drug	"[{""token"": ""alanine"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""bilirubin"", ""start_span"": 316, ""end_span"": 325, ""type"": ""Chemical/Drug""}, {""token"": ""bilirubin"", ""start_span"": 372, ""end_span"": 381, ""type"": ""Chemical/Drug""}]"	train
METHODS: In this study, we evaluated the performance of dopamine beta - hydroxylase knockout ( Dbh - / -) mice, which lack norepinephrine ( NE), in the elevated plus maze ( EPM) to examine the contribution of noradrenergic signaling to cocaine - induced anxiety.	dopamine,56,64,Chemical/Drug	norepinephrine,123,137,Chemical/Drug	NE,140,142,Chemical/Drug	cocaine,236,243,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""norepinephrine"", ""start_span"": 123, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""NE"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Chemical/Drug""}]"	train
In experiments using specific adrenergic antagonists, we found that pretreatment with the beta - adrenergic receptor antagonist propranolol blocked cocaine - induced anxiety - like behavior in Dbh + / - and wild - type C57BL6 / J mice, while the alpha ( 1) antagonist prazosin and the alpha ( 2) antagonist yohimbine had no effect.	propranolol,128,139,Chemical/Drug	cocaine,148,155,Chemical/Drug	prazosin,268,276,Chemical/Drug	yohimbine,307,316,Chemical/Drug	"[{""token"": ""propranolol"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""prazosin"", ""start_span"": 268, ""end_span"": 276, ""type"": ""Chemical/Drug""}, {""token"": ""yohimbine"", ""start_span"": 307, ""end_span"": 316, ""type"": ""Chemical/Drug""}]"	train
METHOD: In a 16 - week multicenter, double - blind trial, 122 children with ADHD were randomly assigned to clonidine ( n = 31), methylphenidate ( n = 29), clonidine and methylphenidate ( n = 32), or placebo ( n = 30).	clonidine,107,116,Chemical/Drug	methylphenidate,128,143,Chemical/Drug	clonidine,155,164,Chemical/Drug	methylphenidate,169,184,Chemical/Drug	"[{""token"": ""clonidine"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""methylphenidate"", ""start_span"": 128, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""clonidine"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Chemical/Drug""}, {""token"": ""methylphenidate"", ""start_span"": 169, ""end_span"": 184, ""type"": ""Chemical/Drug""}]"	train
In addition, the role of dopamine receptors in mediating nicotine - induced locomotor stimulation was investigated by examining the effects of selective D1 and D2 dopamine receptor antagonists on activity induced by nicotine.	dopamine,25,33,Chemical/Drug	nicotine,57,65,Chemical/Drug	dopamine,163,171,Chemical/Drug	nicotine,216,224,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 216, ""end_span"": 224, ""type"": ""Chemical/Drug""}]"	train
Nicotine - induced hyperactivity was blocked by the selective D1 antagonist SCH 23390, the selective D2 antagonist raclopride and the D1 / D2 antagonist fluphenazine.	Nicotine,0,8,Chemical/Drug	SCH 23390,76,85,Chemical/Drug	raclopride,115,125,Chemical/Drug	fluphenazine,153,165,Chemical/Drug	"[{""token"": ""Nicotine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""SCH 23390"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""raclopride"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""fluphenazine"", ""start_span"": 153, ""end_span"": 165, ""type"": ""Chemical/Drug""}]"	train
Methamphetamine ( METH) damages dopamine ( DA) nerve endings by a process that has been linked to microglial activation but the signaling pathways that mediate this response have not yet been delineated.	Methamphetamine,0,15,Chemical/Drug	METH,18,22,Chemical/Drug	dopamine,32,40,Chemical/Drug	DA,43,45,Chemical/Drug	"[{""token"": ""Methamphetamine"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Chemical/Drug""}, {""token"": ""METH"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Chemical/Drug""}]"	train
Because the CNS damage caused by METH and MPTP is highly selective for the DA neuronal system in mouse models of neurotoxicity, we hypothesized that the CX3CR1 plays a role in METH - induced neurotoxicity and microglial activation.	METH,33,37,Chemical/Drug	MPTP,42,46,Chemical/Drug	DA,75,77,Chemical/Drug	METH,176,180,Chemical/Drug	"[{""token"": ""METH"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""MPTP"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 75, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""METH"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Chemical/Drug""}]"	train
VPU was more potent than VPA, exhibiting the median effective dose ( ED ( 50)) of 49 mg / kg in protecting rats against pilocarpine - induced seizure whereas the corresponding value for VPA was 322 mg / kg.	VPU,0,3,Chemical/Drug	VPA,25,28,Chemical/Drug	pilocarpine,120,131,Chemical/Drug	VPA,186,189,Chemical/Drug	"[{""token"": ""VPU"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical/Drug""}, {""token"": ""VPA"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""VPA"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Chemical/Drug""}]"	train
In addition, a statistically significant reduction was also observed on the level of GABA and glycine but less than a drastic reduction of glutamate and aspartate level.	GABA,85,89,Chemical/Drug	glycine,94,101,Chemical/Drug	glutamate,139,148,Chemical/Drug	aspartate,153,162,Chemical/Drug	"[{""token"": ""GABA"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""glycine"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 139, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 153, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	train
RESULTS: Omission of fentanyl did not reduce the overall incidence of postoperative nausea and vomiting, but did reduce the incidence of vomiting and / or moderate to severe nausea prior to discharge from 20% and 17% with fentanyl and fentanyl - dexamethasone, respectively, to 5% ( P = 0. 013).	fentanyl,21,29,Chemical/Drug	fentanyl,222,230,Chemical/Drug	fentanyl,235,243,Chemical/Drug	dexamethasone,246,259,Chemical/Drug	"[{""token"": ""fentanyl"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""fentanyl"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Chemical/Drug""}, {""token"": ""fentanyl"", ""start_span"": 235, ""end_span"": 243, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 246, ""end_span"": 259, ""type"": ""Chemical/Drug""}]"	train
Ezetimibe undergoes extensive glucuronidation by uridine diphosphate glucoronosyltransferases ( UGT) in the intestine and liver and may have inhibited the glucuronidation of simvastatin hydroxy acid, resulting in increased simvastatin exposure and subsequent hepatotoxicity.	Ezetimibe,0,9,Chemical/Drug	uridine diphosphate,49,68,Chemical/Drug	simvastatin hydroxy acid,174,198,Chemical/Drug	simvastatin,223,234,Chemical/Drug	"[{""token"": ""Ezetimibe"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""uridine diphosphate"", ""start_span"": 49, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""simvastatin hydroxy acid"", ""start_span"": 174, ""end_span"": 198, ""type"": ""Chemical/Drug""}, {""token"": ""simvastatin"", ""start_span"": 223, ""end_span"": 234, ""type"": ""Chemical/Drug""}]"	train
The present study was aimed to investigate the combined effects of green tea and vitamin E on heart weight, body weight, serum marker enzymes, lipid peroxidation, endogenous antioxidants and membrane bound ATPases in isoproterenol ( ISO) - induced myocardial infarction in rats.	green tea,67,76,Chemical/Drug	vitamin E,81,90,Chemical/Drug	isoproterenol,217,230,Chemical/Drug	ISO,233,236,Chemical/Drug	"[{""token"": ""green tea"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin E"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""isoproterenol"", ""start_span"": 217, ""end_span"": 230, ""type"": ""Chemical/Drug""}, {""token"": ""ISO"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Chemical/Drug""}]"	train
Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model.	Bradykinin,0,10,Chemical/Drug	nitric oxide,37,49,Chemical/Drug	vincristine,73,84,Chemical/Drug	streptozotocin,89,103,Chemical/Drug	"[{""token"": ""Bradykinin"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""nitric oxide"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""vincristine"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""streptozotocin"", ""start_span"": 89, ""end_span"": 103, ""type"": ""Chemical/Drug""}]"	train
It was also shown that both products of inducible NO synthase and neuronal NO synthase activation as well as bradykinin are involved in hyperalgesia produced by vincristine.	NO,50,52,Chemical/Drug	NO,75,77,Chemical/Drug	bradykinin,109,119,Chemical/Drug	vincristine,161,172,Chemical/Drug	"[{""token"": ""NO"", ""start_span"": 50, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 75, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""bradykinin"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""vincristine"", ""start_span"": 161, ""end_span"": 172, ""type"": ""Chemical/Drug""}]"	train
To address the potential confounding effects of the cannabis use of the ecstasy using group, a second analysis included 14 previously tested cannabis users ( Nestor, L., Roberts, G., Garavan, H., Hester, R., 2008. Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users. Neuroimage 40, 1328 - 1339).	cannabis,52,60,Chemical/Drug	ecstasy,72,79,Chemical/Drug	cannabis,141,149,Chemical/Drug	cannabis,312,320,Chemical/Drug	"[{""token"": ""cannabis"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""ecstasy"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""cannabis"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""cannabis"", ""start_span"": 312, ""end_span"": 320, ""type"": ""Chemical/Drug""}]"	train
However, the observation that antagonists of the glutamate N - methyl - D - aspartate ( NMDA) receptor produce schizophrenic - like symptoms in humans has led to the idea of a dysfunctioning of the glutamatergic system via its NMDA receptor.	glutamate,49,58,Chemical/Drug	N - methyl - D - aspartate,59,85,Chemical/Drug	NMDA,88,92,Chemical/Drug	NMDA,227,231,Chemical/Drug	"[{""token"": ""glutamate"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""N - methyl - D - aspartate"", ""start_span"": 59, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Chemical/Drug""}]"	train
This study aimed at investigating the potential antipsychotic - like properties of SSR103800, with a particular focus on models of hyperactivity, involving either drug challenge ( ie, amphetamine and MK - 801) or transgenic mice ( ie, NMDA Nr1 ( neo - / -) and DAT ( - / -)).	SSR103800,83,92,Chemical/Drug	amphetamine,184,195,Chemical/Drug	MK - 801,200,208,Chemical/Drug	NMDA,235,239,Chemical/Drug	"[{""token"": ""SSR103800"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Chemical/Drug""}, {""token"": ""MK - 801"", ""start_span"": 200, ""end_span"": 208, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Chemical/Drug""}]"	train
Results showed that SSR103800 ( 10 - 30 mg / kg p. o.) blocked hyperactivity induced by the non - competitive NMDA receptor antagonist, MK - 801 and partially reversed spontaneous hyperactivity of NMDA Nr1 ( neo - / -) mice.	SSR103800,20,29,Chemical/Drug	NMDA,110,114,Chemical/Drug	MK - 801,136,144,Chemical/Drug	NMDA,197,201,Chemical/Drug	"[{""token"": ""SSR103800"", ""start_span"": 20, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""MK - 801"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Chemical/Drug""}]"	train
Importantly, both classical ( haloperidol) and atypical ( olanzapine, clozapine and aripiprazole) antipsychotics were effective in all these models of hyperactivity.	haloperidol,30,41,Chemical/Drug	olanzapine,58,68,Chemical/Drug	clozapine,70,79,Chemical/Drug	aripiprazole,84,96,Chemical/Drug	"[{""token"": ""haloperidol"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""olanzapine"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""clozapine"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""aripiprazole"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Chemical/Drug""}]"	train
Other antibacterial agents that showed associations included erythromycins ( 2 defects), penicillins ( 1 defect), cephalosporins ( 1 defect), and quinolones ( 1 defect).	erythromycins,61,74,Chemical/Drug	penicillins,89,100,Chemical/Drug	cephalosporins,114,128,Chemical/Drug	quinolones,146,156,Chemical/Drug	"[{""token"": ""erythromycins"", ""start_span"": 61, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""penicillins"", ""start_span"": 89, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""cephalosporins"", ""start_span"": 114, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""quinolones"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Chemical/Drug""}]"	train
In all clones with combined immune escape and LAM resistance mutations, the nucleotide analogues adefovir and tenofovir remained effective in suppressing viral replication in vitro.	LAM,46,49,Chemical/Drug	nucleotide,76,86,Chemical/Drug	adefovir,97,105,Chemical/Drug	tenofovir,110,119,Chemical/Drug	"[{""token"": ""LAM"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""nucleotide"", ""start_span"": 76, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""adefovir"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""tenofovir"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Chemical/Drug""}]"	train
METHODS: Following induction of anesthesia by fentanyl ( 0. 15 mg kg ( - 1)) and propofol ( 2. 0 mg kg ( - 1)), 13 patients received phenylephrine ( 0. 1 mg iv) and 12 patients received ephedrine ( 10 mg iv) to restore mean arterial pressure ( MAP).	fentanyl,46,54,Chemical/Drug	propofol,81,89,Chemical/Drug	phenylephrine,133,146,Chemical/Drug	ephedrine,186,195,Chemical/Drug	"[{""token"": ""fentanyl"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""propofol"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""phenylephrine"", ""start_span"": 133, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""ephedrine"", ""start_span"": 186, ""end_span"": 195, ""type"": ""Chemical/Drug""}]"	train
OBJECTIVE: To determine the safety and efficacy of adjunctive bupropion sustained - release ( SR) on male sexual dysfunction ( SD) induced by a selective serotonin reuptake inhibitor ( SSRI), as SD is a common side - effect of SSRIs and the most effective treatments have yet to be determined.	bupropion,62,71,Chemical/Drug	selective serotonin reuptake inhibitor,144,182,Chemical/Drug	SSRI,185,189,Chemical/Drug	SSRIs,227,232,Chemical/Drug	"[{""token"": ""bupropion"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""selective serotonin reuptake inhibitor"", ""start_span"": 144, ""end_span"": 182, ""type"": ""Chemical/Drug""}, {""token"": ""SSRI"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Chemical/Drug""}, {""token"": ""SSRIs"", ""start_span"": 227, ""end_span"": 232, ""type"": ""Chemical/Drug""}]"	train
OBJECTIVE: to analyze aspects of TEE safety associated to the use of Midazolan ( MZ) and Flumazenil ( FL) and the influence of the clinical variables on the event rate.	Midazolan,69,78,Chemical/Drug	MZ,81,83,Chemical/Drug	Flumazenil,89,99,Chemical/Drug	FL,102,104,Chemical/Drug	"[{""token"": ""Midazolan"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""MZ"", ""start_span"": 81, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""Flumazenil"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""FL"", ""start_span"": 102, ""end_span"": 104, ""type"": ""Chemical/Drug""}]"	train
With last observations carried forward ( LOCF), mean Positive and Negative Syndrome Scale total score reductions from baseline to endpoint were significantly greater with asenapine at 5 mg BID ( - 16. 2) and haloperidol ( - 15. 4) than placebo ( - 10. 7; both P < 0. 05); using mixed model for repeated measures ( MMRM), changes at day 42 were significantly greater with asenapine at 5 and 10 mg BID ( - 21. 3 and - 19. 4, respectively) and haloperidol ( - 20. 0) than placebo ( - 14. 6; all P < 0. 05).	asenapine,171,180,Chemical/Drug	haloperidol,208,219,Chemical/Drug	asenapine,371,380,Chemical/Drug	haloperidol,441,452,Chemical/Drug	"[{""token"": ""asenapine"", ""start_span"": 171, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 208, ""end_span"": 219, ""type"": ""Chemical/Drug""}, {""token"": ""asenapine"", ""start_span"": 371, ""end_span"": 380, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 441, ""end_span"": 452, ""type"": ""Chemical/Drug""}]"	train
At the end of study period, serum phenobarbitone and carbamazepine, whole brain malondialdehyde and reduced glutathione levels were estimated.	phenobarbitone,34,48,Chemical/Drug	carbamazepine,53,66,Chemical/Drug	malondialdehyde,80,95,Chemical/Drug	glutathione,108,119,Chemical/Drug	"[{""token"": ""phenobarbitone"", ""start_span"": 34, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""carbamazepine"", ""start_span"": 53, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""malondialdehyde"", ""start_span"": 80, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""glutathione"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Chemical/Drug""}]"	train
Similarly, pre - test scopolamine partially reversed the scopolamine - induced amnesia, but not significantly; and pre - test cycloheximide failed to reverse the cycloheximide - induced amnesia.	scopolamine,22,33,Chemical/Drug	scopolamine,57,68,Chemical/Drug	cycloheximide,126,139,Chemical/Drug	cycloheximide,162,175,Chemical/Drug	"[{""token"": ""scopolamine"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""cycloheximide"", ""start_span"": 126, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""cycloheximide"", ""start_span"": 162, ""end_span"": 175, ""type"": ""Chemical/Drug""}]"	train
As naloxone and clonidine do not appear to interact with the same receptor site, the observed functional antagonism suggests the release of an endogenous opiate by clonidine or alpha - methyldopa and the possible role of the opiate in the central control of sympathetic tone.	naloxone,3,11,Chemical/Drug	clonidine,16,25,Chemical/Drug	clonidine,164,173,Chemical/Drug	alpha - methyldopa,177,195,Chemical/Drug	"[{""token"": ""naloxone"", ""start_span"": 3, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""clonidine"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""clonidine"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Chemical/Drug""}, {""token"": ""alpha - methyldopa"", ""start_span"": 177, ""end_span"": 195, ""type"": ""Chemical/Drug""}]"	train
In vitro, gamma - HCH, pentylenetetrazol and picrotoxin were shown to inhibit 3H - TBOB binding in mouse whole brain, with IC50 values of 4. 6, 404 and 9. 4 microM, respectively.	gamma - HCH,10,21,Chemical/Drug	pentylenetetrazol,23,40,Chemical/Drug	picrotoxin,45,55,Chemical/Drug	3H - TBOB,78,87,Chemical/Drug	"[{""token"": ""gamma - HCH"", ""start_span"": 10, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""pentylenetetrazol"", ""start_span"": 23, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""picrotoxin"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""3H - TBOB"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Chemical/Drug""}]"	train
The biochemical results of brain biogenic amines of BALB / C mouse strain suggest a probable decrease of catecholamine turnover rate and / or metabolism by monoamine oxidase and a resulting increase in O - methylation of norepinephrine which may account for a behavioral depression caused by amantadine in the BALB / C mice.	amines,42,48,Chemical/Drug	catecholamine,105,118,Chemical/Drug	norepinephrine,221,235,Chemical/Drug	amantadine,292,302,Chemical/Drug	"[{""token"": ""amines"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""catecholamine"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""norepinephrine"", ""start_span"": 221, ""end_span"": 235, ""type"": ""Chemical/Drug""}, {""token"": ""amantadine"", ""start_span"": 292, ""end_span"": 302, ""type"": ""Chemical/Drug""}]"	train
It is suggested that the effects of Captopril on the lungs may be attributable to a vasodilatory effect due to a reduction in the circulating level of Angiotension II and an increase in prostacyclin ( secondary to an increase in bradykinin).	Captopril,36,45,Chemical/Drug	Angiotension II,151,166,Chemical/Drug	prostacyclin,186,198,Chemical/Drug	bradykinin,229,239,Chemical/Drug	"[{""token"": ""Captopril"", ""start_span"": 36, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""Angiotension II"", ""start_span"": 151, ""end_span"": 166, ""type"": ""Chemical/Drug""}, {""token"": ""prostacyclin"", ""start_span"": 186, ""end_span"": 198, ""type"": ""Chemical/Drug""}, {""token"": ""bradykinin"", ""start_span"": 229, ""end_span"": 239, ""type"": ""Chemical/Drug""}]"	train
In conclusion, reductions in creatinine clearance and renal amphotericin B accumulation after chronic amphotericin B administration were enhanced by salt depletion and attenuated by sodium loading in rats.	creatinine,29,39,Chemical/Drug	amphotericin B,60,74,Chemical/Drug	amphotericin B,102,116,Chemical/Drug	sodium,182,188,Chemical/Drug	"[{""token"": ""creatinine"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""amphotericin B"", ""start_span"": 60, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""amphotericin B"", ""start_span"": 102, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""sodium"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Chemical/Drug""}]"	train
The cataleptogenic effect of THC was significantly reduced in rats treated with 6 - OHDA and in rats with lesions of the locus coeruleus but not in rats treated with desipramine and 6 - OHDA, as compared with control rats.	THC,29,32,Chemical/Drug	6 - OHDA,80,88,Chemical/Drug	desipramine,166,177,Chemical/Drug	6 - OHDA,182,190,Chemical/Drug	"[{""token"": ""THC"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Chemical/Drug""}]"	train
On the contrary, the cataleptogenic effect of haloperidol was significantly reduced in rats treated with desipramine and 6 - OHDA but not in rats treated with 6 - OHDA or in rats with lesions of the locus coeruleus.	haloperidol,46,57,Chemical/Drug	desipramine,105,116,Chemical/Drug	6 - OHDA,121,129,Chemical/Drug	6 - OHDA,159,167,Chemical/Drug	"[{""token"": ""haloperidol"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Chemical/Drug""}]"	train
Myopathy, associated in some cases with myoglobinuria, and in 2 cases with transient renal failure, has been rarely reported with lovastatin, especially in patients concomitantly treated with cyclosporin, gemfibrozil or niacin.	lovastatin,130,140,Chemical/Drug	cyclosporin,192,203,Chemical/Drug	gemfibrozil,205,216,Chemical/Drug	niacin,220,226,Chemical/Drug	"[{""token"": ""lovastatin"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""cyclosporin"", ""start_span"": 192, ""end_span"": 203, ""type"": ""Chemical/Drug""}, {""token"": ""gemfibrozil"", ""start_span"": 205, ""end_span"": 216, ""type"": ""Chemical/Drug""}, {""token"": ""niacin"", ""start_span"": 220, ""end_span"": 226, ""type"": ""Chemical/Drug""}]"	train
Use of verapamil in combination with carbamazepine should either be avoided or prescribed only with appropriate adjustment of the carbamazepine dose ( usually reduction of the carbamazepine dose by one half).	verapamil,7,16,Chemical/Drug	carbamazepine,37,50,Chemical/Drug	carbamazepine,130,143,Chemical/Drug	carbamazepine,176,189,Chemical/Drug	"[{""token"": ""verapamil"", ""start_span"": 7, ""end_span"": 16, ""type"": ""Chemical/Drug""}, {""token"": ""carbamazepine"", ""start_span"": 37, ""end_span"": 50, ""type"": ""Chemical/Drug""}, {""token"": ""carbamazepine"", ""start_span"": 130, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""carbamazepine"", ""start_span"": 176, ""end_span"": 189, ""type"": ""Chemical/Drug""}]"	train
Severe complications of antianginal drug therapy in a patient identified as a poor metabolizer of metoprolol, propafenone, diltiazem, and sparteine.	metoprolol,98,108,Chemical/Drug	propafenone,110,121,Chemical/Drug	diltiazem,123,132,Chemical/Drug	sparteine,138,147,Chemical/Drug	"[{""token"": ""metoprolol"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""propafenone"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Chemical/Drug""}, {""token"": ""sparteine"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Chemical/Drug""}]"	train
Flow and metabolism were measured 5 - 13 days after the subarachnoid haemorrhage by a modification of the classical Kety - Schmidt technique using xenon - 133 i. v. Anaesthesia was maintained with an inspired isoflurane concentration of 0. 75% ( plus 67% nitrous oxide in oxygen), during which CBF and CMRO2 were 34. 3 + / - 2. 1 ml / 100 g min - 1 and 2. 32 + / - 0. 16 ml / 100 g min - 1 at PaCO2 4. 1 + / - 0. 1 kPa ( mean + / - SEM).	xenon,147,152,Chemical/Drug	isoflurane,209,219,Chemical/Drug	nitrous oxide,255,268,Chemical/Drug	oxygen,272,278,Chemical/Drug	"[{""token"": ""xenon"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""isoflurane"", ""start_span"": 209, ""end_span"": 219, ""type"": ""Chemical/Drug""}, {""token"": ""nitrous oxide"", ""start_span"": 255, ""end_span"": 268, ""type"": ""Chemical/Drug""}, {""token"": ""oxygen"", ""start_span"": 272, ""end_span"": 278, ""type"": ""Chemical/Drug""}]"	train
A patient who allegedly consumed 100 tablets of an over - the - counter analgesic containing sodium acetylsalicylate, caffeine, and acetaminophen displayed no significant CNS stimulation despite the presence of 175 micrograms of caffeine per mL of serum.	sodium acetylsalicylate,93,116,Chemical/Drug	caffeine,118,126,Chemical/Drug	acetaminophen,132,145,Chemical/Drug	caffeine,229,237,Chemical/Drug	"[{""token"": ""sodium acetylsalicylate"", ""start_span"": 93, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""caffeine"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""caffeine"", ""start_span"": 229, ""end_span"": 237, ""type"": ""Chemical/Drug""}]"	train
Studies in DBA / 2J mice showed that: 1) pretreatment with acetaminophen ( 100 mg / kg) increased the interval between the administration of caffeine ( 300 to 450 mg / kg IP) and the onset of fatal convulsions by a factor of about two; and 2) pretreatment with acetaminophen ( 75 mg / kg) reduced the incidence of audiogenic seizures produced in the presence of caffeine ( 12. 5 to 75 mg / kg IP).	acetaminophen,59,72,Chemical/Drug	caffeine,141,149,Chemical/Drug	acetaminophen,261,274,Chemical/Drug	caffeine,362,370,Chemical/Drug	"[{""token"": ""acetaminophen"", ""start_span"": 59, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""caffeine"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 261, ""end_span"": 274, ""type"": ""Chemical/Drug""}, {""token"": ""caffeine"", ""start_span"": 362, ""end_span"": 370, ""type"": ""Chemical/Drug""}]"	train
Patients tapped faster after propranolol than diazepam and they were more sedated after diazepam than propranolol.	propranolol,29,40,Chemical/Drug	diazepam,46,54,Chemical/Drug	diazepam,88,96,Chemical/Drug	propranolol,102,113,Chemical/Drug	"[{""token"": ""propranolol"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical/Drug""}]"	train
The effect of a widely used organic solvent, polyethylene glycol 400 ( PEG 400), on the toxic action of an acute or chronic treatment with adriamycin ( ADR) was evaluated in mice.	polyethylene glycol 400,45,68,Chemical/Drug	PEG 400,71,78,Chemical/Drug	adriamycin,139,149,Chemical/Drug	ADR,152,155,Chemical/Drug	"[{""token"": ""polyethylene glycol 400"", ""start_span"": 45, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""PEG 400"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""adriamycin"", ""start_span"": 139, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""ADR"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Chemical/Drug""}]"	train
An autoradiographic study was performed on male F - 344 rats fed diet containing FANFT at a level of 0. 2% and / or aspirin at a level of 0. 5% to evaluate the effect of aspirin on the increased cell proliferation induced by FANFT in the forestomach and bladder.	FANFT,81,86,Chemical/Drug	aspirin,116,123,Chemical/Drug	aspirin,170,177,Chemical/Drug	FANFT,225,230,Chemical/Drug	"[{""token"": ""FANFT"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""FANFT"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Chemical/Drug""}]"	train
Intrarenal compared with intravenous infusion of noradrenaline caused higher plasma noradrenaline concentrations and a shift of the plasma noradrenaline concentration - blood pressure effect curve towards lower plasma noradrenaline levels.	noradrenaline,49,62,Chemical/Drug	noradrenaline,84,97,Chemical/Drug	noradrenaline,139,152,Chemical/Drug	noradrenaline,218,231,Chemical/Drug	"[{""token"": ""noradrenaline"", ""start_span"": 49, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""noradrenaline"", ""start_span"": 84, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""noradrenaline"", ""start_span"": 139, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""noradrenaline"", ""start_span"": 218, ""end_span"": 231, ""type"": ""Chemical/Drug""}]"	train
"The yield of severe cirrhosis of the liver ( defined as a shrunken finely nodular liver with micronodular histology, ascites greater than 30 ml, plasma albumin less than 2. 2 g / dl, splenomegaly 2 - 3 times normal, and testicular atrophy approximately half normal weight) after 12 doses of carbon tetrachloride given intragastrically in the phenobarbitone - primed rat was increased from 25% to 56% by giving the initial "" calibrating "" dose of carbon tetrachloride at the peak of the phenobarbitone - induced enlargement of the liver."	carbon tetrachloride,291,311,Chemical/Drug	phenobarbitone,342,356,Chemical/Drug	carbon tetrachloride,446,466,Chemical/Drug	phenobarbitone,486,500,Chemical/Drug	"[{""token"": ""carbon tetrachloride"", ""start_span"": 291, ""end_span"": 311, ""type"": ""Chemical/Drug""}, {""token"": ""phenobarbitone"", ""start_span"": 342, ""end_span"": 356, ""type"": ""Chemical/Drug""}, {""token"": ""carbon tetrachloride"", ""start_span"": 446, ""end_span"": 466, ""type"": ""Chemical/Drug""}, {""token"": ""phenobarbitone"", ""start_span"": 486, ""end_span"": 500, ""type"": ""Chemical/Drug""}]"	train
The role of the renin - - angiotensin system in the maintenance of blood pressure during halothane anesthesia and sodium nitroprusside ( SNP) - induced hypotension was evaluated.	angiotensin,26,37,Chemical/Drug	halothane,89,98,Chemical/Drug	sodium nitroprusside,114,134,Chemical/Drug	SNP,137,140,Chemical/Drug	"[{""token"": ""angiotensin"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""halothane"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""sodium nitroprusside"", ""start_span"": 114, ""end_span"": 134, ""type"": ""Chemical/Drug""}, {""token"": ""SNP"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Chemical/Drug""}]"	train
This study indicates that with stable halothane anesthesia, the partial recovery of blood pressure during SNP infusion and the post - SNP rebound of blood pressure can be completely blocked by saralasin.	halothane,38,47,Chemical/Drug	SNP,106,109,Chemical/Drug	SNP,134,137,Chemical/Drug	saralasin,193,202,Chemical/Drug	"[{""token"": ""halothane"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""SNP"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""SNP"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""saralasin"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Chemical/Drug""}]"	train
The effect of amiloride on lithium - induced polydipsia and polyuria and on the lithium concentration in the plasma, brain, kidney, thyroid and red blood cells was investigated in rats, chronically treated with LiCl.	amiloride,14,23,Chemical/Drug	lithium,27,34,Chemical/Drug	lithium,80,87,Chemical/Drug	LiCl,211,215,Chemical/Drug	"[{""token"": ""amiloride"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""LiCl"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Chemical/Drug""}]"	train
In all the experiments, the attenuation of the lithium - induced diabetes - insipidus - like syndrome by amiloride was accompanied by a reduction of the ratio between the lithium concentration in the renal medulla and its levels in the blood and an elevation in the plasma potassium level.	lithium,47,54,Chemical/Drug	amiloride,105,114,Chemical/Drug	lithium,171,178,Chemical/Drug	potassium,273,282,Chemical/Drug	"[{""token"": ""lithium"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""amiloride"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 273, ""end_span"": 282, ""type"": ""Chemical/Drug""}]"	train
It is concluded that acute amiloride administration to lithium - treated patients suffering from polydipsia and polyuria might relieve these patients but prolonged amiloride supplementation would result in elevated lithium levels and might be hazardous.	amiloride,27,36,Chemical/Drug	lithium,55,62,Chemical/Drug	amiloride,164,173,Chemical/Drug	lithium,215,222,Chemical/Drug	"[{""token"": ""amiloride"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""amiloride"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 215, ""end_span"": 222, ""type"": ""Chemical/Drug""}]"	train
A prospective, randomized study was conducted to evaluate the role of vitamin B12 and folinic acid supplementation in preventing zidovudine ( ZDV) - induced bone marrow suppression.	vitamin B12,70,81,Chemical/Drug	folinic acid,86,98,Chemical/Drug	zidovudine,129,139,Chemical/Drug	ZDV,142,145,Chemical/Drug	"[{""token"": ""vitamin B12"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""folinic acid"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 129, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""ZDV"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Chemical/Drug""}]"	train
Vitamin B12 and folinic acid supplementation of ZDV therapy does not seem useful in preventing or reducing ZDV - induced myelotoxicity in the overall treated population, although a beneficial effect in certain subgroups of patients cannot be excluded.	Vitamin B12,0,11,Chemical/Drug	folinic acid,16,28,Chemical/Drug	ZDV,48,51,Chemical/Drug	ZDV,107,110,Chemical/Drug	"[{""token"": ""Vitamin B12"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""folinic acid"", ""start_span"": 16, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""ZDV"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""ZDV"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Chemical/Drug""}]"	train
A 61 - year - old man was treated with combination chemotherapy incorporating cisplatinum, etoposide, high - dose 5 - fluorouracil ( 2, 250 mg / m2 / 24 hours) and folinic acid for an inoperable gastric adenocarcinoma.	cisplatinum,78,89,Chemical/Drug	etoposide,91,100,Chemical/Drug	5 - fluorouracil,114,130,Chemical/Drug	folinic acid,164,176,Chemical/Drug	"[{""token"": ""cisplatinum"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""etoposide"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""5 - fluorouracil"", ""start_span"": 114, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""folinic acid"", ""start_span"": 164, ""end_span"": 176, ""type"": ""Chemical/Drug""}]"	train
CONCLUSIONS: A comparison of frequency of adverse reactions to indocyanine green with the previously reported frequency of such reactions to fluorescein sodium indicated that indocyanine green is a safe as fluorescein for use in angiography.	indocyanine green,63,80,Chemical/Drug	fluorescein sodium,141,159,Chemical/Drug	indocyanine green,175,192,Chemical/Drug	fluorescein,206,217,Chemical/Drug	"[{""token"": ""indocyanine green"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""fluorescein sodium"", ""start_span"": 141, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""indocyanine green"", ""start_span"": 175, ""end_span"": 192, ""type"": ""Chemical/Drug""}, {""token"": ""fluorescein"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Chemical/Drug""}]"	train
A detailed clinical history, together with skin tests, RAST ( radioallergosorbent test), and controlled challenge tests, was used to establish whether patients allergic to beta - lactam antibiotics had selective immediate allergic responses to amoxicillin ( AX) or were cross - reacting with other penicillin derivatives.	beta - lactam,172,185,Chemical/Drug	amoxicillin,244,255,Chemical/Drug	AX,258,260,Chemical/Drug	penicillin,298,308,Chemical/Drug	"[{""token"": ""beta - lactam"", ""start_span"": 172, ""end_span"": 185, ""type"": ""Chemical/Drug""}, {""token"": ""amoxicillin"", ""start_span"": 244, ""end_span"": 255, ""type"": ""Chemical/Drug""}, {""token"": ""AX"", ""start_span"": 258, ""end_span"": 260, ""type"": ""Chemical/Drug""}, {""token"": ""penicillin"", ""start_span"": 298, ""end_span"": 308, ""type"": ""Chemical/Drug""}]"	train
The convulsant activity of bupivacaine was not significantly modified but calcium channel blockers decreased the time of latency to obtain bupivacaine - induced convulsions; this effect was less pronounced with bepridil.	bupivacaine,27,38,Chemical/Drug	calcium,74,81,Chemical/Drug	bupivacaine,139,150,Chemical/Drug	bepridil,211,219,Chemical/Drug	"[{""token"": ""bupivacaine"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""bupivacaine"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""bepridil"", ""start_span"": 211, ""end_span"": 219, ""type"": ""Chemical/Drug""}]"	train
A total of 38 consecutive patients who presented to our clinic with impotence received 0. 2 ml. of a combination of 3 drugs: 6 mg. papaverine, 100 micrograms. phentolamine and 10 micrograms. prostaglandin E1 with ( pH 7. 05) or without ( pH 4. 17) the addition of sodium bicarbonate ( 0. 03 mEq.).	papaverine,131,141,Chemical/Drug	phentolamine,159,171,Chemical/Drug	prostaglandin E1,191,207,Chemical/Drug	sodium bicarbonate,264,282,Chemical/Drug	"[{""token"": ""papaverine"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""phentolamine"", ""start_span"": 159, ""end_span"": 171, ""type"": ""Chemical/Drug""}, {""token"": ""prostaglandin E1"", ""start_span"": 191, ""end_span"": 207, ""type"": ""Chemical/Drug""}, {""token"": ""sodium bicarbonate"", ""start_span"": 264, ""end_span"": 282, ""type"": ""Chemical/Drug""}]"	train
The use and toxicity of didanosine ( ddI) in HIV antibody - positive individuals intolerant to zidovudine ( AZT)	didanosine,24,34,Chemical/Drug	ddI,37,40,Chemical/Drug	zidovudine,95,105,Chemical/Drug	AZT,108,111,Chemical/Drug	"[{""token"": ""didanosine"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""ddI"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Chemical/Drug""}]"	train
One hundred and fifty - one patients intolerant to zidovudine ( AZT) received didanosine ( ddI) to a maximum dose of 12. 5 mg / kg / day.	zidovudine,51,61,Chemical/Drug	AZT,64,67,Chemical/Drug	didanosine,78,88,Chemical/Drug	ddI,91,94,Chemical/Drug	"[{""token"": ""zidovudine"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""didanosine"", ""start_span"": 78, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""ddI"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Chemical/Drug""}]"	train
Preliminary results of an Eastern Cooperative Oncology Group study of single - agent paclitaxel ( Taxol; Bristol - Myers Squibb Company, Princeton, NJ) reported a 37% response rate in patients with head and neck cancer, and the paclitaxel / cisplatin combination has been used successfully and has significantly improved median response duration in ovarian cancer patients.	paclitaxel,85,95,Chemical/Drug	Taxol,98,103,Chemical/Drug	paclitaxel,228,238,Chemical/Drug	cisplatin,241,250,Chemical/Drug	"[{""token"": ""paclitaxel"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""Taxol"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""paclitaxel"", ""start_span"": 228, ""end_span"": 238, ""type"": ""Chemical/Drug""}, {""token"": ""cisplatin"", ""start_span"": 241, ""end_span"": 250, ""type"": ""Chemical/Drug""}]"	train
In addition, reflex bradycardia caused by injected norepinephrine was significantly enhanced by L - dopa, DL - Threo - dihydroxyphenylserine had no effect on blood pressure, heart rate or reflex responses to norepinephrine.	norepinephrine,51,65,Chemical/Drug	L - dopa,96,104,Chemical/Drug	DL - Threo - dihydroxyphenylserine,106,140,Chemical/Drug	norepinephrine,208,222,Chemical/Drug	"[{""token"": ""norepinephrine"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""L - dopa"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""DL - Threo - dihydroxyphenylserine"", ""start_span"": 106, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""norepinephrine"", ""start_span"": 208, ""end_span"": 222, ""type"": ""Chemical/Drug""}]"	train
In both cases, discontinuation of FK506 and treatment with plasma exchange, fresh frozen plasma replacement, corticosteroids, aspirin, and dipyridamole led to resolution of MAHA.	FK506,34,39,Chemical/Drug	corticosteroids,109,124,Chemical/Drug	aspirin,126,133,Chemical/Drug	dipyridamole,139,151,Chemical/Drug	"[{""token"": ""FK506"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""corticosteroids"", ""start_span"": 109, ""end_span"": 124, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Chemical/Drug""}, {""token"": ""dipyridamole"", ""start_span"": 139, ""end_span"": 151, ""type"": ""Chemical/Drug""}]"	train
We studied three calcium channel blockers of different structure, nifedipine, diltiazem, and verapamil, along with the new agent.	calcium,17,24,Chemical/Drug	nifedipine,66,76,Chemical/Drug	diltiazem,78,87,Chemical/Drug	verapamil,93,102,Chemical/Drug	"[{""token"": ""calcium"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""nifedipine"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""verapamil"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Chemical/Drug""}]"	train
Treatment of previously treated metastatic breast cancer by mitoxantrone and 48 - hour continuous infusion of high - dose 5 - FU and leucovorin ( MFL): low palliative benefit and high treatment - related toxicity.	mitoxantrone,60,72,Chemical/Drug	5 - FU,122,128,Chemical/Drug	leucovorin,133,143,Chemical/Drug	MFL,146,149,Chemical/Drug	"[{""token"": ""mitoxantrone"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""leucovorin"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""MFL"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Chemical/Drug""}]"	train
The expression of arginine vasopressin ( AVP) gene in the paraventricular ( PVN) and supraoptic nuclei ( SON) was investigated in rats with lithium ( Li) - induced polyuria, using in situ hybridization histochemistry and radioimmunoassay.	arginine vasopressin,18,38,Chemical/Drug	AVP,41,44,Chemical/Drug	lithium,140,147,Chemical/Drug	Li,150,152,Chemical/Drug	"[{""token"": ""arginine vasopressin"", ""start_span"": 18, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""AVP"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""Li"", ""start_span"": 150, ""end_span"": 152, ""type"": ""Chemical/Drug""}]"	train
TRI given repeatedly to rats increases the locomotor hyperactivity induced by d - amphetamine, quinpirole and ( +) - 7 - hydroxy - dipropyloaminotetralin ( dopamine D2 and D3 effects).	TRI,0,3,Chemical/Drug	d - amphetamine,78,93,Chemical/Drug	quinpirole,95,105,Chemical/Drug	dopamine,156,164,Chemical/Drug	"[{""token"": ""TRI"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical/Drug""}, {""token"": ""d - amphetamine"", ""start_span"": 78, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""quinpirole"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 156, ""end_span"": 164, ""type"": ""Chemical/Drug""}]"	train
Effects of acetylsalicylic acid, dipyridamole, and hydrocortisone on epinephrine - induced myocardial injury in dogs.	acetylsalicylic acid,11,31,Chemical/Drug	dipyridamole,33,45,Chemical/Drug	hydrocortisone,51,65,Chemical/Drug	epinephrine,69,80,Chemical/Drug	"[{""token"": ""acetylsalicylic acid"", ""start_span"": 11, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""dipyridamole"", ""start_span"": 33, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""hydrocortisone"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Chemical/Drug""}]"	train
Patients with aneurysmal subarachnoid hemorrhage ( SAH) were randomized to receive either ketoprofen, 100 mg, three times a day ( ketoprofen group, n = 9) or a weak NSAID, acetaminophen, 1 g, three times a day ( acetaminophen group, n = 9) starting immediately after the diagnosis of aneurysmal SAH.	ketoprofen,90,100,Chemical/Drug	ketoprofen,130,140,Chemical/Drug	acetaminophen,172,185,Chemical/Drug	acetaminophen,212,225,Chemical/Drug	"[{""token"": ""ketoprofen"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""ketoprofen"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 172, ""end_span"": 185, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 212, ""end_span"": 225, ""type"": ""Chemical/Drug""}]"	valid
The indications for switch were chronic CsA or Tac nephrotoxicity ( 12), acute CsA or Tac toxicity ( 3), severe facial dysmorphism ( 2), posttransplant lymphoproliferative disorder ( PTLD) in remission ( 2), and hepatotoxicity in 1.	CsA,40,43,Chemical/Drug	Tac,47,50,Chemical/Drug	CsA,79,82,Chemical/Drug	Tac,86,89,Chemical/Drug	"[{""token"": ""CsA"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""Tac"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Chemical/Drug""}, {""token"": ""CsA"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""Tac"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Chemical/Drug""}]"	valid
STUDY OBJECTIVE: To determine the effect of metoprolol on dobutamine stress testing with technetium - 99m sestamibi single - photon emission computed tomography imaging and ST - segment monitoring, and to assess the impact of intravenous glucagon on metoprolol ' s effects.	metoprolol,44,54,Chemical/Drug	dobutamine,58,68,Chemical/Drug	technetium - 99m sestamibi,89,115,Chemical/Drug	metoprolol,250,260,Chemical/Drug	"[{""token"": ""metoprolol"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""dobutamine"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""technetium - 99m sestamibi"", ""start_span"": 89, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""metoprolol"", ""start_span"": 250, ""end_span"": 260, ""type"": ""Chemical/Drug""}]"	valid
Reduced cardiotoxicity and preserved antitumor efficacy of liposome - encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer.	doxorubicin,83,94,Chemical/Drug	cyclophosphamide,99,115,Chemical/Drug	doxorubicin,143,154,Chemical/Drug	cyclophosphamide,159,175,Chemical/Drug	"[{""token"": ""doxorubicin"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 99, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 159, ""end_span"": 175, ""type"": ""Chemical/Drug""}]"	valid
PURPOSE: To determine whether Myocet ( liposome - encapsulated doxorubicin; The Liposome Company, Elan Corporation, Princeton, NJ) in combination with cyclophosphamide significantly reduces doxorubicin cardiotoxicity while providing comparable antitumor efficacy in first - line treatment of metastatic breast cancer ( MBC).	Myocet,30,36,Chemical/Drug	doxorubicin,63,74,Chemical/Drug	cyclophosphamide,151,167,Chemical/Drug	doxorubicin,190,201,Chemical/Drug	"[{""token"": ""Myocet"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 151, ""end_span"": 167, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Chemical/Drug""}]"	valid
METHODS: To evaluate the potential mechanisms of AF promotion by Ca ( 2 +) channel blockers, we administered verapamil to morphine - chloralose anesthetized dogs.	Ca,65,67,Chemical/Drug	verapamil,109,118,Chemical/Drug	morphine,122,130,Chemical/Drug	chloralose,133,143,Chemical/Drug	"[{""token"": ""Ca"", ""start_span"": 65, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""verapamil"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""chloralose"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Chemical/Drug""}]"	valid
Previous studies evaluated the tolerance of nimesulide and paracetamol in subjects with cutaneous, respiratory and anaphylactoid reactions induced by nonsteroidal anti - inflammatory drugs ( NSAIDs).	nimesulide,44,54,Chemical/Drug	paracetamol,59,70,Chemical/Drug	nonsteroidal anti - inflammatory drugs,150,188,Chemical/Drug	NSAIDs,191,197,Chemical/Drug	"[{""token"": ""nimesulide"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""paracetamol"", ""start_span"": 59, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""nonsteroidal anti - inflammatory drugs"", ""start_span"": 150, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""NSAIDs"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Chemical/Drug""}]"	valid
DESIGN: This trial evaluated the effect of placebo, 0. 5% aqueous timolol ( timolol solution) and a 0. 5% timolol suspension that forms a gel on application to the conjunctiva ( timolol gellan) on the 24 - hour heart rate in patients currently being treated for glaucoma to quantify the reduction in mean heart rate.	timolol,66,73,Chemical/Drug	timolol,76,83,Chemical/Drug	timolol,106,113,Chemical/Drug	timolol,178,185,Chemical/Drug	"[{""token"": ""timolol"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""timolol"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""timolol"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""timolol"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Chemical/Drug""}]"	valid
This hypothesis stems from findings that PREGS is a potent positive modulator of N - methyl - d - aspartate receptors ( NMDARs) and a negative modulator of gamma - aminobutyric acid ( A) receptors ( GABA ( A) Rs).	PREGS,41,46,Chemical/Drug	N - methyl - d - aspartate,81,107,Chemical/Drug	gamma - aminobutyric acid,156,181,Chemical/Drug	GABA,199,203,Chemical/Drug	"[{""token"": ""PREGS"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""N - methyl - d - aspartate"", ""start_span"": 81, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""gamma - aminobutyric acid"", ""start_span"": 156, ""end_span"": 181, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Chemical/Drug""}]"	valid
In addition PJ34 significantly reduced the DOX - induced increase in the serum lactate dehydrogenase and creatine kinase activities but not metalloproteinase activation in the heart.	PJ34,12,16,Chemical/Drug	DOX,43,46,Chemical/Drug	lactate,79,86,Chemical/Drug	creatine,105,113,Chemical/Drug	"[{""token"": ""PJ34"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""lactate"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""creatine"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Chemical/Drug""}]"	valid
RESULTS: Patients receiving concomitant AmB and spironolactone had significantly higher plasma potassium levels than those receiving AmB alone ( P = 0. 0027).	AmB,40,43,Chemical/Drug	spironolactone,48,62,Chemical/Drug	potassium,95,104,Chemical/Drug	AmB,133,136,Chemical/Drug	"[{""token"": ""AmB"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""spironolactone"", ""start_span"": 48, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 95, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""AmB"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Chemical/Drug""}]"	valid
Those patients receiving AmB and spironolactone required significantly less potassium supplementation to maintain their plasma potassium within the normal range ( P = 0. 022).	AmB,25,28,Chemical/Drug	spironolactone,33,47,Chemical/Drug	potassium,76,85,Chemical/Drug	potassium,127,136,Chemical/Drug	"[{""token"": ""AmB"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""spironolactone"", ""start_span"": 33, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Chemical/Drug""}]"	valid
Moreover, urinary potassium losses were significantly less in patients receiving AmB and spironolactone than those receiving AmB alone ( P = 0. 040).	potassium,18,27,Chemical/Drug	AmB,81,84,Chemical/Drug	spironolactone,89,103,Chemical/Drug	AmB,125,128,Chemical/Drug	"[{""token"": ""potassium"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""AmB"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""spironolactone"", ""start_span"": 89, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""AmB"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Chemical/Drug""}]"	valid
CONCLUSION: This study showed that spironolactone can reduce potassium requirements and prevent hypokalemia by reducing urinary potassium loss in neutropenic patients on AmB treatment.	spironolactone,35,49,Chemical/Drug	potassium,61,70,Chemical/Drug	potassium,128,137,Chemical/Drug	AmB,170,173,Chemical/Drug	"[{""token"": ""spironolactone"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 128, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""AmB"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Chemical/Drug""}]"	valid
After premedication with diazepam, glycopyrrolate and local anaesthesia, and induction with standard doses of ketamine, a maintenance dose of 10 - 20 microg / kg / min of ketamine proved safe and effective.	diazepam,25,33,Chemical/Drug	glycopyrrolate,35,49,Chemical/Drug	ketamine,110,118,Chemical/Drug	ketamine,171,179,Chemical/Drug	"[{""token"": ""diazepam"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""glycopyrrolate"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 171, ""end_span"": 179, ""type"": ""Chemical/Drug""}]"	valid
Low - molecular - weight heparin ( LMWH) offers theoretical advantages over UH, but is not currently considered in clinical guidelines as an alternative to UH in patients with prosthetic valves.	Low - molecular - weight heparin,0,32,Chemical/Drug	LMWH,35,39,Chemical/Drug	UH,76,78,Chemical/Drug	UH,156,158,Chemical/Drug	"[{""token"": ""Low - molecular - weight heparin"", ""start_span"": 0, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""LMWH"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""UH"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""UH"", ""start_span"": 156, ""end_span"": 158, ""type"": ""Chemical/Drug""}]"	valid
Group PS, the control group, received normal saline and succinylcholine 1. 5 mg x kg ( - 1); Group LS, lidocaine 1. 5 mg x kg ( - 1) and succinylcholine 1. 5 mg x kg ( - 1); Group PR, normal saline and rocuronium 0. 6 mg x kg ( - 1).	succinylcholine,56,71,Chemical/Drug	lidocaine,103,112,Chemical/Drug	succinylcholine,137,152,Chemical/Drug	rocuronium,202,212,Chemical/Drug	"[{""token"": ""succinylcholine"", ""start_span"": 56, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""lidocaine"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""succinylcholine"", ""start_span"": 137, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""rocuronium"", ""start_span"": 202, ""end_span"": 212, ""type"": ""Chemical/Drug""}]"	valid
Two of the 64 patients in the iodixanol group ( 3 percent) had an increase in the creatinine concentration of 0. 5 mg per deciliter or more, as compared with 17 of the 65 patients in the iohexol group ( 26 percent) ( P = 0. 002; odds ratio for such an increase in the iodixanol group, 0. 09 [ 95 percent confidence interval, 0. 02 to 0. 41]).	iodixanol,30,39,Chemical/Drug	creatinine,82,92,Chemical/Drug	iohexol,187,194,Chemical/Drug	iodixanol,268,277,Chemical/Drug	"[{""token"": ""iodixanol"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 268, ""end_span"": 277, ""type"": ""Chemical/Drug""}]"	valid
The pressor responses and bradycardia to the alpha 1 - agonist cirazoline ( 0. 6 and 2 micrograms kg - 1 i. v.), the alpha 2 - agonist Abbott - 53693 ( 1 and 3 micrograms kg - 1 i. v.), and noradrenaline ( 0. 1 and 1. 0 micrograms kg - 1 i. v.) were determined in conscious SHR with and without chronic prazosin pretreatment.	cirazoline,63,73,Chemical/Drug	Abbott - 53693,135,149,Chemical/Drug	noradrenaline,190,203,Chemical/Drug	prazosin,303,311,Chemical/Drug	"[{""token"": ""cirazoline"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""Abbott - 53693"", ""start_span"": 135, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""noradrenaline"", ""start_span"": 190, ""end_span"": 203, ""type"": ""Chemical/Drug""}, {""token"": ""prazosin"", ""start_span"": 303, ""end_span"": 311, ""type"": ""Chemical/Drug""}]"	valid
One, two or three doses of mesna were replaced with dexamethasone alone or with dexamethasone plus mesna.	mesna,27,32,Chemical/Drug	dexamethasone,52,65,Chemical/Drug	dexamethasone,80,93,Chemical/Drug	mesna,99,104,Chemical/Drug	"[{""token"": ""mesna"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 52, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 80, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""mesna"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Chemical/Drug""}]"	valid
The combinations of loreclezole ( 2. 5 mg / kg) with valproate, clonazepam, or carbamazepine ( applied at their subprotective doses) also exhibited antiseizure effect in this test.	loreclezole,20,31,Chemical/Drug	valproate,53,62,Chemical/Drug	clonazepam,64,74,Chemical/Drug	carbamazepine,79,92,Chemical/Drug	"[{""token"": ""loreclezole"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""valproate"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""clonazepam"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""carbamazepine"", ""start_span"": 79, ""end_span"": 92, ""type"": ""Chemical/Drug""}]"	valid
Nineteen sexually dysfunctional women receiving either fluoxetine, sertraline, or paroxetine participated in an eight - week, double - blind, placebo - controlled, cross - over study of the effects of ephedrine ( 50 mg) on self - report measures of sexual desire, arousal, orgasm, and sexual satisfaction.	fluoxetine,55,65,Chemical/Drug	sertraline,67,77,Chemical/Drug	paroxetine,82,92,Chemical/Drug	ephedrine,201,210,Chemical/Drug	"[{""token"": ""fluoxetine"", ""start_span"": 55, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""sertraline"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""paroxetine"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""ephedrine"", ""start_span"": 201, ""end_span"": 210, ""type"": ""Chemical/Drug""}]"	valid
The incidence of cardiovascular thrombotic events ( cardiac, cerebrovascular and peripheral vascular, or arterial thrombotic) was determined by analyzing pooled valdecoxib ( 10 - 80 mg daily), nonselective NSAID ( diclofenac 75 mg bid, ibuprofen 800 mg tid, or naproxen 500 mg bid) and placebo data from 10 randomized osteoarthritis and rheumatoid arthritis trials that were 6 - 52 weeks in duration.	valdecoxib,161,171,Chemical/Drug	diclofenac,214,224,Chemical/Drug	ibuprofen,236,245,Chemical/Drug	naproxen,261,269,Chemical/Drug	"[{""token"": ""valdecoxib"", ""start_span"": 161, ""end_span"": 171, ""type"": ""Chemical/Drug""}, {""token"": ""diclofenac"", ""start_span"": 214, ""end_span"": 224, ""type"": ""Chemical/Drug""}, {""token"": ""ibuprofen"", ""start_span"": 236, ""end_span"": 245, ""type"": ""Chemical/Drug""}, {""token"": ""naproxen"", ""start_span"": 261, ""end_span"": 269, ""type"": ""Chemical/Drug""}]"	valid
RESULTS: After adjustment for cardiovascular disease risk factors, type of diabetes medication used, duration of diabetes, and intakes of folate, vitamin E, and beta - carotene, the adjusted relative risks of total cardiovascular disease mortality were 1. 0, 0. 97, 1. 11, 1. 47, and 1. 84 ( P for trend < 0. 01) across quintiles of total vitamin C intake from food and supplements.	folate,138,144,Chemical/Drug	vitamin E,146,155,Chemical/Drug	beta - carotene,161,176,Chemical/Drug	vitamin C,339,348,Chemical/Drug	"[{""token"": ""folate"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin E"", ""start_span"": 146, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""beta - carotene"", ""start_span"": 161, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin C"", ""start_span"": 339, ""end_span"": 348, ""type"": ""Chemical/Drug""}]"	valid
To examine the relationship between quantitative stimulant drug levels, catecholamines, and psychotic symptoms, nineteen patients in a psychiatric emergency service with a diagnosis of amphetamine - or cocaine - induced psychosis were interviewed, and plasma and urine were collected for quantitative assays of stimulant drug and catecholamine metabolite levels.	catecholamines,72,86,Chemical/Drug	amphetamine,185,196,Chemical/Drug	cocaine,202,209,Chemical/Drug	catecholamine,330,343,Chemical/Drug	"[{""token"": ""catecholamines"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 185, ""end_span"": 196, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Chemical/Drug""}, {""token"": ""catecholamine"", ""start_span"": 330, ""end_span"": 343, ""type"": ""Chemical/Drug""}]"	valid
Oxidative stress was assessed by determining plasma and liver levels of 15 - F ( 2t) - IsoP, lipid hydroperoxides ( LPO), and thiobarbituric acid reactive substances ( TBARs).	lipid hydroperoxides,93,113,Chemical/Drug	LPO,116,119,Chemical/Drug	thiobarbituric acid reactive substances,126,165,Chemical/Drug	TBARs,168,173,Chemical/Drug	"[{""token"": ""lipid hydroperoxides"", ""start_span"": 93, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""LPO"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""thiobarbituric acid reactive substances"", ""start_span"": 126, ""end_span"": 165, ""type"": ""Chemical/Drug""}, {""token"": ""TBARs"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Chemical/Drug""}]"	valid
Dexrazoxane protects against myelosuppression from the DNA cleavage - enhancing drugs etoposide and daunorubicin but not doxorubicin.	Dexrazoxane,0,11,Chemical/Drug	etoposide,86,95,Chemical/Drug	daunorubicin,100,112,Chemical/Drug	doxorubicin,121,132,Chemical/Drug	"[{""token"": ""Dexrazoxane"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""etoposide"", ""start_span"": 86, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""daunorubicin"", ""start_span"": 100, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Chemical/Drug""}]"	valid
Likewise, in vivo, B6D2F1 mice were treated with etoposide, daunorubicin, and doxorubicin, with or without dexrazoxane over a wide range of doses: posttreatment, a full hematologic evaluation was done.	etoposide,49,58,Chemical/Drug	daunorubicin,60,72,Chemical/Drug	doxorubicin,78,89,Chemical/Drug	dexrazoxane,107,118,Chemical/Drug	"[{""token"": ""etoposide"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""daunorubicin"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""dexrazoxane"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Chemical/Drug""}]"	valid
Corticosteroids ( dexamethasone and methylprednisolone), benzodiazepines ( midazolam) and general anaesthesia have been the specific agents mentioned most frequently in the literature as being associated with the development of hiccups.	dexamethasone,18,31,Chemical/Drug	methylprednisolone,36,54,Chemical/Drug	benzodiazepines,57,72,Chemical/Drug	midazolam,75,84,Chemical/Drug	"[{""token"": ""dexamethasone"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""methylprednisolone"", ""start_span"": 36, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""benzodiazepines"", ""start_span"": 57, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""midazolam"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Chemical/Drug""}]"	valid
In contrast, a significant decline in glomerular filtration rate was found after the introduction of suprofen to the kidney perfused with uric acid; no changes were found with suprofen in the absence of uric acid.	suprofen,101,109,Chemical/Drug	uric acid,138,147,Chemical/Drug	suprofen,176,184,Chemical/Drug	uric acid,203,212,Chemical/Drug	"[{""token"": ""suprofen"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""uric acid"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""suprofen"", ""start_span"": 176, ""end_span"": 184, ""type"": ""Chemical/Drug""}, {""token"": ""uric acid"", ""start_span"": 203, ""end_span"": 212, ""type"": ""Chemical/Drug""}]"	valid
Because 5 - HT transporters play a key element in the regulation of synaptic 5 - HT transmission it may be important to control for the potential covariance effect of a polymorphism in the 5 - HT transporter promoter gene region ( 5 - HTTLPR) when studying the effects of MDMA as well as cognitive functioning.	5 - HT,8,14,Chemical/Drug	5 - HT,77,83,Chemical/Drug	5 - HT,189,195,Chemical/Drug	MDMA,272,276,Chemical/Drug	"[{""token"": ""5 - HT"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 189, ""end_span"": 195, ""type"": ""Chemical/Drug""}, {""token"": ""MDMA"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Chemical/Drug""}]"	valid
Co - administration of lidocaine, bupivacaine or tricaine with desipramine reversed this effect.	lidocaine,23,32,Chemical/Drug	bupivacaine,34,45,Chemical/Drug	tricaine,49,57,Chemical/Drug	desipramine,63,74,Chemical/Drug	"[{""token"": ""lidocaine"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""bupivacaine"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""tricaine"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical/Drug""}]"	valid
The rat received either alpha - TC ( 20 mg / kg) intraperitoneally for 3 days and 30 min prior to MA administration or DFO ( 50 mg / kg) subcutaneously 30 min before MA administration.	alpha - TC,24,34,Chemical/Drug	MA,98,100,Chemical/Drug	DFO,119,122,Chemical/Drug	MA,166,168,Chemical/Drug	"[{""token"": ""alpha - TC"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""MA"", ""start_span"": 98, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""DFO"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Chemical/Drug""}, {""token"": ""MA"", ""start_span"": 166, ""end_span"": 168, ""type"": ""Chemical/Drug""}]"	valid
Dopamine antagonist fluphenazine, D - 1 antagonist SCH 23390 or D - 2 antagonist sulpiride induced catalepsy.	Dopamine,0,8,Chemical/Drug	fluphenazine,20,32,Chemical/Drug	SCH 23390,51,60,Chemical/Drug	sulpiride,81,90,Chemical/Drug	"[{""token"": ""Dopamine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""fluphenazine"", ""start_span"": 20, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""SCH 23390"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""sulpiride"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Chemical/Drug""}]"	valid
Digitalis arrhythmia, which is suppressed by Na channel blockers, was induced by intermittent intravenous ( i. v.) injection of ouabain in pentobarbital - anesthetized dogs.	Digitalis,0,9,Chemical/Drug	Na,45,47,Chemical/Drug	ouabain,128,135,Chemical/Drug	pentobarbital,139,152,Chemical/Drug	"[{""token"": ""Digitalis"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 45, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""ouabain"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Chemical/Drug""}, {""token"": ""pentobarbital"", ""start_span"": 139, ""end_span"": 152, ""type"": ""Chemical/Drug""}]"	valid
Lithium was associated with a significantly higher incidence ( p < 0. 05) of tremor ( 18. 4%) than quetiapine ( 5. 6%); cerebellar tremor, which is a known adverse effect of lithium, may have contributed to the elevated rate of tremor in patients receiving lithium therapy.	Lithium,0,7,Chemical/Drug	quetiapine,99,109,Chemical/Drug	lithium,174,181,Chemical/Drug	lithium,257,264,Chemical/Drug	"[{""token"": ""Lithium"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""quetiapine"", ""start_span"": 99, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 257, ""end_span"": 264, ""type"": ""Chemical/Drug""}]"	valid
The goal of this study was to assess the interactive effects of chronic anabolic androgenic steroid ( AAS) exposure and brain serotonin ( 5 - hydroxytryptamine, 5 - HT) depletion on behavior of pubertal male rats.	steroid,92,99,Chemical/Drug	serotonin,126,135,Chemical/Drug	5 - hydroxytryptamine,138,159,Chemical/Drug	5 - HT,161,167,Chemical/Drug	"[{""token"": ""steroid"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Chemical/Drug""}, {""token"": ""5 - hydroxytryptamine"", ""start_span"": 138, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Chemical/Drug""}]"	valid
Chronic T treatment significantly decreased 5 - HT and 5 - HIAA in certain brain areas, but to a much lesser extent than PCPA.	T,8,9,Chemical/Drug	5 - HT,44,50,Chemical/Drug	5 - HIAA,55,63,Chemical/Drug	PCPA,121,125,Chemical/Drug	"[{""token"": ""T"", ""start_span"": 8, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HIAA"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""PCPA"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Chemical/Drug""}]"	valid
Radiolabeled metaiodobenzylguanidine ( MIBG), an analog of norepinephrine ( NE), serves as an index of adrenergic neuron integrity and function.	Radiolabeled metaiodobenzylguanidine,0,36,Chemical/Drug	MIBG,39,43,Chemical/Drug	norepinephrine,59,73,Chemical/Drug	NE,76,78,Chemical/Drug	"[{""token"": ""Radiolabeled metaiodobenzylguanidine"", ""start_span"": 0, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""MIBG"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""norepinephrine"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""NE"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Chemical/Drug""}]"	valid
RESULTS: We identified 27 reports of toxic leukoencephalopathy in patients treated with methotrexate ( intrathecal, systemic), 5 - fluorouracil and its derivative carmofur, and capecitabine.	methotrexate,88,100,Chemical/Drug	5 - fluorouracil,127,143,Chemical/Drug	carmofur,163,171,Chemical/Drug	capecitabine,177,189,Chemical/Drug	"[{""token"": ""methotrexate"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""5 - fluorouracil"", ""start_span"": 127, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""carmofur"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Chemical/Drug""}, {""token"": ""capecitabine"", ""start_span"": 177, ""end_span"": 189, ""type"": ""Chemical/Drug""}]"	valid
Remifentanil - related complications were assessed during the remifentanil infusion, and pain caused by propofol was evaluated using a four - point scale during the propofol infusion.	Remifentanil,0,12,Chemical/Drug	remifentanil,62,74,Chemical/Drug	propofol,104,112,Chemical/Drug	propofol,165,173,Chemical/Drug	"[{""token"": ""Remifentanil"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""remifentanil"", ""start_span"": 62, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""propofol"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""propofol"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Chemical/Drug""}]"	valid
CONCLUSIONS: During induction of anaesthesia with TCI of propofol and remifentanil, a significant reduction in propofol infusion pain was achieved without significant complications by prior administration of remifentanil at a target Ce of 4 ng ml ( - 1).	propofol,57,65,Chemical/Drug	remifentanil,70,82,Chemical/Drug	propofol,111,119,Chemical/Drug	remifentanil,208,220,Chemical/Drug	"[{""token"": ""propofol"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""remifentanil"", ""start_span"": 70, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""propofol"", ""start_span"": 111, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""remifentanil"", ""start_span"": 208, ""end_span"": 220, ""type"": ""Chemical/Drug""}]"	valid
Four binary comparisons were made: WT control versus CYP treatment ( 48 h), VIP ( - / -) control versus CYP treatment ( 48 h), WT control versus VIP ( - / -) control, and WT with CYP treatment ( 48 h) versus VIP ( - / -) with CYP treatment ( 48 h).	CYP,53,56,Chemical/Drug	CYP,104,107,Chemical/Drug	CYP,179,182,Chemical/Drug	CYP,226,229,Chemical/Drug	"[{""token"": ""CYP"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""CYP"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""CYP"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Chemical/Drug""}, {""token"": ""CYP"", ""start_span"": 226, ""end_span"": 229, ""type"": ""Chemical/Drug""}]"	valid
Thirty patients were treated with three 21 - day cycles of bortezomib 1. 3 mg / m ( 2) on days 1, 4, 8, and 11 plus dexamethasone 40 mg on the day of bortezomib injection and the day after plus cyclophosphamide at 900, 1, 200, or 1, 500 mg / m ( 2) on day 1.	bortezomib,59,69,Chemical/Drug	dexamethasone,116,129,Chemical/Drug	bortezomib,150,160,Chemical/Drug	cyclophosphamide,194,210,Chemical/Drug	"[{""token"": ""bortezomib"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 116, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""bortezomib"", ""start_span"": 150, ""end_span"": 160, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 194, ""end_span"": 210, ""type"": ""Chemical/Drug""}]"	valid
Similarly, the total protein abundance of the Na - K - 2Cl cotransporter ( NKCC2) in the medulla but not in the cortex of the + / + mice was significantly reduced by lithium treatment.	Na,46,48,Chemical/Drug	K,51,52,Chemical/Drug	2Cl,55,58,Chemical/Drug	lithium,166,173,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 51, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""2Cl"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Chemical/Drug""}]"	valid
Specific dopamine - 1, ( DA1) and dopamine - 2 ( DA2) receptor agonists are now under clinical investigation.	dopamine,9,17,Chemical/Drug	DA1,25,28,Chemical/Drug	dopamine,34,42,Chemical/Drug	DA2,49,52,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""DA1"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""DA2"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Chemical/Drug""}]"	valid
Systemic aortic blood pressure and renal blood flow were measured continuously with a carotid arterial catheter and an electromagnetic flow probe respectively, in order to compare the cardiovascular and renal vascular effects of fenoldopam and sodium nitroprusside in ten dogs under halothane general anaesthesia.	fenoldopam,229,239,Chemical/Drug	sodium,244,250,Chemical/Drug	nitroprusside,251,264,Chemical/Drug	halothane,283,292,Chemical/Drug	"[{""token"": ""fenoldopam"", ""start_span"": 229, ""end_span"": 239, ""type"": ""Chemical/Drug""}, {""token"": ""sodium"", ""start_span"": 244, ""end_span"": 250, ""type"": ""Chemical/Drug""}, {""token"": ""nitroprusside"", ""start_span"": 251, ""end_span"": 264, ""type"": ""Chemical/Drug""}, {""token"": ""halothane"", ""start_span"": 283, ""end_span"": 292, ""type"": ""Chemical/Drug""}]"	valid
An activated moiety, i. e. N - acylimidazole derivative of etodolac ( EAI), was condensed with the polysaccharide polymer dextran of different molecular weights ( 40000, 60000, 110000 and 200000).	N - acylimidazole,27,44,Chemical/Drug	etodolac,59,67,Chemical/Drug	EAI,70,73,Chemical/Drug	dextran,122,129,Chemical/Drug	"[{""token"": ""N - acylimidazole"", ""start_span"": 27, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""etodolac"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""EAI"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""dextran"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Chemical/Drug""}]"	valid
[ Ca ( 2 +)] ( i) overload induced by aconitine or ouabain was reduced in isolated myocytes pretreated with pilocarpine.	Ca,2,4,Chemical/Drug	aconitine,38,47,Chemical/Drug	ouabain,51,58,Chemical/Drug	pilocarpine,108,119,Chemical/Drug	"[{""token"": ""Ca"", ""start_span"": 2, ""end_span"": 4, ""type"": ""Chemical/Drug""}, {""token"": ""aconitine"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""ouabain"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Chemical/Drug""}]"	valid
Moreover, M ( 3) - muscarinic acetylcholine receptor ( mAChR) antagonist 4 - DAMP ( 4 - diphenylacetoxy - N - methylpiperidine - methiodide) partially abolished the beneficial effects of pilocarpine.	acetylcholine,30,43,Chemical/Drug	4 - DAMP,73,81,Chemical/Drug	4 - diphenylacetoxy - N - methylpiperidine - methiodide,84,139,Chemical/Drug	pilocarpine,187,198,Chemical/Drug	"[{""token"": ""acetylcholine"", ""start_span"": 30, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""4 - DAMP"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""4 - diphenylacetoxy - N - methylpiperidine - methiodide"", ""start_span"": 84, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 187, ""end_span"": 198, ""type"": ""Chemical/Drug""}]"	valid
We tested the hypothesis that nimodipine ( NIMO) administered at the onset of nitroglycerin ( NTG) - induced hypotension would preserve long - term associative memory.	nimodipine,30,40,Chemical/Drug	NIMO,43,47,Chemical/Drug	nitroglycerin,78,91,Chemical/Drug	NTG,94,97,Chemical/Drug	"[{""token"": ""nimodipine"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""NIMO"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""nitroglycerin"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""NTG"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Chemical/Drug""}]"	valid
AMN082 ( 2. 5 and 5 mg / kg) reduces apomorphine - induced rotations in unilateral 6 - hydroxydopamine ( 6 - OHDA) - lesioned rats.	AMN082,0,6,Chemical/Drug	apomorphine,37,48,Chemical/Drug	6 - hydroxydopamine,83,102,Chemical/Drug	6 - OHDA,105,113,Chemical/Drug	"[{""token"": ""AMN082"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical/Drug""}, {""token"": ""apomorphine"", ""start_span"": 37, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""6 - hydroxydopamine"", ""start_span"": 83, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Chemical/Drug""}]"	valid
Cessation of sorafenib and administration of Ca - channel blocker and nitrates ameliorated his symptoms, but relapse occurred after resumption of sorafenib.	sorafenib,13,22,Chemical/Drug	Ca,45,47,Chemical/Drug	nitrates,70,78,Chemical/Drug	sorafenib,146,155,Chemical/Drug	"[{""token"": ""sorafenib"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 45, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""nitrates"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""sorafenib"", ""start_span"": 146, ""end_span"": 155, ""type"": ""Chemical/Drug""}]"	valid
The toxic effects of tacrine - loaded poly - L - lactid acid nanoparticles ( 5mg / kg), a saline solution of tacrine ( 5mg / kg) and an empty colloidal nanoparticle suspension were compared following i. p. administration in LiCl - pre - treated Wistar rats.	tacrine,21,28,Chemical/Drug	poly - L - lactid acid,38,60,Chemical/Drug	tacrine,109,116,Chemical/Drug	LiCl,224,228,Chemical/Drug	"[{""token"": ""tacrine"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""poly - L - lactid acid"", ""start_span"": 38, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""tacrine"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""LiCl"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Chemical/Drug""}]"	valid
Aventyl ( nortriptyline) and Elavil ( amitriptyline) each produced left bundle branch block in a 73 year old woman.	Aventyl,0,7,Chemical/Drug	nortriptyline,10,23,Chemical/Drug	Elavil,29,35,Chemical/Drug	amitriptyline,38,51,Chemical/Drug	"[{""token"": ""Aventyl"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""nortriptyline"", ""start_span"": 10, ""end_span"": 23, ""type"": ""Chemical/Drug""}, {""token"": ""Elavil"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Chemical/Drug""}, {""token"": ""amitriptyline"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Chemical/Drug""}]"	valid
Anesthesia was maintained with fentanyl, nitrous oxide, oxygen, and isoflurane.	fentanyl,31,39,Chemical/Drug	nitrous oxide,41,54,Chemical/Drug	oxygen,56,62,Chemical/Drug	isoflurane,68,78,Chemical/Drug	"[{""token"": ""fentanyl"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""nitrous oxide"", ""start_span"": 41, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""oxygen"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""isoflurane"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Chemical/Drug""}]"	valid
Coenzyme Q10 significantly reduced blood urea nitrogen and serum creatinine levels which were increased by cisplatin.	Coenzyme Q10,0,12,Chemical/Drug	blood urea nitrogen,35,54,Chemical/Drug	creatinine,65,75,Chemical/Drug	cisplatin,107,116,Chemical/Drug	"[{""token"": ""Coenzyme Q10"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""blood urea nitrogen"", ""start_span"": 35, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""cisplatin"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Chemical/Drug""}]"	valid
Here we show that the recently reported ability of L - dihydroxyphenylalanine to reverse the protective effect of alpha - methyl - para - tyrosine on METH - induced DA neurotoxicity is also confounded by drug effects on body temperature.	L - dihydroxyphenylalanine,51,77,Chemical/Drug	alpha - methyl - para - tyrosine,114,146,Chemical/Drug	METH,150,154,Chemical/Drug	DA,165,167,Chemical/Drug	"[{""token"": ""L - dihydroxyphenylalanine"", ""start_span"": 51, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""alpha - methyl - para - tyrosine"", ""start_span"": 114, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""METH"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 165, ""end_span"": 167, ""type"": ""Chemical/Drug""}]"	valid
The condition is treated with intravenous thyroxine ( T4) or intravenous tri - iodo - thyronine ( T3).	thyroxine,42,51,Chemical/Drug	T4,54,56,Chemical/Drug	tri - iodo - thyronine,73,95,Chemical/Drug	T3,98,100,Chemical/Drug	"[{""token"": ""thyroxine"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""T4"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""tri - iodo - thyronine"", ""start_span"": 73, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""T3"", ""start_span"": 98, ""end_span"": 100, ""type"": ""Chemical/Drug""}]"	valid
METHODS: Male adult Wistar rats ( n = 90 and 260 - 290 g) were divided into 1, control; 2 and 3, crocins ( 15 and 30 mg / kg); 4, STZ; 5 and 6, STZ + crocins ( 15 and 30 mg / kg) groups.	crocins,97,104,Chemical/Drug	STZ,130,133,Chemical/Drug	STZ,144,147,Chemical/Drug	crocins,150,157,Chemical/Drug	"[{""token"": ""crocins"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""STZ"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Chemical/Drug""}, {""token"": ""STZ"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""crocins"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Chemical/Drug""}]"	valid
Increased extracellular concentrations of uridine ( Urd) have been reported to reduce, in vitro, azidothymidine ( AZT) - induced inhibition of human granulocyte - macrophage progenitor cells without impairment of its antihuman immunodeficiency virus ( HIV) activity.	uridine,42,49,Chemical/Drug	Urd,52,55,Chemical/Drug	azidothymidine,97,111,Chemical/Drug	AZT,114,117,Chemical/Drug	"[{""token"": ""uridine"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""Urd"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""azidothymidine"", ""start_span"": 97, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Chemical/Drug""}]"	valid
Because of the clinical toxicities associated with chronic Urd administration, the ability of benzylacyclouridine ( BAU) to effect, in vivo, AZT - induced anemia and leukopenia was assessed.	Urd,59,62,Chemical/Drug	benzylacyclouridine,94,113,Chemical/Drug	BAU,116,119,Chemical/Drug	AZT,141,144,Chemical/Drug	"[{""token"": ""Urd"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""benzylacyclouridine"", ""start_span"": 94, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""BAU"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Chemical/Drug""}]"	valid
In mice rendered anemic and leukopenic by the administration of AZT for 28 days in drinking water ( 1. 5 mg / mL), the continued administration of AZT plus daily BAU ( 300 mg / kg, orally) partially reversed AZT - induced anemia and leukopenia ( P less than. 05), increased peripheral reticulocytes ( to 4. 9%, P less than. 01), increased cellularity in the marrow, and improved megaloblastosis.	AZT,64,67,Chemical/Drug	AZT,147,150,Chemical/Drug	BAU,162,165,Chemical/Drug	AZT,208,211,Chemical/Drug	"[{""token"": ""AZT"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""BAU"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Chemical/Drug""}]"	valid
Further, 5, 7 - DHT lesion of serotonin nerves travelling in the median forebrain bundle, one of the main ascending pathways from the B3 serotonin cells, did not affect the fall in blood pressure associated with a midline B3 serotonin methyldopa injection.	serotonin,30,39,Chemical/Drug	serotonin,137,146,Chemical/Drug	serotonin,225,234,Chemical/Drug	methyldopa,235,245,Chemical/Drug	"[{""token"": ""serotonin"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 225, ""end_span"": 234, ""type"": ""Chemical/Drug""}, {""token"": ""methyldopa"", ""start_span"": 235, ""end_span"": 245, ""type"": ""Chemical/Drug""}]"	valid
The incidence of ischemic episodes per patient per hour was 0. 05 + / - 0. 02 prior to 5 - FU infusion v 0. 13 + / - 0. 03 during 5 - FU infusion ( P less than. 001); the duration of ECG changes was 0. 6 + / - 0. 3 minutes per patient per hour before 5 - FU v 1. 9 + / - 0. 5 minutes per patient per hour during 5 - FU ( P less than. 01).	5 - FU,87,93,Chemical/Drug	5 - FU,130,136,Chemical/Drug	5 - FU,251,257,Chemical/Drug	5 - FU,312,318,Chemical/Drug	"[{""token"": ""5 - FU"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 251, ""end_span"": 257, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 312, ""end_span"": 318, ""type"": ""Chemical/Drug""}]"	valid
This program consists of double screenings of pregnant women and prophylactic treatment to the infants born to both hepatitis B surface antigen ( HBsAg) and hepatitis B e antigen ( HBeAg) positive mothers.	hepatitis B surface antigen,116,143,Chemical/Drug	HBsAg,146,151,Chemical/Drug	hepatitis B e antigen,157,178,Chemical/Drug	HBeAg,181,186,Chemical/Drug	"[{""token"": ""hepatitis B surface antigen"", ""start_span"": 116, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""HBsAg"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""hepatitis B e antigen"", ""start_span"": 157, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""HBeAg"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Chemical/Drug""}]"	valid
The protection from gentamicin nephrotoxicity was studied in non - diabetic rats with chronic solute diuresis induced by blockage of tubular glucose reabsorption with phlorizin ( P).	gentamicin,20,30,Chemical/Drug	glucose,141,148,Chemical/Drug	phlorizin,167,176,Chemical/Drug	P,179,180,Chemical/Drug	"[{""token"": ""gentamicin"", ""start_span"": 20, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 141, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""phlorizin"", ""start_span"": 167, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""P"", ""start_span"": 179, ""end_span"": 180, ""type"": ""Chemical/Drug""}]"	valid
There was mutual potentiation between sub - effective doses of ketamine and morphine, but sub - effective doses of ketamine partly antagonized fully - effective doses of morphine.	ketamine,63,71,Chemical/Drug	morphine,76,84,Chemical/Drug	ketamine,115,123,Chemical/Drug	morphine,170,178,Chemical/Drug	"[{""token"": ""ketamine"", ""start_span"": 63, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 170, ""end_span"": 178, ""type"": ""Chemical/Drug""}]"	valid
Rats, tolerant to ketamine - dominant combinations, were cross - tolerant to both drugs, while those tolerant to morphine - dominant combinations were cross - tolerant to morphine but showed either no cross - tolerance or an augmented response to ketamine.	ketamine,18,26,Chemical/Drug	morphine,113,121,Chemical/Drug	morphine,171,179,Chemical/Drug	ketamine,247,255,Chemical/Drug	"[{""token"": ""ketamine"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 171, ""end_span"": 179, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Chemical/Drug""}]"	valid
50 mg / kg, i. v. thiopental produced respiratory arrest with further increase in GABA and decrease in glutamate again in cortex and brain stem without affecting any of the amino acids studied in four regions of rat brain.	thiopental,18,28,Chemical/Drug	GABA,82,86,Chemical/Drug	glutamate,103,112,Chemical/Drug	amino acids,173,184,Chemical/Drug	"[{""token"": ""thiopental"", ""start_span"": 18, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""amino acids"", ""start_span"": 173, ""end_span"": 184, ""type"": ""Chemical/Drug""}]"	valid
The data indicate that diazepam acts through the benzodiazepine - GABA - chloride channel macromolecular complex within the central nervous system to facilitate reflex bradycardia mediated through baroreceptor reflexes in response to an acute increase in arterial pressure.	diazepam,23,31,Chemical/Drug	benzodiazepine,49,63,Chemical/Drug	GABA,66,70,Chemical/Drug	chloride,73,81,Chemical/Drug	"[{""token"": ""diazepam"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""benzodiazepine"", ""start_span"": 49, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""chloride"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Chemical/Drug""}]"	valid
In the normal - sodium group the highest mean potassium deficit was 176 mmol on day 9, after which some potassium was regained; in the low - sodium group the highest deficit was 276 mmol on day 13.	sodium,16,22,Chemical/Drug	potassium,46,55,Chemical/Drug	potassium,104,113,Chemical/Drug	sodium,141,147,Chemical/Drug	"[{""token"": ""sodium"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""sodium"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Chemical/Drug""}]"	valid
The normal - sodium group showed an immediate but temporary rise of the renin and aldosterone levels; in the low - sodium group renin and aldosterone increased more slowly but remained elevated.	sodium,13,19,Chemical/Drug	aldosterone,82,93,Chemical/Drug	sodium,115,121,Chemical/Drug	aldosterone,138,149,Chemical/Drug	"[{""token"": ""sodium"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""aldosterone"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""sodium"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""aldosterone"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Chemical/Drug""}]"	valid
A series of aryl - piperazine analogues of buspirone and other 5 - hydroxytryptaminergic agonists were tested for their ability to reverse haloperidol induced catalepsy.	aryl - piperazine,12,29,Chemical/Drug	buspirone,43,52,Chemical/Drug	5 - hydroxytryptaminergic agonists,63,97,Chemical/Drug	haloperidol,139,150,Chemical/Drug	"[{""token"": ""aryl - piperazine"", ""start_span"": 12, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""buspirone"", ""start_span"": 43, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""5 - hydroxytryptaminergic agonists"", ""start_span"": 63, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Chemical/Drug""}]"	valid
A strong association has been found between nephritis and dermatitis due to Tiopronin ( a D - Penicillamine like compound) and class I antigens B35 - Cw4, and between dermatitis due to gold thiosulphate and B35.	Tiopronin,76,85,Chemical/Drug	D - Penicillamine,90,107,Chemical/Drug	gold,185,189,Chemical/Drug	thiosulphate,190,202,Chemical/Drug	"[{""token"": ""Tiopronin"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""D - Penicillamine"", ""start_span"": 90, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""gold"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Chemical/Drug""}, {""token"": ""thiosulphate"", ""start_span"": 190, ""end_span"": 202, ""type"": ""Chemical/Drug""}]"	valid
The potential modifying effect of retinyl acetate ( RA) on butylated hydroxyanisole ( BHA) - induced rat forestomach tumorigenesis was examined.	retinyl acetate,34,49,Chemical/Drug	RA,52,54,Chemical/Drug	butylated hydroxyanisole,59,83,Chemical/Drug	BHA,86,89,Chemical/Drug	"[{""token"": ""retinyl acetate"", ""start_span"": 34, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""RA"", ""start_span"": 52, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""butylated hydroxyanisole"", ""start_span"": 59, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""BHA"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Chemical/Drug""}]"	valid
We observed no changes in nicotine - induced locomotor response, striatal L - [ 3H] nicotine and [ 3H] spiperone binding in the animals pretreated with nicotine for 1 day.	nicotine,26,34,Chemical/Drug	nicotine,84,92,Chemical/Drug	spiperone,103,112,Chemical/Drug	nicotine,152,160,Chemical/Drug	"[{""token"": ""nicotine"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""spiperone"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Chemical/Drug""}]"	valid
These results suggest that chronic nicotine - treated rats develop locomotor hyperactivity in response to nicotine initially due to increases of both the density of nicotinic receptors and DA concentration, followed by inducing DA receptor supersensitivity in the striatum.	nicotine,35,43,Chemical/Drug	nicotine,106,114,Chemical/Drug	DA,189,191,Chemical/Drug	DA,228,230,Chemical/Drug	"[{""token"": ""nicotine"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 228, ""end_span"": 230, ""type"": ""Chemical/Drug""}]"	valid
Ototoxicity occurred in four ( 9. 5%) of 42 netilmicin and piperacillin and in 12 ( 22%) of 54 tobramycin and piperacillin - treated patients.	netilmicin,44,54,Chemical/Drug	piperacillin,59,71,Chemical/Drug	tobramycin,95,105,Chemical/Drug	piperacillin,110,122,Chemical/Drug	"[{""token"": ""netilmicin"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 59, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""tobramycin"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 110, ""end_span"": 122, ""type"": ""Chemical/Drug""}]"	valid
Of those evaluated with posttherapy audiograms, three of four netilmicin and piperacillin - treated patients had auditory thresholds return to baseline compared with one of nine tobramycin and piperacillin - treated patients.	netilmicin,62,72,Chemical/Drug	piperacillin,77,89,Chemical/Drug	tobramycin,178,188,Chemical/Drug	piperacillin,193,205,Chemical/Drug	"[{""token"": ""netilmicin"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""tobramycin"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Chemical/Drug""}]"	valid
The number of greater than or equal to 15 - dB increases in auditory threshold as a proportion of total greater than or equal to 15 - dB changes ( increases and decreases) was significantly lower in netilmicin and piperacillin - vs tobramycin and piperacillin - treated patients ( 18 of 78 vs 67 of 115).	netilmicin,199,209,Chemical/Drug	piperacillin,214,226,Chemical/Drug	tobramycin,232,242,Chemical/Drug	piperacillin,247,259,Chemical/Drug	"[{""token"": ""netilmicin"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 214, ""end_span"": 226, ""type"": ""Chemical/Drug""}, {""token"": ""tobramycin"", ""start_span"": 232, ""end_span"": 242, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 247, ""end_span"": 259, ""type"": ""Chemical/Drug""}]"	valid
Aspirin or salicylate ingestion had occurred in only one of the 20 cases ( 5%), and paracetamol ( acetaminophen) had been administered in only six of the cases ( 30%).	Aspirin,0,7,Chemical/Drug	salicylate,11,21,Chemical/Drug	paracetamol,84,95,Chemical/Drug	acetaminophen,98,111,Chemical/Drug	"[{""token"": ""Aspirin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""salicylate"", ""start_span"": 11, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""paracetamol"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 98, ""end_span"": 111, ""type"": ""Chemical/Drug""}]"	valid
Thus, myocardial electrical excitability was measured in patients with mild essential hypertension and known coronary artery disease after 8 weeks of treatment with a potassium - conserving diuretic ( amiloride) and a similar period on a potassium - losing diuretic ( chlorthalidone) in a randomised study.	potassium,167,176,Chemical/Drug	amiloride,201,210,Chemical/Drug	potassium,238,247,Chemical/Drug	chlorthalidone,268,282,Chemical/Drug	"[{""token"": ""potassium"", ""start_span"": 167, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""amiloride"", ""start_span"": 201, ""end_span"": 210, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 238, ""end_span"": 247, ""type"": ""Chemical/Drug""}, {""token"": ""chlorthalidone"", ""start_span"": 268, ""end_span"": 282, ""type"": ""Chemical/Drug""}]"	valid
We studied a thiamine - dependent enzyme, transketolase, from fibroblasts of a diabetic patient who developed Wernicke ' s encephalopathy when treated with tolazamide, in order to delineate if this patient also had transketolase abnormality [ high Km for thiamine pyrophosphate ( TPP)], as previously reported in postalcoholic Wernicke - Korsakoff syndrome.	thiamine,13,21,Chemical/Drug	tolazamide,156,166,Chemical/Drug	thiamine pyrophosphate,255,277,Chemical/Drug	TPP,280,283,Chemical/Drug	"[{""token"": ""thiamine"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""tolazamide"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Chemical/Drug""}, {""token"": ""thiamine pyrophosphate"", ""start_span"": 255, ""end_span"": 277, ""type"": ""Chemical/Drug""}, {""token"": ""TPP"", ""start_span"": 280, ""end_span"": 283, ""type"": ""Chemical/Drug""}]"	valid
The present work has been planned in order to elucidate the effect of phenobarbital ( PB: 15 mg per rat of ingested dose) on carcinogenesis when it is administered simultaneously with diethylnitrosamine ( DEN: 10 mg / kg / day).	phenobarbital,70,83,Chemical/Drug	PB,86,88,Chemical/Drug	diethylnitrosamine,184,202,Chemical/Drug	DEN,205,208,Chemical/Drug	"[{""token"": ""phenobarbital"", ""start_span"": 70, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""PB"", ""start_span"": 86, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""diethylnitrosamine"", ""start_span"": 184, ""end_span"": 202, ""type"": ""Chemical/Drug""}, {""token"": ""DEN"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Chemical/Drug""}]"	valid
Tri - ortho - tolyl phosphate ( TOTP), 360 mg / kg, po, and 0, 0 ' - diisopropyl phosphorofluoridate ( DFP), 1 mg / kg sc, were administered to adult White Leghorn chickens 24 hr after they were placed on diets containing 0 to 300 ppm corticosterone.	Tri - ortho - tolyl phosphate,0,29,Chemical/Drug	TOTP,32,36,Chemical/Drug	DFP,103,106,Chemical/Drug	corticosterone,235,249,Chemical/Drug	"[{""token"": ""Tri - ortho - tolyl phosphate"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""TOTP"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""DFP"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""corticosterone"", ""start_span"": 235, ""end_span"": 249, ""type"": ""Chemical/Drug""}]"	valid
Although low concentrations ( less than or equal to 50 ppm) of corticosterone had beneficial effects on TOTP - induced neuropathy, greater than or equal to 200 ppm exacerbated clinical signs in chickens given either TOTP or DFP.	corticosterone,63,77,Chemical/Drug	TOTP,104,108,Chemical/Drug	TOTP,216,220,Chemical/Drug	DFP,224,227,Chemical/Drug	"[{""token"": ""corticosterone"", ""start_span"": 63, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""TOTP"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""TOTP"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Chemical/Drug""}, {""token"": ""DFP"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Chemical/Drug""}]"	valid
Local anesthetics that are commonly used in ophthalmic surgery ( 0. 75% bupivacaine hydrochloride, 2. 0% mepivacaine hydrochloride, and 2. 0% lidocaine hydrochloride plus 1: 100, 000 epinephrine) were injected into the retrobulbar area of rat eyes.	bupivacaine hydrochloride,72,97,Chemical/Drug	mepivacaine hydrochloride,105,130,Chemical/Drug	lidocaine hydrochloride,142,165,Chemical/Drug	epinephrine,183,194,Chemical/Drug	"[{""token"": ""bupivacaine hydrochloride"", ""start_span"": 72, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""mepivacaine hydrochloride"", ""start_span"": 105, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""lidocaine hydrochloride"", ""start_span"": 142, ""end_span"": 165, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 183, ""end_span"": 194, ""type"": ""Chemical/Drug""}]"	valid
Tiapride, a substituted benzamide derivative closely related to metoclopramide, reduced levodopa - induced peak dose involuntary movements in 16 patients with idiopathic Parkinson ' s disease.	Tiapride,0,8,Chemical/Drug	benzamide,24,33,Chemical/Drug	metoclopramide,64,78,Chemical/Drug	levodopa,88,96,Chemical/Drug	"[{""token"": ""Tiapride"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""benzamide"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""metoclopramide"", ""start_span"": 64, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""levodopa"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Chemical/Drug""}]"	valid
Mean serum potassium level fell, and urea and uric acid levels rose, in men and women taking bendrofluazide.	potassium,11,20,Chemical/Drug	urea,37,41,Chemical/Drug	uric acid,46,55,Chemical/Drug	bendrofluazide,93,107,Chemical/Drug	"[{""token"": ""potassium"", ""start_span"": 11, ""end_span"": 20, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""uric acid"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""bendrofluazide"", ""start_span"": 93, ""end_span"": 107, ""type"": ""Chemical/Drug""}]"	valid
In the propranolol group, serum potassium and uric acid levels rose in both sexes, but the urea level rose significantly in women only.	propranolol,7,18,Chemical/Drug	potassium,32,41,Chemical/Drug	uric acid,46,55,Chemical/Drug	urea,91,95,Chemical/Drug	"[{""token"": ""propranolol"", ""start_span"": 7, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 32, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""uric acid"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Chemical/Drug""}]"	valid
However, ranitidine was threefold more potent than cimetidine both in acute inhibition studies and in the median maintenance dose needed ( 1. 2 g per day for ranitidine and 3. 6 g per day for cimetidine).	ranitidine,9,19,Chemical/Drug	cimetidine,51,61,Chemical/Drug	ranitidine,158,168,Chemical/Drug	cimetidine,192,202,Chemical/Drug	"[{""token"": ""ranitidine"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""cimetidine"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""ranitidine"", ""start_span"": 158, ""end_span"": 168, ""type"": ""Chemical/Drug""}, {""token"": ""cimetidine"", ""start_span"": 192, ""end_span"": 202, ""type"": ""Chemical/Drug""}]"	valid
Captopril had little or no demonstrable effects on serum electrolyte concentrations, excretion of urine, sodium and potassium, endogenous creatinine clearance, body weight, and food and water consumption.	Captopril,0,9,Chemical/Drug	sodium,105,111,Chemical/Drug	potassium,116,125,Chemical/Drug	creatinine,138,148,Chemical/Drug	"[{""token"": ""Captopril"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""sodium"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Chemical/Drug""}]"	valid
Ketamine was more potent in the hypophysectomized chick and the circadian rhythm noted in the intact chick was absent; furthermore, melatonin did not augment the ketamine DOC whereas dopamine continued to do so.	Ketamine,0,8,Chemical/Drug	melatonin,132,141,Chemical/Drug	ketamine,162,170,Chemical/Drug	dopamine,183,191,Chemical/Drug	"[{""token"": ""Ketamine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""melatonin"", ""start_span"": 132, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Chemical/Drug""}]"	valid
This study was undertaken to investigate the links between the long - term administration of digoxin therapy and sexual behavior, and the effect of digoxin on plasma levels of estradiol, testosterone, and LH.	digoxin,93,100,Chemical/Drug	digoxin,148,155,Chemical/Drug	estradiol,176,185,Chemical/Drug	testosterone,187,199,Chemical/Drug	"[{""token"": ""digoxin"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""digoxin"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""estradiol"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Chemical/Drug""}, {""token"": ""testosterone"", ""start_span"": 187, ""end_span"": 199, ""type"": ""Chemical/Drug""}]"	valid
Twelve healthy volunteers were assigned to take BPT / CLZ in the following schedule; BPT: 40 micrograms at day 1 and 120 micrograms t. i. d. from day 7 to 14, CLZ: 200 mg t. i. d. from day 3 to 14.	BPT,48,51,Chemical/Drug	CLZ,54,57,Chemical/Drug	BPT,85,88,Chemical/Drug	CLZ,159,162,Chemical/Drug	"[{""token"": ""BPT"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""CLZ"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""BPT"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""CLZ"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	valid
Intraventricular infusion of dopamine sufficient to raise the brain dopamine to the same extent did not prevent the ammonia coma nor affect the blood and brain ammonia concentrations.	dopamine,29,37,Chemical/Drug	dopamine,68,76,Chemical/Drug	ammonia,116,123,Chemical/Drug	ammonia,160,167,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""ammonia"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""ammonia"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Chemical/Drug""}]"	valid
Thus, the reduction in blood and brain ammonia and the prevention of ammonia coma after L - dopa, can be accounted for by the peripheral effect of dopamine on renal function rather than its central action.	ammonia,39,46,Chemical/Drug	ammonia,69,76,Chemical/Drug	L - dopa,88,96,Chemical/Drug	dopamine,147,155,Chemical/Drug	"[{""token"": ""ammonia"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""ammonia"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""L - dopa"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 147, ""end_span"": 155, ""type"": ""Chemical/Drug""}]"	valid
This supports and extends previous evidence for a mechanism by which enflurane and / or isoflurane could produce a hypersensitivity condition similar to that of halothane hepatitis either alone or subsequent to halothane administration.	enflurane,69,78,Chemical/Drug	isoflurane,88,98,Chemical/Drug	halothane,161,170,Chemical/Drug	halothane,211,220,Chemical/Drug	"[{""token"": ""enflurane"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""isoflurane"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""halothane"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Chemical/Drug""}, {""token"": ""halothane"", ""start_span"": 211, ""end_span"": 220, ""type"": ""Chemical/Drug""}]"	valid
Increased plasma malondialdehyde was also recorded in two other groups of animals subjected to the same experimental model, one receiving 20 mg / kg b. w. of the cyclooxygenase inhibitor acetylsalicylate intravenously immediately before ischemia, the other receiving 650 micrograms / kg b. w. of the hypotensive drug nitroprusside at a flow rate of 103 microliters / min intravenously during ischemia, although in this latter group malondialdehyde was significantly higher.	malondialdehyde,17,32,Chemical/Drug	acetylsalicylate,187,203,Chemical/Drug	nitroprusside,317,330,Chemical/Drug	malondialdehyde,432,447,Chemical/Drug	"[{""token"": ""malondialdehyde"", ""start_span"": 17, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""acetylsalicylate"", ""start_span"": 187, ""end_span"": 203, ""type"": ""Chemical/Drug""}, {""token"": ""nitroprusside"", ""start_span"": 317, ""end_span"": 330, ""type"": ""Chemical/Drug""}, {""token"": ""malondialdehyde"", ""start_span"": 432, ""end_span"": 447, ""type"": ""Chemical/Drug""}]"	valid
We conducted a double - blind, randomized phase II study to evaluate the safety and activity of combination therapy with N - butyl - deoxynojirimycin ( SC - 48334) ( an alpha - glucosidase I inhibitor) and zidovudine versus zidovudine alone.	N - butyl - deoxynojirimycin,121,149,Chemical/Drug	SC - 48334,152,162,Chemical/Drug	zidovudine,206,216,Chemical/Drug	zidovudine,224,234,Chemical/Drug	"[{""token"": ""N - butyl - deoxynojirimycin"", ""start_span"": 121, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""SC - 48334"", ""start_span"": 152, ""end_span"": 162, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 206, ""end_span"": 216, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 224, ""end_span"": 234, ""type"": ""Chemical/Drug""}]"	valid
Patients with 200 to 500 CD4 cells / mm3 who tolerated < or = 12 weeks of prior zidovudine therapy received SC - 48334 ( 1000 mg every 8 h) and zidovudine ( 100 mg every 8 h) or zidovudine and placebo.	zidovudine,80,90,Chemical/Drug	SC - 48334,108,118,Chemical/Drug	zidovudine,144,154,Chemical/Drug	zidovudine,178,188,Chemical/Drug	"[{""token"": ""zidovudine"", ""start_span"": 80, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""SC - 48334"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Chemical/Drug""}]"	valid
The oxytocin should be given only in Ringers lactate or, alternately, in Ringers lactate and a 5 per cent dextrose and water solutions.	oxytocin,4,12,Chemical/Drug	lactate,45,52,Chemical/Drug	lactate,81,88,Chemical/Drug	dextrose,106,114,Chemical/Drug	"[{""token"": ""oxytocin"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""lactate"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""lactate"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""dextrose"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Chemical/Drug""}]"	valid
RESULTS: Among women, lovastatin ( 20 to 80 mg / d) produced sustained ( 12 - to 48 - week), dose - related changes ( P < 0. 001): decreases in LDL cholesterol ( 24% to 40%) and triglycerides ( 9% to 18%), and increases in HDL cholesterol ( 6. 7% to 8. 6%).	lovastatin,22,32,Chemical/Drug	cholesterol,148,159,Chemical/Drug	triglycerides,178,191,Chemical/Drug	cholesterol,227,238,Chemical/Drug	"[{""token"": ""lovastatin"", ""start_span"": 22, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""triglycerides"", ""start_span"": 178, ""end_span"": 191, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 227, ""end_span"": 238, ""type"": ""Chemical/Drug""}]"	valid
In a phase I study to determine the maximum tolerated dose of paclitaxel ( Taxol; Bristol - Myers Squibb Company, Princeton, NJ) given as a 3 - hour infusion in combination with carboplatin administered every 21 days to women with advanced ovarian cancer, paclitaxel doses were escalated as follows: level 1, 135 mg / m2; level 2, 160 mg / m2; level 3, 185 mg / m2; and level 4, 210 mg / m2.	paclitaxel,62,72,Chemical/Drug	Taxol,75,80,Chemical/Drug	carboplatin,178,189,Chemical/Drug	paclitaxel,256,266,Chemical/Drug	"[{""token"": ""paclitaxel"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""Taxol"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""carboplatin"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Chemical/Drug""}, {""token"": ""paclitaxel"", ""start_span"": 256, ""end_span"": 266, ""type"": ""Chemical/Drug""}]"	valid
Therefore, 60 male rats were randomly assigned to receive daily injection of saline ( C), methylprednisolone ( M), or triamcinolone ( T) 80 mg / kg / d for 5 d.	methylprednisolone,90,108,Chemical/Drug	M,111,112,Chemical/Drug	triamcinolone,118,131,Chemical/Drug	T,134,135,Chemical/Drug	"[{""token"": ""methylprednisolone"", ""start_span"": 90, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""M"", ""start_span"": 111, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""triamcinolone"", ""start_span"": 118, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""T"", ""start_span"": 134, ""end_span"": 135, ""type"": ""Chemical/Drug""}]"	valid
Recently, we demonstrated the hepatoprotective effects of nicotinic acid amide, a selective inhibitor of poly ( ADP - ribose) polymerase ( PARP; EC 2. 4. 2. 30) on mice suffering from acetaminophen ( AAP) - hepatitis, suggesting that the AAP - induced liver injury involves a step which depends on adenoribosylation.	nicotinic acid amide,58,78,Chemical/Drug	acetaminophen,184,197,Chemical/Drug	AAP,200,203,Chemical/Drug	AAP,238,241,Chemical/Drug	"[{""token"": ""nicotinic acid amide"", ""start_span"": 58, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 184, ""end_span"": 197, ""type"": ""Chemical/Drug""}, {""token"": ""AAP"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Chemical/Drug""}, {""token"": ""AAP"", ""start_span"": 238, ""end_span"": 241, ""type"": ""Chemical/Drug""}]"	valid
Liver injuries were quantified as serum activities of glutamate - oxaloacetate transaminase ( GOT) and glutamate - pyruvate transaminase ( GPT).	glutamate,54,63,Chemical/Drug	oxaloacetate,66,78,Chemical/Drug	glutamate,103,112,Chemical/Drug	pyruvate,115,123,Chemical/Drug	"[{""token"": ""glutamate"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""oxaloacetate"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""pyruvate"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Chemical/Drug""}]"	valid
Our results provide evidence that the AAP - induced hepatitis and its exacerbation by ethanol can either be reduced by end - product inhibition of PARP by NAA or by dietary depletion of the enzyme ' s substrate NAD.	AAP,38,41,Chemical/Drug	ethanol,86,93,Chemical/Drug	NAA,155,158,Chemical/Drug	NAD,211,214,Chemical/Drug	"[{""token"": ""AAP"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""ethanol"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""NAA"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""NAD"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Chemical/Drug""}]"	valid
A phase I clinical study of the antipurine antifolate lometrexol ( DDATHF) given with oral folic acid.	antipurine,32,42,Chemical/Drug	lometrexol,54,64,Chemical/Drug	DDATHF,67,73,Chemical/Drug	folic acid,91,101,Chemical/Drug	"[{""token"": ""antipurine"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""lometrexol"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""DDATHF"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""folic acid"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Chemical/Drug""}]"	valid
This observation prompted a Phase I clinical study of lometrexol given with folic acid supplementation which has confirmed that the toxicity of lometrexol can be markedly reduced by folic acid supplementation.	lometrexol,54,64,Chemical/Drug	folic acid,76,86,Chemical/Drug	lometrexol,144,154,Chemical/Drug	folic acid,182,192,Chemical/Drug	"[{""token"": ""lometrexol"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""folic acid"", ""start_span"": 76, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""lometrexol"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""folic acid"", ""start_span"": 182, ""end_span"": 192, ""type"": ""Chemical/Drug""}]"	valid
Superoxide and hydrogen peroxide production in neutrophils stimulated with formyl - methionyl - leucyl - phenylalanine ( fMLP) from a further 18 ALF patients was unaffected compared with control neutrophils.	Superoxide,0,10,Chemical/Drug	hydrogen peroxide,15,32,Chemical/Drug	formyl - methionyl - leucyl - phenylalanine,75,118,Chemical/Drug	fMLP,121,125,Chemical/Drug	"[{""token"": ""Superoxide"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""hydrogen peroxide"", ""start_span"": 15, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""formyl - methionyl - leucyl - phenylalanine"", ""start_span"": 75, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""fMLP"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Chemical/Drug""}]"	valid
Our findings do suggest that CS - mediated protection is dependent on the action of the intact anionic CS molecule ( non - hydrolyzable CSE was as protective as CS), whose mechanism has yet to be defined.	CS,29,31,Chemical/Drug	CS,103,105,Chemical/Drug	CSE,136,139,Chemical/Drug	CS,161,163,Chemical/Drug	"[{""token"": ""CS"", ""start_span"": 29, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""CS"", ""start_span"": 103, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""CSE"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""CS"", ""start_span"": 161, ""end_span"": 163, ""type"": ""Chemical/Drug""}]"	valid
Therefore, the effects of carteolol, a beta - adrenoceptor antagonist, on haloperidol - induced catalepsy in rats were behaviorally studied and compared with those of propranolol and biperiden, a muscarinic receptor antagonist.	carteolol,26,35,Chemical/Drug	haloperidol,74,85,Chemical/Drug	propranolol,167,178,Chemical/Drug	biperiden,183,192,Chemical/Drug	"[{""token"": ""carteolol"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""biperiden"", ""start_span"": 183, ""end_span"": 192, ""type"": ""Chemical/Drug""}]"	valid
Carteolol, as well as propranolol and biperiden, inhibited the haloperidol - induced catalepsy.	Carteolol,0,9,Chemical/Drug	propranolol,22,33,Chemical/Drug	biperiden,38,47,Chemical/Drug	haloperidol,63,74,Chemical/Drug	"[{""token"": ""Carteolol"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""biperiden"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical/Drug""}]"	valid
The effects of NIK - 247 on cholinesterase, scopolamine - induced amnesia and spontaneous movement were examined and compared with those of the well - known cholinesterase inhibitors tacrine and E - 2020.	NIK - 247,15,24,Chemical/Drug	scopolamine,44,55,Chemical/Drug	tacrine,183,190,Chemical/Drug	E - 2020,195,203,Chemical/Drug	"[{""token"": ""NIK - 247"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 44, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""tacrine"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""E - 2020"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Chemical/Drug""}]"	valid
We therefore conducted the present acute dose - response study in four 1 - methyl - 4 - phenyl - 1, 2, 3, 6 - tetrahydropyridine ( MPTP) - exposed cynomolgus monkeys primed to exhibit levodopa - induced dyskinesias to evaluate the locomotor and dyskinetic effects on challenge with four doses ( from 0. 03 to 1. 0 mg / kg) of A - 86929 ( [ -] - [ 5aR, 11bS] - 4, 5, 5a, 6, 7, 11b - hexahydro - 2 - propyl - 3 - thia - 5 - + + + azacyclopent - 1 - ena [ c] phenathrene - 9 - 10 - diol), a selective and full DA D1 - like receptor agonist with an intermediate duration of action.	MPTP,131,135,Chemical/Drug	levodopa,184,192,Chemical/Drug	A - 86929,326,335,Chemical/Drug	DA,507,509,Chemical/Drug	"[{""token"": ""MPTP"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Chemical/Drug""}, {""token"": ""levodopa"", ""start_span"": 184, ""end_span"": 192, ""type"": ""Chemical/Drug""}, {""token"": ""A - 86929"", ""start_span"": 326, ""end_span"": 335, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 507, ""end_span"": 509, ""type"": ""Chemical/Drug""}]"	valid
METHOD: Sphincter of Oddi spasm was induced by prostigmine - morphine administration ( 0. 5 mg prostigmine intramuscularly and 10 mg morphine subcutaneously) and visualized by quantitative hepatobiliary scintigraphy.	prostigmine,47,58,Chemical/Drug	morphine,61,69,Chemical/Drug	prostigmine,95,106,Chemical/Drug	morphine,133,141,Chemical/Drug	"[{""token"": ""prostigmine"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""prostigmine"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Chemical/Drug""}]"	valid
Glyceryl trinitrate infusion completely normalized the prostigmine - morphine - induced alterations in these quantitative parameters ( TmaX over the LP: 11. 33 + / - 1. 13; over the HH: 18. 88 + / - 1. 48; and over the CBD: 36. 22 + / - 1. 92; and T1 / 2 over the LP: 28. 21 + / - 1. 83; over the HH: 33. 42 + / - 3. 10; and over the CBD: 41. 66 + / - 6. 33), suggesting an effective sphincter - relaxing effect of glyceryl trinitrate.	Glyceryl trinitrate,0,19,Chemical/Drug	prostigmine,55,66,Chemical/Drug	morphine,69,77,Chemical/Drug	glyceryl trinitrate,415,434,Chemical/Drug	"[{""token"": ""Glyceryl trinitrate"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""prostigmine"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""glyceryl trinitrate"", ""start_span"": 415, ""end_span"": 434, ""type"": ""Chemical/Drug""}]"	valid
BACKGROUND: The most striking of carboplatin ' s advantages ( CBDCA) over cisplatin ( CDDP) is its markedly reduced rate of neurotoxic effects.	carboplatin,33,44,Chemical/Drug	CBDCA,62,67,Chemical/Drug	cisplatin,74,83,Chemical/Drug	CDDP,86,90,Chemical/Drug	"[{""token"": ""carboplatin"", ""start_span"": 33, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""CBDCA"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""cisplatin"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""CDDP"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Chemical/Drug""}]"	valid
In cisapride - treated diarrhoea - predominant patients the mean contraction amplitude was higher ( 29. 3 + / - 3. 2 versus 24. 9 + / - 2. 6 mm Hg, cisapride versus placebo ( P < 0. 001); pretreatment, 25. 7 + / - 6. 0 mm Hg), the mean contraction duration longer ( 3. 4 + / - 0. 2 versus 3. 0 + / - 0. 2 sec, cisapride versus placebo ( P < 0. 001); pretreatment, 3. 1 + / - 0. 5 sec), and the mean contraction frequency lower ( 2. 0 + / - 0. 2 versus 2. 5 + / - 0. 4 cont. / min, cisapride versus placebo ( P < 0. 001); pretreatment, 2. 5 + / - 1. 1 cont. / min] than patients treated with placebo.	cisapride,3,12,Chemical/Drug	cisapride,148,157,Chemical/Drug	cisapride,310,319,Chemical/Drug	cisapride,481,490,Chemical/Drug	"[{""token"": ""cisapride"", ""start_span"": 3, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 310, ""end_span"": 319, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 481, ""end_span"": 490, ""type"": ""Chemical/Drug""}]"	valid
In the motor activity test measured with an Animex - activity meter neither of the K ( +) - channel blockers affected morphine - induced hypoactivity, but both K ( +) - channel blockers prevented morphine - induced secondary hyperactivity.	K,83,84,Chemical/Drug	morphine,118,126,Chemical/Drug	K,160,161,Chemical/Drug	morphine,196,204,Chemical/Drug	"[{""token"": ""K"", ""start_span"": 83, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 160, ""end_span"": 161, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Chemical/Drug""}]"	test
These results suggest the involvement of quinine - sensitive but not 4 - aminopyridine - sensitive K ( +) - channels in morphine reward.	quinine,41,48,Chemical/Drug	4 - aminopyridine,69,86,Chemical/Drug	K,99,100,Chemical/Drug	morphine,120,128,Chemical/Drug	"[{""token"": ""quinine"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""4 - aminopyridine"", ""start_span"": 69, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 99, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Chemical/Drug""}]"	test
Nociceptin / orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice.	Nociceptin,0,10,Chemical/Drug	orphanin FQ,13,24,Chemical/Drug	nocistatin,29,39,Chemical/Drug	scopolamine,85,96,Chemical/Drug	"[{""token"": ""Nociceptin"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""orphanin FQ"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""nocistatin"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 85, ""end_span"": 96, ""type"": ""Chemical/Drug""}]"	test
The present study was designed to investigate whether nociceptin / orphanin FQ and nocistatin could modulate impairment of learning and memory induced by scopolamine, a muscarinic cholinergic receptor antagonist, using spontaneous alternation of Y - maze and step - down type passive avoidance tasks in mice.	nociceptin,54,64,Chemical/Drug	orphanin FQ,67,78,Chemical/Drug	nocistatin,83,93,Chemical/Drug	scopolamine,154,165,Chemical/Drug	"[{""token"": ""nociceptin"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""orphanin FQ"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""nocistatin"", ""start_span"": 83, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 154, ""end_span"": 165, ""type"": ""Chemical/Drug""}]"	test
These data show that the catechol and hydroquinone metabolites of remoxipride have direct toxic effects in HL60 and HBMP cells, leading to apoptosis, while the phenol metabolites were inactive.	catechol,25,33,Chemical/Drug	hydroquinone,38,50,Chemical/Drug	remoxipride,66,77,Chemical/Drug	phenol,160,166,Chemical/Drug	"[{""token"": ""catechol"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""hydroquinone"", ""start_span"": 38, ""end_span"": 50, ""type"": ""Chemical/Drug""}, {""token"": ""remoxipride"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""phenol"", ""start_span"": 160, ""end_span"": 166, ""type"": ""Chemical/Drug""}]"	test
Similarly, benzene - derived catechol and hydroquinone, but not phenol, induce apoptosis in HBMP cells [ Moran et al., Mol. Pharmacol., 50 ( 1996) 610 - 615].	benzene,11,18,Chemical/Drug	catechol,29,37,Chemical/Drug	hydroquinone,42,54,Chemical/Drug	phenol,64,70,Chemical/Drug	"[{""token"": ""benzene"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""catechol"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""hydroquinone"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""phenol"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Chemical/Drug""}]"	test
We compared the toxicity of NS - 718 with that of Fungizone ( amphotericin B - sodium deoxycholate; D - AmB) in vitro using renal cell cultures and in vivo by biochemical analysis, histopathological study of the kidney and pharmacokinetic study of amphotericin B following intravenous infusion of the formulation in rats.	Fungizone,50,59,Chemical/Drug	amphotericin B - sodium deoxycholate,62,98,Chemical/Drug	D - AmB,100,107,Chemical/Drug	amphotericin B,248,262,Chemical/Drug	"[{""token"": ""Fungizone"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""amphotericin B - sodium deoxycholate"", ""start_span"": 62, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""D - AmB"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""amphotericin B"", ""start_span"": 248, ""end_span"": 262, ""type"": ""Chemical/Drug""}]"	test
Their combined cardiac toxicity may be due to independent effects of each drug; however, they may also be due to cocaethylene ( CE), a cocaine metabolite formed only in the presence of ethanol.	cocaethylene,113,125,Chemical/Drug	CE,128,130,Chemical/Drug	cocaine,135,142,Chemical/Drug	ethanol,185,192,Chemical/Drug	"[{""token"": ""cocaethylene"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""CE"", ""start_span"": 128, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Chemical/Drug""}, {""token"": ""ethanol"", ""start_span"": 185, ""end_span"": 192, ""type"": ""Chemical/Drug""}]"	test
METHODS: Twenty - three dogs were randomized to receive either 1) three intravenous ( IV) boluses of cocaine 7. 5 mg / kg with ethanol ( 1 g / kg) as an IV infusion ( C + E, n = 8), 2) three cocaine boluses only ( C, n = 6), 3) ethanol infusion only ( E, n = 5), or 4) placebo boluses and infusion ( n = 4).	cocaine,101,108,Chemical/Drug	ethanol,127,134,Chemical/Drug	cocaine,191,198,Chemical/Drug	ethanol,228,235,Chemical/Drug	"[{""token"": ""cocaine"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""ethanol"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 191, ""end_span"": 198, ""type"": ""Chemical/Drug""}, {""token"": ""ethanol"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Chemical/Drug""}]"	test
Overexpression of copper / zinc - superoxide dismutase protects from kanamycin - induced hearing loss.	copper,18,24,Chemical/Drug	zinc,27,31,Chemical/Drug	superoxide,34,44,Chemical/Drug	kanamycin,69,78,Chemical/Drug	"[{""token"": ""copper"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""zinc"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""superoxide"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""kanamycin"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Chemical/Drug""}]"	test
With provision of adequate oleic acid as a substrate for the isolated perfused liver, a direct relationship was observed between dose of tetracycline and both accumulation of triglyceride in the liver and depression of output of triglyceride by livers from male and female rats.	oleic acid,27,37,Chemical/Drug	tetracycline,137,149,Chemical/Drug	triglyceride,175,187,Chemical/Drug	triglyceride,229,241,Chemical/Drug	"[{""token"": ""oleic acid"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""tetracycline"", ""start_span"": 137, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""triglyceride"", ""start_span"": 175, ""end_span"": 187, ""type"": ""Chemical/Drug""}, {""token"": ""triglyceride"", ""start_span"": 229, ""end_span"": 241, ""type"": ""Chemical/Drug""}]"	test
Depressed hepatic secretion of triglyceride accounted only for 30 to 50% of accumulated hepatic triglyceride, indicating that additional mechanisms must be involved in the production of the triglyceride - rich fatty liver in response to tetracycline.	triglyceride,31,43,Chemical/Drug	triglyceride,96,108,Chemical/Drug	triglyceride,190,202,Chemical/Drug	tetracycline,237,249,Chemical/Drug	"[{""token"": ""triglyceride"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""triglyceride"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""triglyceride"", ""start_span"": 190, ""end_span"": 202, ""type"": ""Chemical/Drug""}, {""token"": ""tetracycline"", ""start_span"": 237, ""end_span"": 249, ""type"": ""Chemical/Drug""}]"	test
There were 6 cases implicating clarithromycin, 13 implicating isoniazid, and 1 case each implicating erythromycin and amoxicillin.	clarithromycin,31,45,Chemical/Drug	isoniazid,62,71,Chemical/Drug	erythromycin,101,113,Chemical/Drug	amoxicillin,118,129,Chemical/Drug	"[{""token"": ""clarithromycin"", ""start_span"": 31, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""isoniazid"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""erythromycin"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""amoxicillin"", ""start_span"": 118, ""end_span"": 129, ""type"": ""Chemical/Drug""}]"	test
However, DCF continued to be effective in reducing pelvic pain for two hours, whereas GTN scores remained more or less stable after 30 min and significantly higher than those for DFC ( after one hour: GTN, - 12. 8 + / - 17. 9; DFC, - 18. 9 + / - 16. 6 and after two hours: GTN, - 23. 7 + / - 20. 5; DFC, - 59. 7 + / - 17. 9, p = 0. 0001).	DCF,9,12,Chemical/Drug	GTN,86,89,Chemical/Drug	GTN,201,204,Chemical/Drug	GTN,273,276,Chemical/Drug	"[{""token"": ""DCF"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""GTN"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""GTN"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Chemical/Drug""}, {""token"": ""GTN"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Chemical/Drug""}]"	test
The purpose of the present study was to determine whether chronic administration of temocapril, a long - acting non - SH group angiotensin converting enzyme ( ACE) inhibitor, reduced proteinuria, inhibited glomerular hypertrophy and prevented glomerulosclerosis in chronic puromycin aminonucleoside ( PAN) - induced nephrotic rats.	temocapril,84,94,Chemical/Drug	angiotensin,127,138,Chemical/Drug	puromycin aminonucleoside,273,298,Chemical/Drug	PAN,301,304,Chemical/Drug	"[{""token"": ""temocapril"", ""start_span"": 84, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""angiotensin"", ""start_span"": 127, ""end_span"": 138, ""type"": ""Chemical/Drug""}, {""token"": ""puromycin aminonucleoside"", ""start_span"": 273, ""end_span"": 298, ""type"": ""Chemical/Drug""}, {""token"": ""PAN"", ""start_span"": 301, ""end_span"": 304, ""type"": ""Chemical/Drug""}]"	test
Four groups were used, i) the PAN group ( 14), ii) PAN / temocapril ( 13), iii) temocapril ( 14) and iv) untreated controls ( 15).	PAN,30,33,Chemical/Drug	PAN,51,54,Chemical/Drug	temocapril,57,67,Chemical/Drug	temocapril,80,90,Chemical/Drug	"[{""token"": ""PAN"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""PAN"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""temocapril"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""temocapril"", ""start_span"": 80, ""end_span"": 90, ""type"": ""Chemical/Drug""}]"	test
BACKGROUND: The 24 - hour continuous infusion of 5 - fluorouracil ( 5 - FU) and folinic acid ( FA) as part of several new multidrug chemotherapy regimens in advanced gastric cancer ( AGC) has shown to be effective, with low toxicity.	5 - fluorouracil,49,65,Chemical/Drug	5 - FU,68,74,Chemical/Drug	folinic acid,80,92,Chemical/Drug	FA,95,97,Chemical/Drug	"[{""token"": ""5 - fluorouracil"", ""start_span"": 49, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""folinic acid"", ""start_span"": 80, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""FA"", ""start_span"": 95, ""end_span"": 97, ""type"": ""Chemical/Drug""}]"	test
In a previous phase II study with 3 - weekly bolus 5 - FU, FA and mitomycin C ( MMC) we found a low toxicity rate and response rates comparable to those of regimens such as ELF, FAM or FAMTX, and a promising median overall survival.	5 - FU,51,57,Chemical/Drug	FA,59,61,Chemical/Drug	mitomycin C,66,77,Chemical/Drug	MMC,80,83,Chemical/Drug	"[{""token"": ""5 - FU"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""FA"", ""start_span"": 59, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""mitomycin C"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""MMC"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Chemical/Drug""}]"	test
In order to improve this MMC - dependent schedule we initiated a phase II study with high - dose 5 - FU / FA and 3 - weekly bolus MMC.	MMC,25,28,Chemical/Drug	5 - FU,97,103,Chemical/Drug	FA,106,108,Chemical/Drug	MMC,130,133,Chemical/Drug	"[{""token"": ""MMC"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""FA"", ""start_span"": 106, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""MMC"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Chemical/Drug""}]"	test
Adrenaline - induced hypertension was used to destroy the BBB, which was evaluated using triphenyltetrazolium ( TTC) staining of the brain slices just after giving adrenaline for 30 s.	Adrenaline,0,10,Chemical/Drug	triphenyltetrazolium,89,109,Chemical/Drug	TTC,112,115,Chemical/Drug	adrenaline,164,174,Chemical/Drug	"[{""token"": ""Adrenaline"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""triphenyltetrazolium"", ""start_span"": 89, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""TTC"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""adrenaline"", ""start_span"": 164, ""end_span"": 174, ""type"": ""Chemical/Drug""}]"	test
Multivariable logistic regression was used to estimate the odds ratio ( OR) of pacemaker insertion associated with amiodarone use, controlling for baseline risk factors and exposure to sotalol, Class I antiarrhythmic agents, beta - blockers, calcium channel blockers, and digoxin.	amiodarone,115,125,Chemical/Drug	sotalol,185,192,Chemical/Drug	calcium,242,249,Chemical/Drug	digoxin,272,279,Chemical/Drug	"[{""token"": ""amiodarone"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""sotalol"", ""start_span"": 185, ""end_span"": 192, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 242, ""end_span"": 249, ""type"": ""Chemical/Drug""}, {""token"": ""digoxin"", ""start_span"": 272, ""end_span"": 279, ""type"": ""Chemical/Drug""}]"	test
After determining the bupivacaine AD50 ( the concentration of bupivacaine that caused 50% of all beating rat heart myocyte cultures to become arrhythmic), we determined the effect of 1 - hour progesterone HCl exposure on myocyte contractile rhythm.	bupivacaine,22,33,Chemical/Drug	bupivacaine,62,73,Chemical/Drug	progesterone,192,204,Chemical/Drug	HCl,205,208,Chemical/Drug	"[{""token"": ""bupivacaine"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""bupivacaine"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""progesterone"", ""start_span"": 192, ""end_span"": 204, ""type"": ""Chemical/Drug""}, {""token"": ""HCl"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Chemical/Drug""}]"	test
Neither progesterone nor estradiol effects on bupivacaine arrhythmogenicity were potentiated by epinephrine.	progesterone,8,20,Chemical/Drug	estradiol,25,34,Chemical/Drug	bupivacaine,46,57,Chemical/Drug	epinephrine,96,107,Chemical/Drug	"[{""token"": ""progesterone"", ""start_span"": 8, ""end_span"": 20, ""type"": ""Chemical/Drug""}, {""token"": ""estradiol"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""bupivacaine"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Chemical/Drug""}]"	test
Phenylalanine, a large neutral amino acid ( LNAA) competing with levodopa for transport across the blood - brain barrier, reduced the hypotensive and antiparkinsonian effects of levodopa.	Phenylalanine,0,13,Chemical/Drug	amino acid,31,41,Chemical/Drug	levodopa,65,73,Chemical/Drug	levodopa,178,186,Chemical/Drug	"[{""token"": ""Phenylalanine"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Chemical/Drug""}, {""token"": ""amino acid"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""levodopa"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""levodopa"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Chemical/Drug""}]"	test
After normal serum sodium levels returned, further doxorubicin and dexamethasone chemotherapy without vincristine did not produce this complication.	sodium,19,25,Chemical/Drug	doxorubicin,51,62,Chemical/Drug	dexamethasone,67,80,Chemical/Drug	vincristine,102,113,Chemical/Drug	"[{""token"": ""sodium"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 67, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""vincristine"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical/Drug""}]"	test
The purpose of the present study was to determine if elevated reactive oxygen ( ROS) / nitrogen species ( RNS) reported to be present in adriamycin ( ADR) - induced cardiotoxicity actually resulted in cardiomyocyte oxidative / nitrative damage, and to quantitatively determine the time course and subcellular localization of these postulated damage products using an in vivo approach.	oxygen,71,77,Chemical/Drug	nitrogen,87,95,Chemical/Drug	adriamycin,137,147,Chemical/Drug	ADR,150,153,Chemical/Drug	"[{""token"": ""oxygen"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""nitrogen"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""adriamycin"", ""start_span"": 137, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""ADR"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Chemical/Drug""}]"	test
Ultrastructural damage and levels of 4 - hydroxy - 2 - nonenal ( 4HNE) - protein adducts and 3 - nitrotyrosine ( 3NT) were analyzed.	4 - hydroxy - 2 - nonenal,37,62,Chemical/Drug	4HNE,65,69,Chemical/Drug	3 - nitrotyrosine,93,110,Chemical/Drug	3NT,113,116,Chemical/Drug	"[{""token"": ""4 - hydroxy - 2 - nonenal"", ""start_span"": 37, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""4HNE"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""3 - nitrotyrosine"", ""start_span"": 93, ""end_span"": 110, ""type"": ""Chemical/Drug""}, {""token"": ""3NT"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Chemical/Drug""}]"	test
This study investigated the expression of nuclear factor - kappaB ( NF - kappaB), mitogen - activated protein ( MAP) kinases and macrophages in the renal cortex and structural and functional renal changes of rats treated with gentamicin or gentamicin + pyrrolidine dithiocarbamate ( PDTC), an NF - kappaB inhibitor.	gentamicin,226,236,Chemical/Drug	gentamicin,240,250,Chemical/Drug	pyrrolidine dithiocarbamate,253,280,Chemical/Drug	PDTC,283,287,Chemical/Drug	"[{""token"": ""gentamicin"", ""start_span"": 226, ""end_span"": 236, ""type"": ""Chemical/Drug""}, {""token"": ""gentamicin"", ""start_span"": 240, ""end_span"": 250, ""type"": ""Chemical/Drug""}, {""token"": ""pyrrolidine dithiocarbamate"", ""start_span"": 253, ""end_span"": 280, ""type"": ""Chemical/Drug""}, {""token"": ""PDTC"", ""start_span"": 283, ""end_span"": 287, ""type"": ""Chemical/Drug""}]"	test
METHODS: 38 female Wistar rats were injected with gentamicin, 40 mg / kg, twice a day for 9 days, 38 with gentamicin + PDTC, and 28 with 0. 15 M NaCl solution.	gentamicin,50,60,Chemical/Drug	gentamicin,106,116,Chemical/Drug	PDTC,119,123,Chemical/Drug	NaCl,145,149,Chemical/Drug	"[{""token"": ""gentamicin"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""gentamicin"", ""start_span"": 106, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""PDTC"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""NaCl"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Chemical/Drug""}]"	test
OBJECTIVE: To study the 2 drugs most clearly implicated ( clozapine and olanzapine) and risperidone using a frequently sampled intravenous glucose tolerance test.	clozapine,58,67,Chemical/Drug	olanzapine,72,82,Chemical/Drug	risperidone,88,99,Chemical/Drug	glucose,139,146,Chemical/Drug	"[{""token"": ""clozapine"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""olanzapine"", ""start_span"": 72, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""risperidone"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Chemical/Drug""}]"	test
CONCLUSIONS: Both nonobese clozapine - and olanzapine - treated groups displayed significant insulin resistance and impairment of glucose effectiveness compared with risperidone - treated subjects.	clozapine,27,36,Chemical/Drug	olanzapine,43,53,Chemical/Drug	glucose,130,137,Chemical/Drug	risperidone,166,177,Chemical/Drug	"[{""token"": ""clozapine"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""olanzapine"", ""start_span"": 43, ""end_span"": 53, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""risperidone"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Chemical/Drug""}]"	test
Safety of celecoxib in patients with adverse skin reactions to acetaminophen ( paracetamol) and nimesulide associated or not with common non - steroidal anti - inflammatory drugs.	celecoxib,10,19,Chemical/Drug	acetaminophen,63,76,Chemical/Drug	paracetamol,79,90,Chemical/Drug	nimesulide,96,106,Chemical/Drug	"[{""token"": ""celecoxib"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 63, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""paracetamol"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""nimesulide"", ""start_span"": 96, ""end_span"": 106, ""type"": ""Chemical/Drug""}]"	test
To investigate how GAP43 expression ( GAP43 - ir) correlates with MFS, we assessed the intensity ( densitometry) and extension ( width) of GAP43 - ir in the inner molecular layer of the dentate gyrus ( IML) of rats subject to status epilepticus induced by pilocarpine ( Pilo), previously injected or not with cycloheximide ( CHX), which has been shown to inhibit MFS.	pilocarpine,256,267,Chemical/Drug	Pilo,270,274,Chemical/Drug	cycloheximide,309,322,Chemical/Drug	CHX,325,328,Chemical/Drug	"[{""token"": ""pilocarpine"", ""start_span"": 256, ""end_span"": 267, ""type"": ""Chemical/Drug""}, {""token"": ""Pilo"", ""start_span"": 270, ""end_span"": 274, ""type"": ""Chemical/Drug""}, {""token"": ""cycloheximide"", ""start_span"": 309, ""end_span"": 322, ""type"": ""Chemical/Drug""}, {""token"": ""CHX"", ""start_span"": 325, ""end_span"": 328, ""type"": ""Chemical/Drug""}]"	test
VCM administration to control rats significantly increased renal malondialdehyde ( MDA) and urinary N - acetyl - beta - d - glucosaminidase ( NAG, a marker of renal tubular injury) excretion but decreased superoxide dismutase ( SOD) and catalase ( CAT) activities.	VCM,0,3,Chemical/Drug	malondialdehyde,65,80,Chemical/Drug	MDA,83,86,Chemical/Drug	superoxide,205,215,Chemical/Drug	"[{""token"": ""VCM"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical/Drug""}, {""token"": ""malondialdehyde"", ""start_span"": 65, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""MDA"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""superoxide"", ""start_span"": 205, ""end_span"": 215, ""type"": ""Chemical/Drug""}]"	test
Erdosteine administration with VCM injections caused significantly decreased renal MDA and urinary NAG excretion, and increased SOD activity, but not CAT activity in renal tissue when compared with VCM alone.	Erdosteine,0,10,Chemical/Drug	VCM,31,34,Chemical/Drug	MDA,83,86,Chemical/Drug	VCM,198,201,Chemical/Drug	"[{""token"": ""Erdosteine"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""VCM"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""MDA"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""VCM"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Chemical/Drug""}]"	test
Instead, oral administration of S - 1 ( a derivative of 5 - FU), at 200 mg / day twice a week, was instituted, because S - 1 has a strong inhibitory effect on dihydropyrimidine dehydrogenase, which catalyzes the degradative of 5 - FU into FBAL.	5 - FU,56,62,Chemical/Drug	dihydropyrimidine,159,176,Chemical/Drug	5 - FU,227,233,Chemical/Drug	FBAL,239,243,Chemical/Drug	"[{""token"": ""5 - FU"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""dihydropyrimidine"", ""start_span"": 159, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 227, ""end_span"": 233, ""type"": ""Chemical/Drug""}, {""token"": ""FBAL"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Chemical/Drug""}]"	test
Because of the relatively short final half - life of monoHER ( about 30 min), it is expected that the time interval between monoHER and DOX might be of influence on the cardioprotective effect of monoHER.	monoHER,53,60,Chemical/Drug	monoHER,124,131,Chemical/Drug	DOX,136,139,Chemical/Drug	monoHER,196,203,Chemical/Drug	"[{""token"": ""monoHER"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""monoHER"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""monoHER"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Chemical/Drug""}]"	test
Chloroacetaldehyde as a sulfhydryl reagent: the role of critical thiol groups in ifosfamide nephropathy.	Chloroacetaldehyde,0,18,Chemical/Drug	sulfhydryl,24,34,Chemical/Drug	thiol,65,70,Chemical/Drug	ifosfamide,81,91,Chemical/Drug	"[{""token"": ""Chloroacetaldehyde"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""sulfhydryl"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""thiol"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""ifosfamide"", ""start_span"": 81, ""end_span"": 91, ""type"": ""Chemical/Drug""}]"	test
Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17. 3% ( 95% CI = 14. 2% - 20. 5%) with olanzapine and 11. 3% ( 95% CI = 8. 4% - 14. 3%) with risperidone.	olanzapine,45,55,Chemical/Drug	risperidone,66,77,Chemical/Drug	olanzapine,186,196,Chemical/Drug	risperidone,240,251,Chemical/Drug	"[{""token"": ""olanzapine"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""risperidone"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""olanzapine"", ""start_span"": 186, ""end_span"": 196, ""type"": ""Chemical/Drug""}, {""token"": ""risperidone"", ""start_span"": 240, ""end_span"": 251, ""type"": ""Chemical/Drug""}]"	test
In the preceding months she had received neo - adjuvant chemotherapy with epirubicin, paclitaxel ( Taxol) and cyclophosphamide.	epirubicin,74,84,Chemical/Drug	paclitaxel,86,96,Chemical/Drug	Taxol,99,104,Chemical/Drug	cyclophosphamide,110,126,Chemical/Drug	"[{""token"": ""epirubicin"", ""start_span"": 74, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""paclitaxel"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""Taxol"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 110, ""end_span"": 126, ""type"": ""Chemical/Drug""}]"	test
RESULTS: Person - years of exposure among non - users of aspirin were: 75, 761 to acetaminophen, 42, 671 to rofecoxib 65, 860 to celecoxib, and 37, 495 to NS - NSAIDs.	aspirin,57,64,Chemical/Drug	acetaminophen,82,95,Chemical/Drug	rofecoxib,108,117,Chemical/Drug	celecoxib,129,138,Chemical/Drug	"[{""token"": ""aspirin"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""rofecoxib"", ""start_span"": 108, ""end_span"": 117, ""type"": ""Chemical/Drug""}, {""token"": ""celecoxib"", ""start_span"": 129, ""end_span"": 138, ""type"": ""Chemical/Drug""}]"	test
Among users of aspirin, they were: 14, 671 to rofecoxib, 22, 875 to celecoxib, 9, 832 to NS - NSAIDs and 38, 048 to acetaminophen.	aspirin,15,22,Chemical/Drug	rofecoxib,46,55,Chemical/Drug	celecoxib,68,77,Chemical/Drug	acetaminophen,116,129,Chemical/Drug	"[{""token"": ""aspirin"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""rofecoxib"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""celecoxib"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 116, ""end_span"": 129, ""type"": ""Chemical/Drug""}]"	test
OBJECTIVE: This study investigated the efficacy and tolerability of valsartan ( VAL) or hydrochlorothiazide ( HCTZ) - monotherapy and higher - dose combinations in patients with essential hypertension.	valsartan,68,77,Chemical/Drug	VAL,80,83,Chemical/Drug	hydrochlorothiazide,88,107,Chemical/Drug	HCTZ,110,114,Chemical/Drug	"[{""token"": ""valsartan"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""VAL"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""hydrochlorothiazide"", ""start_span"": 88, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""HCTZ"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Chemical/Drug""}]"	test
Patients with essential hypertension ( mean sitting diastolic BP [ MSDBP], > or = 95 mm Hg and < 110 mm Hg) were randomized to 1 of 8 treatment groups: VAL 160 or 320 mg; HCTZ 12. 5 or 25 mg; VAL / HCTZ 160 / 12. 5, 320 / 12. 5, or 320 / 25 mg; or placebo.	VAL,152,155,Chemical/Drug	HCTZ,171,175,Chemical/Drug	VAL,192,195,Chemical/Drug	HCTZ,198,202,Chemical/Drug	"[{""token"": ""VAL"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""HCTZ"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Chemical/Drug""}, {""token"": ""VAL"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Chemical/Drug""}, {""token"": ""HCTZ"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Chemical/Drug""}]"	test
The reduction in MSSBP was significantly greater with VAL / HCTZ 320 / 25 mg compared with VAL / HCTZ 160 / 12. 5 mg ( P < 0. 002).	VAL,54,57,Chemical/Drug	HCTZ,60,64,Chemical/Drug	VAL,91,94,Chemical/Drug	HCTZ,97,101,Chemical/Drug	"[{""token"": ""VAL"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""HCTZ"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""VAL"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""HCTZ"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Chemical/Drug""}]"	test
This study was designed to evaluate the alterations in offspring rat cerebellum induced by maternal exposure to carmustine - [ 1, 3 - bis ( 2 - chloroethyl) - 1 - nitrosoure] ( BCNU) and to investigate the effects of exogenous melatonin upon cerebellar BCNU - induced cortical dysplasia, using histological and biochemical analyses.	carmustine,112,122,Chemical/Drug	BCNU,177,181,Chemical/Drug	melatonin,227,236,Chemical/Drug	BCNU,253,257,Chemical/Drug	"[{""token"": ""carmustine"", ""start_span"": 112, ""end_span"": 122, ""type"": ""Chemical/Drug""}, {""token"": ""BCNU"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Chemical/Drug""}, {""token"": ""melatonin"", ""start_span"": 227, ""end_span"": 236, ""type"": ""Chemical/Drug""}, {""token"": ""BCNU"", ""start_span"": 253, ""end_span"": 257, ""type"": ""Chemical/Drug""}]"	test
Pregnant Wistar rats were assigned to five groups: intact - control, saline - control, melatonin - treated, BCNU - exposed and BCNU - exposed plus melatonin.	melatonin,87,96,Chemical/Drug	BCNU,108,112,Chemical/Drug	BCNU,127,131,Chemical/Drug	melatonin,147,156,Chemical/Drug	"[{""token"": ""melatonin"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""BCNU"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""BCNU"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""melatonin"", ""start_span"": 147, ""end_span"": 156, ""type"": ""Chemical/Drug""}]"	test
However, the maximal reduction in body weight seen in animals that received polymer - bound DOX ( 4 mg / kg) was significantly lower than that observed in those that received free DOX ( 4 mg / kg) or a mixture of the unmodified parent HPMA copolymer and free DOX ( 4 mg / kg; P less than 0. 01).	DOX,92,95,Chemical/Drug	DOX,180,183,Chemical/Drug	HPMA,235,239,Chemical/Drug	DOX,259,262,Chemical/Drug	"[{""token"": ""DOX"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Chemical/Drug""}, {""token"": ""HPMA"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 259, ""end_span"": 262, ""type"": ""Chemical/Drug""}]"	test
Throughout the study ( 20 weeks), deaths related to cardiotoxicity were observed only in animals that received either free DOX or the mixture of HPMA copolymer and free DOX; in these cases, histological investigations revealed marked changes in the heart that were consistent with DOX - induced cardiotoxicity.	DOX,123,126,Chemical/Drug	HPMA,145,149,Chemical/Drug	DOX,169,172,Chemical/Drug	DOX,281,284,Chemical/Drug	"[{""token"": ""DOX"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""HPMA"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 281, ""end_span"": 284, ""type"": ""Chemical/Drug""}]"	test
This study shows that MIP synthase inhibition does not replicate or augment the effects of lithium in the inositol sensitive pilocarpine - induced seizures model.	MIP,22,25,Chemical/Drug	lithium,91,98,Chemical/Drug	inositol,106,114,Chemical/Drug	pilocarpine,125,136,Chemical/Drug	"[{""token"": ""MIP"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""inositol"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Chemical/Drug""}]"	test
He then presented to the emergency department feeling quite ill and was found to have a blood urea nitrogen ( BUN) concentration of of 147 mg / dl, creatinine of 15. 3 mg / dl and serum potassium of 8. 7 mEq / l.	blood urea nitrogen,88,107,Chemical/Drug	BUN,110,113,Chemical/Drug	creatinine,148,158,Chemical/Drug	potassium,186,195,Chemical/Drug	"[{""token"": ""blood urea nitrogen"", ""start_span"": 88, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""BUN"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 148, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 186, ""end_span"": 195, ""type"": ""Chemical/Drug""}]"	test
CONCLUSIONS: Initiating treatment of type 2 diabetes with glibenclamide or glipizide is associated with increased risk of CAD in comparison to gliclazide or glimepiride.	glibenclamide,58,71,Chemical/Drug	glipizide,75,84,Chemical/Drug	gliclazide,143,153,Chemical/Drug	glimepiride,157,168,Chemical/Drug	"[{""token"": ""glibenclamide"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""glipizide"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""gliclazide"", ""start_span"": 143, ""end_span"": 153, ""type"": ""Chemical/Drug""}, {""token"": ""glimepiride"", ""start_span"": 157, ""end_span"": 168, ""type"": ""Chemical/Drug""}]"	test
BACKGROUND: The aim of the study was to investigate the antihypertensive effects of angiotensin II type - 1 receptor blocker, losartan, and its potential in slowing down renal disease progression in spontaneously hypertensive rats ( SHR) with adriamycin ( ADR) nephropathy.	angiotensin II,84,98,Chemical/Drug	losartan,126,134,Chemical/Drug	adriamycin,243,253,Chemical/Drug	ADR,256,259,Chemical/Drug	"[{""token"": ""angiotensin II"", ""start_span"": 84, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""losartan"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Chemical/Drug""}, {""token"": ""adriamycin"", ""start_span"": 243, ""end_span"": 253, ""type"": ""Chemical/Drug""}, {""token"": ""ADR"", ""start_span"": 256, ""end_span"": 259, ""type"": ""Chemical/Drug""}]"	test
( +) - Propranolol had no effect on fatty acid mobilization but significantly reduced the increments in both lactate and glucose. 4.	Propranolol,7,18,Chemical/Drug	fatty acid,36,46,Chemical/Drug	lactate,109,116,Chemical/Drug	glucose,121,128,Chemical/Drug	"[{""token"": ""Propranolol"", ""start_span"": 7, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""fatty acid"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""lactate"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Chemical/Drug""}]"	test
Anti - thyroid drugs, like carbimazole and propylthiouracil ( PTU) are commonly prescribed for the treatment of hyperthyroidism.	Anti - thyroid drugs,0,20,Chemical/Drug	carbimazole,27,38,Chemical/Drug	propylthiouracil,43,59,Chemical/Drug	PTU,62,65,Chemical/Drug	"[{""token"": ""Anti - thyroid drugs"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Chemical/Drug""}, {""token"": ""carbimazole"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""propylthiouracil"", ""start_span"": 43, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""PTU"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Chemical/Drug""}]"	test
Citrate dialysate, a new dialysate with citric acid can be used for anticoagulation in patients who cannot tolerate heparin or regional citrate.	Citrate,0,7,Chemical/Drug	citric acid,40,51,Chemical/Drug	heparin,116,123,Chemical/Drug	citrate,136,143,Chemical/Drug	"[{""token"": ""Citrate"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""citric acid"", ""start_span"": 40, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""heparin"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""citrate"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Chemical/Drug""}]"	test
The obtained data revealed that BCNU administration resulted in deterioration of learning and short - term memory ( STM), as measured by using radial arm water maze, accompanied with decreased hippocampal glutathione reductase ( GR) activity and reduced glutathione ( GSH) content.	BCNU,32,36,Chemical/Drug	glutathione,205,216,Chemical/Drug	glutathione,254,265,Chemical/Drug	GSH,268,271,Chemical/Drug	"[{""token"": ""BCNU"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""glutathione"", ""start_span"": 205, ""end_span"": 216, ""type"": ""Chemical/Drug""}, {""token"": ""glutathione"", ""start_span"": 254, ""end_span"": 265, ""type"": ""Chemical/Drug""}, {""token"": ""GSH"", ""start_span"": 268, ""end_span"": 271, ""type"": ""Chemical/Drug""}]"	test
Also, BCNU administration increased serum tumor necrosis factor - alpha ( TNFalpha), hippocampal MT and malondialdehyde ( MDA) contents as well as caspase - 3 activity in addition to histological alterations.	BCNU,6,10,Chemical/Drug	MT,97,99,Chemical/Drug	malondialdehyde,104,119,Chemical/Drug	MDA,122,125,Chemical/Drug	"[{""token"": ""BCNU"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""MT"", ""start_span"": 97, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""malondialdehyde"", ""start_span"": 104, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""MDA"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Chemical/Drug""}]"	test
In conclusion, MT induction halts BCNU - induced hippocampal toxicity as it prevented GR inhibition and GSH depletion and counteracted the increased levels of TNFalpha, MDA and caspase - 3 activity with subsequent preservation of cognition.	MT,15,17,Chemical/Drug	BCNU,34,38,Chemical/Drug	GSH,104,107,Chemical/Drug	MDA,169,172,Chemical/Drug	"[{""token"": ""MT"", ""start_span"": 15, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""BCNU"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""GSH"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""MDA"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Chemical/Drug""}]"	test
RESULTS: The maximum nonsedating doses were: morphine, 3. 2 mg / kg; CNSB002 10. 0 mg / kg; 5. 0 mg / kg CNSB002 with morphine 3. 2 mg / kg in combination.	morphine,45,53,Chemical/Drug	CNSB002,69,76,Chemical/Drug	CNSB002,105,112,Chemical/Drug	morphine,118,126,Chemical/Drug	"[{""token"": ""morphine"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Chemical/Drug""}, {""token"": ""CNSB002"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""CNSB002"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Chemical/Drug""}]"	test
The doses calculated to cause 50% reversal of hyperalgesia ( ED50) were 7. 54 ( 1. 81) and 4. 83 ( 1. 54) in the carrageenan model and 44. 18 ( 1. 37) and 9. 14 ( 1. 24) in the STZ - induced neuropathy model for CNSB002 and morphine, respectively ( mg / kg; mean, SEM).	carrageenan,113,124,Chemical/Drug	STZ,177,180,Chemical/Drug	CNSB002,212,219,Chemical/Drug	morphine,224,232,Chemical/Drug	"[{""token"": ""carrageenan"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Chemical/Drug""}, {""token"": ""STZ"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""CNSB002"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 224, ""end_span"": 232, ""type"": ""Chemical/Drug""}]"	test
Treatment was empirically initiated with vancomycin, levofloxacin, and piperacillin / tazobactam.	vancomycin,41,51,Chemical/Drug	levofloxacin,53,65,Chemical/Drug	piperacillin,71,83,Chemical/Drug	tazobactam,86,96,Chemical/Drug	"[{""token"": ""vancomycin"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""levofloxacin"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""tazobactam"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Chemical/Drug""}]"	test
The rats in the control group were intraperitoneally ( i. p.) injected with 0. 9% saline ( 4 ml / kg); the rats in the model group were i. p. injected with CYP ( 150 mg / kg); and the rats in the intervention group were i. p. injected with CYP with subsequently perfusion of bladder with P2X3 and NK1 receptors ' antagonists, Suramin and GR 82334.	CYP,156,159,Chemical/Drug	CYP,240,243,Chemical/Drug	Suramin,326,333,Chemical/Drug	GR 82334,338,346,Chemical/Drug	"[{""token"": ""CYP"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""CYP"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Chemical/Drug""}, {""token"": ""Suramin"", ""start_span"": 326, ""end_span"": 333, ""type"": ""Chemical/Drug""}, {""token"": ""GR 82334"", ""start_span"": 338, ""end_span"": 346, ""type"": ""Chemical/Drug""}]"	test
Bortezomib ( bort) - dexamethasone ( dex) is an effective therapy for relapsed / refractory ( R / R) multiple myeloma ( MM).	Bortezomib,0,10,Chemical/Drug	bort,13,17,Chemical/Drug	dexamethasone,21,34,Chemical/Drug	dex,37,40,Chemical/Drug	"[{""token"": ""Bortezomib"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""bort"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 21, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""dex"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Chemical/Drug""}]"	test
Busulfan levels were measured by a gas chromatographic - mass spectrometry assay in the plasma and cerebrospinal fluid of 9 children without central nervous system disease under 600 mg / m2 busulfan with clonazepam: busulfan cerebrospinal fluid: plasma ratio was 1. 39.	Busulfan,0,8,Chemical/Drug	busulfan,190,198,Chemical/Drug	clonazepam,204,214,Chemical/Drug	busulfan,216,224,Chemical/Drug	"[{""token"": ""Busulfan"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""busulfan"", ""start_span"": 190, ""end_span"": 198, ""type"": ""Chemical/Drug""}, {""token"": ""clonazepam"", ""start_span"": 204, ""end_span"": 214, ""type"": ""Chemical/Drug""}, {""token"": ""busulfan"", ""start_span"": 216, ""end_span"": 224, ""type"": ""Chemical/Drug""}]"	test
In this retrospective single - centre analysis, patients with relapsed or refractory HL treated with gemcitabine 1, 000 mg / m ( 2) day ( D) 1, D8 and D15; methylprednisolone 1, 000 mg D1 - 5; and cisplatin 100 mg / m ( 2) D15, every 28 days ( GEM - P) were included.	gemcitabine,101,112,Chemical/Drug	methylprednisolone,156,174,Chemical/Drug	cisplatin,197,206,Chemical/Drug	GEM,244,247,Chemical/Drug	"[{""token"": ""gemcitabine"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""methylprednisolone"", ""start_span"": 156, ""end_span"": 174, ""type"": ""Chemical/Drug""}, {""token"": ""cisplatin"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Chemical/Drug""}, {""token"": ""GEM"", ""start_span"": 244, ""end_span"": 247, ""type"": ""Chemical/Drug""}]"	test
Wistar rats ( n = 66) received DOX injections intraperitoneally and were randomly assigned to 2 experimental protocols: ( 1) rats were killed before ( - 24 h, n = 8) and 24 h after ( + 24 h, n = 8) a single dose of DOX ( 4 mg / kg body weight) to determine the DOX acute effect and ( 2) rats ( n = 58) received 4 injections of DOX ( 4 mg / kg body weight / week) and were killed before the first injection ( M0) and 1 week after each injection ( M1, M2, M3, and M4) to determine the chronological effects.	DOX,31,34,Chemical/Drug	DOX,215,218,Chemical/Drug	DOX,261,264,Chemical/Drug	DOX,327,330,Chemical/Drug	"[{""token"": ""DOX"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 261, ""end_span"": 264, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 327, ""end_span"": 330, ""type"": ""Chemical/Drug""}]"	test
The present results demonstrate that CCK - 8 attenuates the effect of morphine on hippocampal LTP through CCK2 receptors and suggest an ameliorative function of CCK - 8 on morphine - induced memory impairment.	CCK - 8,37,44,Chemical/Drug	morphine,70,78,Chemical/Drug	CCK - 8,161,168,Chemical/Drug	morphine,172,180,Chemical/Drug	"[{""token"": ""CCK - 8"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""CCK - 8"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Chemical/Drug""}]"	test
All of the patients ' plasma blood urea nitrogen ( BUN) and creatinine levels were measured on the second and seventh day after the administration of intravenous contrast material.	blood urea nitrogen,29,48,Chemical/Drug	BUN,51,54,Chemical/Drug	creatinine,60,70,Chemical/Drug	contrast,162,170,Chemical/Drug	"[{""token"": ""blood urea nitrogen"", ""start_span"": 29, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""BUN"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""contrast"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Chemical/Drug""}]"	test
CONCLUSION: There was no significant difference between isotonic sodium chloride, sodium bicarbonate and isotonic sodium chloride with diltiazem application in prevention of CIN.	sodium chloride,65,80,Chemical/Drug	sodium bicarbonate,82,100,Chemical/Drug	sodium chloride,114,129,Chemical/Drug	diltiazem,135,144,Chemical/Drug	"[{""token"": ""sodium chloride"", ""start_span"": 65, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""sodium bicarbonate"", ""start_span"": 82, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""sodium chloride"", ""start_span"": 114, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Chemical/Drug""}]"	test
CONCLUSION: We conclude that pre - treatment with propofol in intralipid, compared with propofol in medialipid or saline, delayed the onset of bupivacaine - induced cardiotoxic effects as well as reduced plasma bupivacaine levels.	propofol,50,58,Chemical/Drug	propofol,88,96,Chemical/Drug	bupivacaine,143,154,Chemical/Drug	bupivacaine,211,222,Chemical/Drug	"[{""token"": ""propofol"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""propofol"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""bupivacaine"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""bupivacaine"", ""start_span"": 211, ""end_span"": 222, ""type"": ""Chemical/Drug""}]"	test
CONCLUSIONS: We conclude that pretreatment with fentanyl or combination of fentanyl and midazolam was effective in preventing etomidate - induced myoclonus.	fentanyl,48,56,Chemical/Drug	fentanyl,75,83,Chemical/Drug	midazolam,88,97,Chemical/Drug	etomidate,126,135,Chemical/Drug	"[{""token"": ""fentanyl"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""fentanyl"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""midazolam"", ""start_span"": 88, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""etomidate"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Chemical/Drug""}]"	test
This retrospective study describes toxicity associated with a protocol of lomustine ( CCNU) and cyclophosphamide ( CTX) in dogs with lymphoma.	lomustine,74,83,Chemical/Drug	CCNU,86,90,Chemical/Drug	cyclophosphamide,96,112,Chemical/Drug	CTX,115,118,Chemical/Drug	"[{""token"": ""lomustine"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""CCNU"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 96, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""CTX"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Chemical/Drug""}]"	test
Thirty - six rats bearing breast tumors induced chemically were divided into 4 groups: control, hydroxytyrosol ( 0. 5mg / kg, 5days / week), doxorubicin ( 1mg / kg / week), and doxorubicin plus hydroxytyrosol.	hydroxytyrosol,96,110,Chemical/Drug	doxorubicin,141,152,Chemical/Drug	doxorubicin,177,188,Chemical/Drug	hydroxytyrosol,194,208,Chemical/Drug	"[{""token"": ""hydroxytyrosol"", ""start_span"": 96, ""end_span"": 110, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""hydroxytyrosol"", ""start_span"": 194, ""end_span"": 208, ""type"": ""Chemical/Drug""}]"	test
Also, the multichannel blockers Amiodarone, Paroxetine, Terfenadine and Citalopram prolonged FPDc in a concentration dependent manner.	Amiodarone,32,42,Chemical/Drug	Paroxetine,44,54,Chemical/Drug	Terfenadine,56,67,Chemical/Drug	Citalopram,72,82,Chemical/Drug	"[{""token"": ""Amiodarone"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""Paroxetine"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""Terfenadine"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""Citalopram"", ""start_span"": 72, ""end_span"": 82, ""type"": ""Chemical/Drug""}]"	test
The expression analysis of Ca ( 2 +) handling proteins demonstrated that aconitine promoted Ca ( 2 +) overload through the expression regulation of Ca ( 2 +) handling proteins.	Ca,27,29,Chemical/Drug	aconitine,73,82,Chemical/Drug	Ca,92,94,Chemical/Drug	Ca,148,150,Chemical/Drug	"[{""token"": ""Ca"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""aconitine"", ""start_span"": 73, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 92, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 148, ""end_span"": 150, ""type"": ""Chemical/Drug""}]"	test
In conclusion, our data suggest that GFC may influence in epileptogenesis and promote anticonvulsant actions in pilocarpine model by modulating the GABA and glutamate contents and of AChE activity in seized mice hippocampus.	GFC,37,40,Chemical/Drug	pilocarpine,112,123,Chemical/Drug	GABA,148,152,Chemical/Drug	glutamate,157,166,Chemical/Drug	"[{""token"": ""GFC"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 112, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 157, ""end_span"": 166, ""type"": ""Chemical/Drug""}]"	test
Four animal groups ( n = 6) were tested during 9 weeks: control, CsA, SRL, and conversion ( CsA for 3 weeks followed by SRL for 6 weeks).	CsA,65,68,Chemical/Drug	SRL,70,73,Chemical/Drug	CsA,92,95,Chemical/Drug	SRL,120,123,Chemical/Drug	"[{""token"": ""CsA"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""CsA"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Chemical/Drug""}]"	test
Conversion to SRL prevented CsA - induced renal damage evolution ( absent / mild grade lesions), while NGAL ( serum versus urine) seems to be a feasible biomarker of CsA replacement to SRL.	SRL,14,17,Chemical/Drug	CsA,28,31,Chemical/Drug	CsA,166,169,Chemical/Drug	SRL,185,188,Chemical/Drug	"[{""token"": ""SRL"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""CsA"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""CsA"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Chemical/Drug""}]"	test
The current study identified the optimal dose of rocuronium to prevent succinylcholine - induced fasciculation and myalgia and evaluated the influence of rocuronium on the speed of onset produced by succinylcholine.	rocuronium,49,59,Chemical/Drug	succinylcholine,71,86,Chemical/Drug	rocuronium,154,164,Chemical/Drug	succinylcholine,199,214,Chemical/Drug	"[{""token"": ""rocuronium"", ""start_span"": 49, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""succinylcholine"", ""start_span"": 71, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""rocuronium"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Chemical/Drug""}, {""token"": ""succinylcholine"", ""start_span"": 199, ""end_span"": 214, ""type"": ""Chemical/Drug""}]"	test
First, pretreatment with MK - 801 produced an effective and dose - dependent anticonvulsant action with the lithium - pilocarpine model but not with rats treated with pilocarpine alone, suggesting that different biochemical mechanisms control seizures in these two models.	MK - 801,25,33,Chemical/Drug	lithium,108,115,Chemical/Drug	pilocarpine,118,129,Chemical/Drug	pilocarpine,167,178,Chemical/Drug	"[{""token"": ""MK - 801"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 118, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Chemical/Drug""}]"	test
Deliberate hypotension induced by labetalol with halothane, enflurane or isoflurane for middle - ear surgery.	labetalol,34,43,Chemical/Drug	halothane,49,58,Chemical/Drug	enflurane,60,69,Chemical/Drug	isoflurane,73,83,Chemical/Drug	"[{""token"": ""labetalol"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""halothane"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""enflurane"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""isoflurane"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Chemical/Drug""}]"	test
The feasibility of using labetalol, an alpha - and beta - adrenergic blocking agent, as a hypotensive agent in combination with inhalation anaesthetics ( halothane, enflurane or isoflurane) was studied in 23 adult patients undergoing middle - ear surgery.	labetalol,25,34,Chemical/Drug	halothane,154,163,Chemical/Drug	enflurane,165,174,Chemical/Drug	isoflurane,178,188,Chemical/Drug	"[{""token"": ""labetalol"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""halothane"", ""start_span"": 154, ""end_span"": 163, ""type"": ""Chemical/Drug""}, {""token"": ""enflurane"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Chemical/Drug""}, {""token"": ""isoflurane"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Chemical/Drug""}]"	test
The effects of oral administration of caffeine ( 10 mg / kg) on behavioral ratings, somatic symptoms, blood pressure and plasma levels of 3 - methoxy - 4 - hydroxyphenethyleneglycol ( MHPG) and cortisol were determined in 17 healthy subjects and 21 patients meeting DSM - III criteria for agoraphobia with panic attacks or panic disorder.	caffeine,38,46,Chemical/Drug	3 - methoxy - 4 - hydroxyphenethyleneglycol,138,181,Chemical/Drug	MHPG,184,188,Chemical/Drug	cortisol,194,202,Chemical/Drug	"[{""token"": ""caffeine"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""3 - methoxy - 4 - hydroxyphenethyleneglycol"", ""start_span"": 138, ""end_span"": 181, ""type"": ""Chemical/Drug""}, {""token"": ""MHPG"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""cortisol"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Chemical/Drug""}]"	test
Control experiments indicated that neither an increase in pain sensitivity ( pre - training naloxone) nor an induced aversive state ( post - training naloxone) appear to be responsible for the influence of naloxone on the scopolamine - induced retention deficit.	naloxone,92,100,Chemical/Drug	naloxone,150,158,Chemical/Drug	naloxone,206,214,Chemical/Drug	scopolamine,222,233,Chemical/Drug	"[{""token"": ""naloxone"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""naloxone"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""naloxone"", ""start_span"": 206, ""end_span"": 214, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 222, ""end_span"": 233, ""type"": ""Chemical/Drug""}]"	test
In contrast to verapamil and diltiazem, which are roughly equipotent in their actions on the heart and vascular smooth muscle, the dihydropyridine calcium channel blockers are a group of potent peripheral vasodilator agents that exert minimal electrophysiologic effects on cardiac nodal or conduction tissue.	verapamil,15,24,Chemical/Drug	diltiazem,29,38,Chemical/Drug	dihydropyridine,131,146,Chemical/Drug	calcium channel blockers,147,171,Chemical/Drug	"[{""token"": ""verapamil"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""dihydropyridine"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""calcium channel blockers"", ""start_span"": 147, ""end_span"": 171, ""type"": ""Chemical/Drug""}]"	test
An experimental model of focal segmental glomerular sclerosis ( FSGS) was developed in rats by the combined administration of puromycin - aminonucleoside ( AMNS) and protamine sulfate ( PS).	puromycin - aminonucleoside,126,153,Chemical/Drug	AMNS,156,160,Chemical/Drug	protamine sulfate,166,183,Chemical/Drug	PS,186,188,Chemical/Drug	"[{""token"": ""puromycin - aminonucleoside"", ""start_span"": 126, ""end_span"": 153, ""type"": ""Chemical/Drug""}, {""token"": ""AMNS"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Chemical/Drug""}, {""token"": ""protamine sulfate"", ""start_span"": 166, ""end_span"": 183, ""type"": ""Chemical/Drug""}, {""token"": ""PS"", ""start_span"": 186, ""end_span"": 188, ""type"": ""Chemical/Drug""}]"	test
Cardiac symptoms, including hypotension, developed in three patients with advanced colorectal carcinoma while being treated with cisplatin ( CDDP) and 5 - fluorouracil ( 5 - FU).	cisplatin,129,138,Chemical/Drug	CDDP,141,145,Chemical/Drug	5 - fluorouracil,151,167,Chemical/Drug	5 - FU,170,176,Chemical/Drug	"[{""token"": ""cisplatin"", ""start_span"": 129, ""end_span"": 138, ""type"": ""Chemical/Drug""}, {""token"": ""CDDP"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""5 - fluorouracil"", ""start_span"": 151, ""end_span"": 167, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Chemical/Drug""}]"	test
The dose of CYA per body surface area was calculated for all patients and the patients were divided into two groups based on daily CYA dose: Group 1, CYA less than or equal to 1. 55 g / m2 / d; Group 2, CYA greater than 1. 55 g / m2 / d.	CYA,12,15,Chemical/Drug	CYA,131,134,Chemical/Drug	CYA,150,153,Chemical/Drug	CYA,203,206,Chemical/Drug	"[{""token"": ""CYA"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Chemical/Drug""}, {""token"": ""CYA"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Chemical/Drug""}, {""token"": ""CYA"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Chemical/Drug""}, {""token"": ""CYA"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Chemical/Drug""}]"	test
We conclude that the CYA cardiotoxicity correlates with CYA dosage as calculated by body surface area, and that patients with aplastic anemia and immunodeficiencies can be effectively prepared for bone marrow grafting at a CYA dose of 1. 55 g / m2 / d for four days with a lower incidence of cardiotoxicity than patients whose CYA dosage is calculated based on weight.	CYA,21,24,Chemical/Drug	CYA,56,59,Chemical/Drug	CYA,223,226,Chemical/Drug	CYA,327,330,Chemical/Drug	"[{""token"": ""CYA"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""CYA"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""CYA"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Chemical/Drug""}, {""token"": ""CYA"", ""start_span"": 327, ""end_span"": 330, ""type"": ""Chemical/Drug""}]"	test
Codeine catalepsy was increased by clonidine and decreased by naphazoline and xylometazoline.	Codeine,0,7,Chemical/Drug	clonidine,35,44,Chemical/Drug	naphazoline,62,73,Chemical/Drug	xylometazoline,78,92,Chemical/Drug	"[{""token"": ""Codeine"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""clonidine"", ""start_span"": 35, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""naphazoline"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""xylometazoline"", ""start_span"": 78, ""end_span"": 92, ""type"": ""Chemical/Drug""}]"	test
The brain concentration of NA was not changed by morphine and fentanyl, but one of the doses of codeine ( 45 mg / kg) slightly enhanced it.	NA,27,29,Chemical/Drug	morphine,49,57,Chemical/Drug	fentanyl,62,70,Chemical/Drug	codeine,96,103,Chemical/Drug	"[{""token"": ""NA"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""fentanyl"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""codeine"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Chemical/Drug""}]"	test
Flurothyl seizure thresholds in mice treated neonatally with a single injection of monosodium glutamate ( MSG): evaluation of experimental parameters in flurothyl seizure testing.	Flurothyl,0,9,Chemical/Drug	monosodium glutamate,83,103,Chemical/Drug	MSG,106,109,Chemical/Drug	flurothyl,153,162,Chemical/Drug	"[{""token"": ""Flurothyl"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""monosodium glutamate"", ""start_span"": 83, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""MSG"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""flurothyl"", ""start_span"": 153, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	test
In animals pretreated with microinjections of isoniazid, 150 micrograms, an inhibitor of activity of the GABA - synthesizing enzyme, L - glutamic acid decarboxylase, into the substantia nigra pars reticulata ( SNR), bilaterally, non - convulsant doses of pilocarpine, 100 and 200 mg / kg, resulted in severe motor limbic seizures and status epilepticus.	isoniazid,46,55,Chemical/Drug	GABA,105,109,Chemical/Drug	L - glutamic acid,133,150,Chemical/Drug	pilocarpine,255,266,Chemical/Drug	"[{""token"": ""isoniazid"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""L - glutamic acid"", ""start_span"": 133, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 255, ""end_span"": 266, ""type"": ""Chemical/Drug""}]"	test
The changes in renal prostaglandin synthesis were accompanied by evidence of renal damage in aspirin - treated jj but not jJ rats as evidenced by: increased incidence and severity of hematuria ( p less than 0. 01); increased serum creatinine ( p less than 0. 05); and increase in outer medullary histopathologic lesions ( p less than 0. 005 compared to either sham - treated jj or aspirin - treated jJ).	prostaglandin,21,34,Chemical/Drug	aspirin,93,100,Chemical/Drug	creatinine,231,241,Chemical/Drug	aspirin,381,388,Chemical/Drug	"[{""token"": ""prostaglandin"", ""start_span"": 21, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 231, ""end_span"": 241, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 381, ""end_span"": 388, ""type"": ""Chemical/Drug""}]"	test
The lack of a similar response to ketamine and xylazine anesthesia revealed that the cardiovascular actions of sodium pentobarbital in barium - treated rats were linked specifically to this anesthetic, and were not representative of a generalized anesthetic response.	ketamine,34,42,Chemical/Drug	xylazine,47,55,Chemical/Drug	sodium pentobarbital,111,131,Chemical/Drug	barium,135,141,Chemical/Drug	"[{""token"": ""ketamine"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""xylazine"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""sodium pentobarbital"", ""start_span"": 111, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""barium"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Chemical/Drug""}]"	test
That propranolol antagonizes the pressor effect of PPA is in contrast to the interaction in which propranolol enhances the pressor effect of norepinephrine.	propranolol,5,16,Chemical/Drug	PPA,51,54,Chemical/Drug	propranolol,98,109,Chemical/Drug	norepinephrine,141,155,Chemical/Drug	"[{""token"": ""propranolol"", ""start_span"": 5, ""end_span"": 16, ""type"": ""Chemical/Drug""}, {""token"": ""PPA"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""norepinephrine"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Chemical/Drug""}]"	test
The role of p - aminophenol in acetaminophen - induced nephrotoxicity: effect of bis ( p - nitrophenyl) phosphate on acetaminophen and p - aminophenol nephrotoxicity and metabolism in Fischer 344 rats.	p - aminophenol,12,27,Chemical/Drug	acetaminophen,31,44,Chemical/Drug	acetaminophen,117,130,Chemical/Drug	p - aminophenol,135,150,Chemical/Drug	"[{""token"": ""p - aminophenol"", ""start_span"": 12, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 31, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""p - aminophenol"", ""start_span"": 135, ""end_span"": 150, ""type"": ""Chemical/Drug""}]"	test
Rather, BNPP pretreatment reduced the fraction of APAP excreted as PAP by 64 and 75% after APAP doses of 750 and 900 mg / kg.	BNPP,8,12,Chemical/Drug	APAP,50,54,Chemical/Drug	PAP,67,70,Chemical/Drug	APAP,91,95,Chemical/Drug	"[{""token"": ""BNPP"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""APAP"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""PAP"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""APAP"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Chemical/Drug""}]"	test
Thus, indomethacin by inhibition of prostaglandin synthesis may diminish the blood pressure maintaining effect of the stimulated renin - angiotensin system in sodium and volume depletion.	indomethacin,6,18,Chemical/Drug	prostaglandin,36,49,Chemical/Drug	angiotensin,137,148,Chemical/Drug	sodium,159,165,Chemical/Drug	"[{""token"": ""indomethacin"", ""start_span"": 6, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""prostaglandin"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""angiotensin"", ""start_span"": 137, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""sodium"", ""start_span"": 159, ""end_span"": 165, ""type"": ""Chemical/Drug""}]"	test
After atropine the CD25 was unchanged after placebo ( 2. 3 + / - 0. 3 micrograms) and atenolol ( 7. 7 + / - 1. 3 micrograms); it was reduced after propranolol ( 24. 8 + / - 5. 0 micrograms), but remained different from atenolol.	atropine,6,14,Chemical/Drug	atenolol,86,94,Chemical/Drug	propranolol,147,158,Chemical/Drug	atenolol,219,227,Chemical/Drug	"[{""token"": ""atropine"", ""start_span"": 6, ""end_span"": 14, ""type"": ""Chemical/Drug""}, {""token"": ""atenolol"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""atenolol"", ""start_span"": 219, ""end_span"": 227, ""type"": ""Chemical/Drug""}]"	test
The analogues CCK - 8 - SE and CCK - 8 - NS ( dose range 0. 2 - 6. 4 mumol / kg) and caerulein dose range 0. 1 - 0. 8 mumol / kg) showed bell - shaped dose - effect curves, with the greatest maximum inhibition for CCK - 8 - NS.	CCK - 8,14,21,Chemical/Drug	CCK - 8,31,38,Chemical/Drug	caerulein,85,94,Chemical/Drug	CCK - 8,214,221,Chemical/Drug	"[{""token"": ""CCK - 8"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""CCK - 8"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""caerulein"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""CCK - 8"", ""start_span"": 214, ""end_span"": 221, ""type"": ""Chemical/Drug""}]"	test
Vasopressin plays a major role in the pathogenesis of DOCA - salt hypertension, since the elevation of blood pressure was not substantial in the rats with lithium - treated diabetes insipidus after DOCA - salt treatment.	Vasopressin,0,11,Chemical/Drug	DOCA,54,58,Chemical/Drug	lithium,155,162,Chemical/Drug	DOCA,198,202,Chemical/Drug	"[{""token"": ""Vasopressin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""DOCA"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Chemical/Drug""}, {""token"": ""DOCA"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Chemical/Drug""}]"	test
Coronary blood flow, cardiac work and metabolism were studied in dogs under sodium nitroprusside ( SNP) and trimetaphan ( TMP) deliberate hypotension ( 20% and 40% mean pressure decrease from baseline).	sodium nitroprusside,76,96,Chemical/Drug	SNP,99,102,Chemical/Drug	trimetaphan,108,119,Chemical/Drug	TMP,122,125,Chemical/Drug	"[{""token"": ""sodium nitroprusside"", ""start_span"": 76, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""SNP"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""trimetaphan"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""TMP"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Chemical/Drug""}]"	test
Treatment of ovarian cancer with a combination of cis - platinum, adriamycin, cyclophosphamide and hexamethylmelamine.	cis - platinum,50,64,Chemical/Drug	adriamycin,66,76,Chemical/Drug	cyclophosphamide,78,94,Chemical/Drug	hexamethylmelamine,99,117,Chemical/Drug	"[{""token"": ""cis - platinum"", ""start_span"": 50, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""adriamycin"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 78, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""hexamethylmelamine"", ""start_span"": 99, ""end_span"": 117, ""type"": ""Chemical/Drug""}]"	test
Adenosine triphosphate ( ATP) and sodium nitroprusside ( SNP) are administered to patients to induce and control hypotension during anesthesia.	Adenosine triphosphate,0,22,Chemical/Drug	ATP,25,28,Chemical/Drug	sodium nitroprusside,34,54,Chemical/Drug	SNP,57,60,Chemical/Drug	"[{""token"": ""Adenosine triphosphate"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""sodium nitroprusside"", ""start_span"": 34, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""SNP"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Chemical/Drug""}]"	test
Side effects of hysterosalpingography with Dimer - X, Hexabrix, Vasurix polyvidone and Endografine in 142 consecutive patients, receiving one of the four tested media were evaluated from replies to postal questionnaires.	Dimer - X,43,52,Chemical/Drug	Hexabrix,54,62,Chemical/Drug	Vasurix polyvidone,64,82,Chemical/Drug	Endografine,87,98,Chemical/Drug	"[{""token"": ""Dimer - X"", ""start_span"": 43, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""Hexabrix"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""Vasurix polyvidone"", ""start_span"": 64, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""Endografine"", ""start_span"": 87, ""end_span"": 98, ""type"": ""Chemical/Drug""}]"	test
Hexabrix and Vasurix polyvidone are considered the best contrast media for hysterosalpingography and perhaps because of its low toxicity Hexabrix should be preferred.	Hexabrix,0,8,Chemical/Drug	Vasurix polyvidone,13,31,Chemical/Drug	contrast media,56,70,Chemical/Drug	Hexabrix,137,145,Chemical/Drug	"[{""token"": ""Hexabrix"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""Vasurix polyvidone"", ""start_span"": 13, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""contrast media"", ""start_span"": 56, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""Hexabrix"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Chemical/Drug""}]"	test
Two well - documented cases of bilateral retinal artery and choriocapillaris occlusions with blindness following head and neck soft - tissue injection with methylprednisolone acetate in combination with lidocaine, epinephrine, or penicillin are reported.	methylprednisolone acetate,156,182,Chemical/Drug	lidocaine,203,212,Chemical/Drug	epinephrine,214,225,Chemical/Drug	penicillin,230,240,Chemical/Drug	"[{""token"": ""methylprednisolone acetate"", ""start_span"": 156, ""end_span"": 182, ""type"": ""Chemical/Drug""}, {""token"": ""lidocaine"", ""start_span"": 203, ""end_span"": 212, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 214, ""end_span"": 225, ""type"": ""Chemical/Drug""}, {""token"": ""penicillin"", ""start_span"": 230, ""end_span"": 240, ""type"": ""Chemical/Drug""}]"	test
We evaluated the severity of motor disability and dyskinesias in seven levodopa - responsive patients with Parkinson ' s disease after an acute challenge with the mixed dopamine agonist, apomorphine, before and after the administration of fluoxetine ( 20 mg twice per day) for 11 + / - 1 days.	levodopa,71,79,Chemical/Drug	dopamine,169,177,Chemical/Drug	apomorphine,187,198,Chemical/Drug	fluoxetine,239,249,Chemical/Drug	"[{""token"": ""levodopa"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 169, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""apomorphine"", ""start_span"": 187, ""end_span"": 198, ""type"": ""Chemical/Drug""}, {""token"": ""fluoxetine"", ""start_span"": 239, ""end_span"": 249, ""type"": ""Chemical/Drug""}]"	test
We conducted a population - based 45 - day follow - up study of 232, 390 people who were prescribed trimethoprim - sulfamethoxazole ( TMP - SMZ), 266, 951 prescribed trimethoprim alone, and 196, 397 prescribed cephalexin, to estimate the risk of serious liver, blood, skin, and renal disorders resulting in referral or hospitalization associated with these drugs.	trimethoprim - sulfamethoxazole,100,131,Chemical/Drug	TMP - SMZ,134,143,Chemical/Drug	trimethoprim,166,178,Chemical/Drug	cephalexin,210,220,Chemical/Drug	"[{""token"": ""trimethoprim - sulfamethoxazole"", ""start_span"": 100, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""TMP - SMZ"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""trimethoprim"", ""start_span"": 166, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""cephalexin"", ""start_span"": 210, ""end_span"": 220, ""type"": ""Chemical/Drug""}]"	test
CONCLUSION: Despite theoretical concerns that lidocaine may enhance cocaine toxicity, the use of lidocaine in patients with cocaine - associated MI was not associated with significant cardiovascular or central nervous system toxicity.	lidocaine,46,55,Chemical/Drug	cocaine,68,75,Chemical/Drug	lidocaine,97,106,Chemical/Drug	cocaine,124,131,Chemical/Drug	"[{""token"": ""lidocaine"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""lidocaine"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Chemical/Drug""}]"	test
The encouraging results obtained in various authoratative departments in myopathic patients by using anabolizing steroids have encouraged the authors to investigate the beneficial effects of one anabolizing agent ( Dianabol, CIBA) at high doses in rats rendered myopathic by a diet deficient in vitamin E.	steroids,113,121,Chemical/Drug	Dianabol,215,223,Chemical/Drug	CIBA,225,229,Chemical/Drug	vitamin E,295,304,Chemical/Drug	"[{""token"": ""steroids"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""Dianabol"", ""start_span"": 215, ""end_span"": 223, ""type"": ""Chemical/Drug""}, {""token"": ""CIBA"", ""start_span"": 225, ""end_span"": 229, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin E"", ""start_span"": 295, ""end_span"": 304, ""type"": ""Chemical/Drug""}]"	test
STUDY HYPOTHESIS: Administration of the benzodiazepine antagonist flumazenil may unmask seizures in mixed cocaine - benzodiazepine intoxication.	benzodiazepine,40,54,Chemical/Drug	flumazenil,66,76,Chemical/Drug	cocaine,106,113,Chemical/Drug	benzodiazepine,116,130,Chemical/Drug	"[{""token"": ""benzodiazepine"", ""start_span"": 40, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""flumazenil"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""benzodiazepine"", ""start_span"": 116, ""end_span"": 130, ""type"": ""Chemical/Drug""}]"	test
DESIGN: Male Sprague - Dawley rats received 100 mg / kg cocaine IP alone, 5 mg / kg diazepam alone, or a combination of diazepam and cocaine.	cocaine,56,63,Chemical/Drug	diazepam,84,92,Chemical/Drug	diazepam,120,128,Chemical/Drug	cocaine,133,140,Chemical/Drug	"[{""token"": ""cocaine"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Chemical/Drug""}]"	test
Superoxide dismutase ( SOD) or dimethylthiourea ( DMTU) significantly lessened the GM - induced decrement in CIn.	Superoxide,0,10,Chemical/Drug	dimethylthiourea,31,47,Chemical/Drug	DMTU,50,54,Chemical/Drug	GM,83,85,Chemical/Drug	"[{""token"": ""Superoxide"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""dimethylthiourea"", ""start_span"": 31, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""DMTU"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""GM"", ""start_span"": 83, ""end_span"": 85, ""type"": ""Chemical/Drug""}]"	test
Sensitivity of cardiac component of baroreflex ( CCB), expressed as a slope of the regression line was determined from relationships between systolic arterial pressure ( SAP) and HR period ( HRp) during phenylephrine ( Phe) - induced hypertension and sodium nitroprusside ( SN) - induced hypotension.	phenylephrine,203,216,Chemical/Drug	Phe,219,222,Chemical/Drug	sodium nitroprusside,251,271,Chemical/Drug	SN,274,276,Chemical/Drug	"[{""token"": ""phenylephrine"", ""start_span"": 203, ""end_span"": 216, ""type"": ""Chemical/Drug""}, {""token"": ""Phe"", ""start_span"": 219, ""end_span"": 222, ""type"": ""Chemical/Drug""}, {""token"": ""sodium nitroprusside"", ""start_span"": 251, ""end_span"": 271, ""type"": ""Chemical/Drug""}, {""token"": ""SN"", ""start_span"": 274, ""end_span"": 276, ""type"": ""Chemical/Drug""}]"	test
Since bupivacaine and epinephrine may both precipitate dysrhythmias, circulating bupivacaine during regional anesthesia could potentiate dysrhythmogenic effects of epinephrine.	bupivacaine,6,17,Chemical/Drug	epinephrine,22,33,Chemical/Drug	bupivacaine,81,92,Chemical/Drug	epinephrine,164,175,Chemical/Drug	"[{""token"": ""bupivacaine"", ""start_span"": 6, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""bupivacaine"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Chemical/Drug""}]"	test
Both CD - 832 and diltiazem, but not nifedipine, significantly reduced the increase in heart rate induced by ISO infusion.	CD - 832,5,13,Chemical/Drug	diltiazem,18,27,Chemical/Drug	nifedipine,37,47,Chemical/Drug	ISO,109,112,Chemical/Drug	"[{""token"": ""CD - 832"", ""start_span"": 5, ""end_span"": 13, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""nifedipine"", ""start_span"": 37, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""ISO"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Chemical/Drug""}]"	test
These data show that CD - 832 improves myocardial ischemia during ISO infusion with stenosis and suggest that the negative chronotropic property of CD - 832 plays a major role in the beneficial effects of CD - 832.	CD - 832,21,29,Chemical/Drug	ISO,66,69,Chemical/Drug	CD - 832,148,156,Chemical/Drug	CD - 832,205,213,Chemical/Drug	"[{""token"": ""CD - 832"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""ISO"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""CD - 832"", ""start_span"": 148, ""end_span"": 156, ""type"": ""Chemical/Drug""}, {""token"": ""CD - 832"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Chemical/Drug""}]"	test
These effects were not mediated by a dopaminergic mechanism as nefiracetam, at millimolar concentrations, failed to displace either [ 3H] SCH 23390 or [ 3H] spiperone binding from D1 or D2 dopamine receptor subtypes, respectively.	nefiracetam,63,74,Chemical/Drug	SCH 23390,138,147,Chemical/Drug	spiperone,157,166,Chemical/Drug	dopamine,189,197,Chemical/Drug	"[{""token"": ""nefiracetam"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""SCH 23390"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""spiperone"", ""start_span"": 157, ""end_span"": 166, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 189, ""end_span"": 197, ""type"": ""Chemical/Drug""}]"	test
With all second - generation OCs as the reference, the odds ratios for VTE were 3. 49 ( 1. 21 - 10. 12) for desogestrel plus 20 g ethinyloestradiol and 1. 18 ( 0. 66 - 2. 17) for the other third - generation progestagens.	OCs,29,32,Chemical/Drug	desogestrel,108,119,Chemical/Drug	ethinyloestradiol,130,147,Chemical/Drug	progestagens,208,220,Chemical/Drug	"[{""token"": ""OCs"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""desogestrel"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""ethinyloestradiol"", ""start_span"": 130, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""progestagens"", ""start_span"": 208, ""end_span"": 220, ""type"": ""Chemical/Drug""}]"	test
Scopolamine ( 10 mg / kg) and pentobarbital ( 5 mg / kg) prevented development of pilocarpine - induced behavioral seizure but MK - 801 ( 0. 5 mg / kg) did not.	Scopolamine,0,11,Chemical/Drug	pentobarbital,30,43,Chemical/Drug	pilocarpine,82,93,Chemical/Drug	MK - 801,127,135,Chemical/Drug	"[{""token"": ""Scopolamine"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""pentobarbital"", ""start_span"": 30, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""MK - 801"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Chemical/Drug""}]"	test
5 - Fluorouracil plus folinic acid and paclitaxel ( Taxol; Bristol - Myers Squibb Company, Princeton, NJ) are effective salvage therapies for metastatic breast cancer patients.	5 - Fluorouracil,0,16,Chemical/Drug	folinic acid,22,34,Chemical/Drug	paclitaxel,39,49,Chemical/Drug	Taxol,52,57,Chemical/Drug	"[{""token"": ""5 - Fluorouracil"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Chemical/Drug""}, {""token"": ""folinic acid"", ""start_span"": 22, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""paclitaxel"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""Taxol"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Chemical/Drug""}]"	test
The following factors appear to predispose to the development of this complication: abnormal cerebrospinal dynamics related to the presence of central nervous system leukemia, and epidural cerebrospinal leakage; elevated cerebrospinal fluid methothexate concentration related to abnormal cerebrospinal fluid dynamics and to inappropriately high methotrexate doses based on body surface area calculations in older children and adults; the presence of neurotoxic preservatives in commercially available methotrexate preparations and diluents; and the use of methotrexate diluents of unphysiologic pH, ionic content and osmolarity.	methothexate,241,253,Chemical/Drug	methotrexate,345,357,Chemical/Drug	methotrexate,501,513,Chemical/Drug	methotrexate,556,568,Chemical/Drug	"[{""token"": ""methothexate"", ""start_span"": 241, ""end_span"": 253, ""type"": ""Chemical/Drug""}, {""token"": ""methotrexate"", ""start_span"": 345, ""end_span"": 357, ""type"": ""Chemical/Drug""}, {""token"": ""methotrexate"", ""start_span"": 501, ""end_span"": 513, ""type"": ""Chemical/Drug""}, {""token"": ""methotrexate"", ""start_span"": 556, ""end_span"": 568, ""type"": ""Chemical/Drug""}]"	test
This study shows that 17alpha - ethinylestradiol ( EE) - induced intrahepatic cholestasis in rats is associated with selective inhibition of the neutral pathway of bile salt ( BS) synthesis.	17alpha - ethinylestradiol,22,48,Chemical/Drug	EE,51,53,Chemical/Drug	bile salt,164,173,Chemical/Drug	BS,176,178,Chemical/Drug	"[{""token"": ""17alpha - ethinylestradiol"", ""start_span"": 22, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""EE"", ""start_span"": 51, ""end_span"": 53, ""type"": ""Chemical/Drug""}, {""token"": ""bile salt"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Chemical/Drug""}, {""token"": ""BS"", ""start_span"": 176, ""end_span"": 178, ""type"": ""Chemical/Drug""}]"	test
The present study was undertaken to investigate the effects of TET and FAN on the experimental thrombosis induced by collagen plus epinephrine ( EP) in mice, and platelet aggregation and blood coagulation in vitro.	TET,63,66,Chemical/Drug	FAN,71,74,Chemical/Drug	epinephrine,131,142,Chemical/Drug	EP,145,147,Chemical/Drug	"[{""token"": ""TET"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""FAN"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Chemical/Drug""}, {""token"": ""EP"", ""start_span"": 145, ""end_span"": 147, ""type"": ""Chemical/Drug""}]"	train
In the in vivo study, the administration ( 50 mg / kg, i. p.) of TET and FAN in mice showed the inhibition of thrombosis by 55% and 35%, respectively, while acetylsalicylic acid ( ASA, 50 mg / kg, i. p.), a positive control, showed only 30% inhibition.	TET,65,68,Chemical/Drug	FAN,73,76,Chemical/Drug	acetylsalicylic acid,157,177,Chemical/Drug	ASA,180,183,Chemical/Drug	"[{""token"": ""TET"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""FAN"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""acetylsalicylic acid"", ""start_span"": 157, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""ASA"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Chemical/Drug""}]"	train
Recent reports indicate that single agent therapy with vinorelbine ( VNB) or gemcitabine ( GEM) may obtain a response rate of 20 - 30% in elderly patients, with acceptable toxicity and improvement in symptoms and quality of life.	vinorelbine,55,66,Chemical/Drug	VNB,69,72,Chemical/Drug	gemcitabine,77,88,Chemical/Drug	GEM,91,94,Chemical/Drug	"[{""token"": ""vinorelbine"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""VNB"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""gemcitabine"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""GEM"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Chemical/Drug""}]"	train
NRA0160 has negligible affinity for the human cloned dopamine D3 receptor ( Ki = 39 nM), rat serotonin ( 5 - HT) 2A receptors ( Ki = 180 nM) and rat alpha1 adrenoceptor ( Ki = 237 nM).	NRA0160,0,7,Chemical/Drug	dopamine,53,61,Chemical/Drug	serotonin,93,102,Chemical/Drug	5 - HT,105,111,Chemical/Drug	"[{""token"": ""NRA0160"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 53, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Chemical/Drug""}]"	train
NRA0160 and clozapine antagonized locomotor hyperactivity induced by methamphetamine ( MAP) in mice.	NRA0160,0,7,Chemical/Drug	clozapine,12,21,Chemical/Drug	methamphetamine,69,84,Chemical/Drug	MAP,87,90,Chemical/Drug	"[{""token"": ""NRA0160"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""clozapine"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 69, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""MAP"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Chemical/Drug""}]"	train
NRA0160 and clozapine significantly shortened the phencyclidine ( PCP) - induced prolonged swimming latency in rats in a water maze task.	NRA0160,0,7,Chemical/Drug	clozapine,12,21,Chemical/Drug	phencyclidine,50,63,Chemical/Drug	PCP,66,69,Chemical/Drug	"[{""token"": ""NRA0160"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""clozapine"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""phencyclidine"", ""start_span"": 50, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""PCP"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Chemical/Drug""}]"	train
When activating the ( Na, K) - ATPase with its substrate ATP, no changes in Km and Vmax values were observed in NO - deficient rats.	Na,22,24,Chemical/Drug	K,26,27,Chemical/Drug	ATP,31,34,Chemical/Drug	NO,112,114,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 22, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 26, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 112, ""end_span"": 114, ""type"": ""Chemical/Drug""}]"	train
After recovery from hypertension, the activity of ( Na, K) - ATPase increased, due to higher affinity of the ATP - binding site, as revealed from the lowered Km value for ATP.	Na,52,54,Chemical/Drug	K,56,57,Chemical/Drug	ATP,61,64,Chemical/Drug	ATP,109,112,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 52, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 56, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Chemical/Drug""}]"	train
In the present paper the authors describe 2 female patients who developed incontinence secondary to the selective serotonin reuptake inhibitors paroxetine and sertraline, as well as a third who developed this side effect on venlafaxine.	serotonin,114,123,Chemical/Drug	paroxetine,144,154,Chemical/Drug	sertraline,159,169,Chemical/Drug	venlafaxine,224,235,Chemical/Drug	"[{""token"": ""serotonin"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""paroxetine"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""sertraline"", ""start_span"": 159, ""end_span"": 169, ""type"": ""Chemical/Drug""}, {""token"": ""venlafaxine"", ""start_span"": 224, ""end_span"": 235, ""type"": ""Chemical/Drug""}]"	train
Two mouse lines were selectively bred according to their sensitivity ( BS line) or resistance ( BR line) to seizures induced by a single i. p. injection of methyl beta - carboline - 3 - carboxylate ( beta - CCM), an inverse agonist of the GABA ( A) receptor benzodiazepine site.	methyl beta - carboline - 3 - carboxylate,156,197,Chemical/Drug	beta - CCM,200,210,Chemical/Drug	GABA,239,243,Chemical/Drug	benzodiazepine,258,272,Chemical/Drug	"[{""token"": ""methyl beta - carboline - 3 - carboxylate"", ""start_span"": 156, ""end_span"": 197, ""type"": ""Chemical/Drug""}, {""token"": ""beta - CCM"", ""start_span"": 200, ""end_span"": 210, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 239, ""end_span"": 243, ""type"": ""Chemical/Drug""}, {""token"": ""benzodiazepine"", ""start_span"": 258, ""end_span"": 272, ""type"": ""Chemical/Drug""}]"	train
We measured diazepam - induced anxiolysis with the elevated plus - maze test, diazepam - induced sedation by recording the vigilance states, and picrotoxin - and pentylenetetrazol - induced seizures after i. p. injections.	diazepam,12,20,Chemical/Drug	diazepam,78,86,Chemical/Drug	picrotoxin,145,155,Chemical/Drug	pentylenetetrazol,162,179,Chemical/Drug	"[{""token"": ""diazepam"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""picrotoxin"", ""start_span"": 145, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""pentylenetetrazol"", ""start_span"": 162, ""end_span"": 179, ""type"": ""Chemical/Drug""}]"	train
In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen - induced nephrotoxicity, amiodarone - induced lung toxicity and doxorubicin - induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract.	acetaminophen,86,99,Chemical/Drug	amiodarone,126,136,Chemical/Drug	doxorubicin,165,176,Chemical/Drug	IH636 grape seed proanthocyanidin extract,213,254,Chemical/Drug	"[{""token"": ""acetaminophen"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""amiodarone"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""IH636 grape seed proanthocyanidin extract"", ""start_span"": 213, ""end_span"": 254, ""type"": ""Chemical/Drug""}]"	train
For the cytoprotection study, animals were orally gavaged 100 mg / Kg GSPE for 7 - 10 days followed by i. p. injections of organ specific three drugs ( AAP: 500 mg / Kg for 24 h; AMI: 50 mg / Kg / day for four days; DOX: 20 mg / Kg for 48 h).	GSPE,70,74,Chemical/Drug	AAP,152,155,Chemical/Drug	AMI,179,182,Chemical/Drug	DOX,216,219,Chemical/Drug	"[{""token"": ""GSPE"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""AAP"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""AMI"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Chemical/Drug""}]"	train
Results indicate that GSPE preexposure prior to AAP, AMI and DOX, provided near complete protection in terms of serum chemistry changes ( ALT, BUN and CPK), and significantly reduced DNA fragmentation.	GSPE,22,26,Chemical/Drug	AAP,48,51,Chemical/Drug	AMI,53,56,Chemical/Drug	DOX,61,64,Chemical/Drug	"[{""token"": ""GSPE"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""AAP"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""AMI"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Chemical/Drug""}]"	train
Interestingly, all the drugs, such as, AAP, AMI and DOX induced apoptotic death in addition to necrosis in the respective organs which was very effectively blocked by GSPE.	AAP,39,42,Chemical/Drug	AMI,44,47,Chemical/Drug	DOX,52,55,Chemical/Drug	GSPE,167,171,Chemical/Drug	"[{""token"": ""AAP"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""AMI"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""GSPE"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Chemical/Drug""}]"	train
Since AAP, AMI and DOX undergo biotransformation and are known to produce damaging radicals in vivo, the protection by GSPE may be linked to both inhibition of metabolism and / or detoxification of cytotoxic radicals.	AAP,6,9,Chemical/Drug	AMI,11,14,Chemical/Drug	DOX,19,22,Chemical/Drug	GSPE,119,123,Chemical/Drug	"[{""token"": ""AAP"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""AMI"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""GSPE"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Chemical/Drug""}]"	train
In behavioral studies, pre - treatment of mice with BD1018, BD1063, or LR132 significantly attenuated cocaine - induced convulsions and lethality.	BD1018,52,58,Chemical/Drug	BD1063,60,66,Chemical/Drug	LR132,71,76,Chemical/Drug	cocaine,102,109,Chemical/Drug	"[{""token"": ""BD1018"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""BD1063"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""LR132"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Chemical/Drug""}]"	train
In contrast to the protection provided by the putative antagonists, the well - characterized sigma receptor agonist di - o - tolylguanidine ( DTG) and the novel sigma receptor agonist BD1031 ( 3R - 1 - [ 2 - ( 3, 4 - dichlorophenyl) ethyl] - 1, 4 - diazabicyclo [ 4. 3. 0] nonane) each worsened the behavioral toxicity of cocaine.	di - o - tolylguanidine,116,139,Chemical/Drug	DTG,142,145,Chemical/Drug	BD1031,184,190,Chemical/Drug	cocaine,322,329,Chemical/Drug	"[{""token"": ""di - o - tolylguanidine"", ""start_span"": 116, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""DTG"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""BD1031"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 322, ""end_span"": 329, ""type"": ""Chemical/Drug""}]"	train
At doses where alone, they produced no significant effects on locomotion, BD1018, BD1063 and LR132 significantly attenuated the locomotor stimulatory effects of cocaine.	BD1018,74,80,Chemical/Drug	BD1063,82,88,Chemical/Drug	LR132,93,98,Chemical/Drug	cocaine,161,168,Chemical/Drug	"[{""token"": ""BD1018"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""BD1063"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""LR132"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Chemical/Drug""}]"	train
The underlying mechanism of withdrawal - emergent RS in the present case may have been related to the pharmacological profile of risperidone, a serotonin - dopamine antagonist, suggesting the pathophysiologic influence of the serotonin system in the development of RS.	risperidone,129,140,Chemical/Drug	serotonin,144,153,Chemical/Drug	dopamine,156,164,Chemical/Drug	serotonin,226,235,Chemical/Drug	"[{""token"": ""risperidone"", ""start_span"": 129, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 144, ""end_span"": 153, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 156, ""end_span"": 164, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 226, ""end_span"": 235, ""type"": ""Chemical/Drug""}]"	train
Pharmacokinetic / pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog.	E4031,63,68,Chemical/Drug	cisapride,70,79,Chemical/Drug	terfenadine,81,92,Chemical/Drug	terodiline,97,107,Chemical/Drug	"[{""token"": ""E4031"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""terfenadine"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""terodiline"", ""start_span"": 97, ""end_span"": 107, ""type"": ""Chemical/Drug""}]"	train
Four compounds known to increase QT interval and cause TDP were investigated: terfenadine, terodiline, cisapride and E4031.	terfenadine,78,89,Chemical/Drug	terodiline,91,101,Chemical/Drug	cisapride,103,112,Chemical/Drug	E4031,117,122,Chemical/Drug	"[{""token"": ""terfenadine"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""terodiline"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""E4031"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Chemical/Drug""}]"	train
These data indicate that the free ED50 in plasma for terfenadine ( 1. 9 nM), terodiline ( 76 nM), cisapride ( 11 nM) and E4031 ( 1. 9 nM) closely correlate with the free concentration in man causing QT effects.	terfenadine,53,64,Chemical/Drug	terodiline,77,87,Chemical/Drug	cisapride,98,107,Chemical/Drug	E4031,121,126,Chemical/Drug	"[{""token"": ""terfenadine"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""terodiline"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""E4031"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Chemical/Drug""}]"	train
Forty - nine percent of patients were pain free 2 h after rizatriptan, compared with 24. 3% treated with ergotamine / caffeine ( p < or = 0. 001), rizatriptan being superior within 1 h of treatment.	rizatriptan,58,69,Chemical/Drug	ergotamine,105,115,Chemical/Drug	caffeine,118,126,Chemical/Drug	rizatriptan,147,158,Chemical/Drug	"[{""token"": ""rizatriptan"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""ergotamine"", ""start_span"": 105, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""caffeine"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""rizatriptan"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Chemical/Drug""}]"	train
CONCLUSION: This rat study demonstrated a synergistic nephrotoxic effect of CsA plus SRL, whereas FK506 plus SRL was better tolerated.	CsA,76,79,Chemical/Drug	SRL,85,88,Chemical/Drug	FK506,98,103,Chemical/Drug	SRL,109,112,Chemical/Drug	"[{""token"": ""CsA"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""FK506"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Chemical/Drug""}]"	train
BACKGROUND: Cyproterone acetate combined with ethinyl estradiol ( CPA / EE) is licensed in the UK for the treatment of women with acne and hirsutism and is also a treatment option for polycystic ovary syndrome ( PCOS).	Cyproterone acetate,12,31,Chemical/Drug	ethinyl estradiol,46,63,Chemical/Drug	CPA,66,69,Chemical/Drug	EE,72,74,Chemical/Drug	"[{""token"": ""Cyproterone acetate"", ""start_span"": 12, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""ethinyl estradiol"", ""start_span"": 46, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""CPA"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""EE"", ""start_span"": 72, ""end_span"": 74, ""type"": ""Chemical/Drug""}]"	train
Rats were treated with the vehicle ( 2 mL / kg of distilled water and 5% w / v cellulose, 10 days), gum Arabic ( 2 mL / kg of a 10% w / v aqueous suspension of gum Arabic powder, orally for 10 days), or gum Arabic concomitantly with GM ( 80mg / kg / day intramuscularly, during the last six days of the treatment period).	gum Arabic,100,110,Chemical/Drug	gum Arabic,160,170,Chemical/Drug	gum Arabic,203,213,Chemical/Drug	GM,233,235,Chemical/Drug	"[{""token"": ""gum Arabic"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Chemical/Drug""}, {""token"": ""gum Arabic"", ""start_span"": 160, ""end_span"": 170, ""type"": ""Chemical/Drug""}, {""token"": ""gum Arabic"", ""start_span"": 203, ""end_span"": 213, ""type"": ""Chemical/Drug""}, {""token"": ""GM"", ""start_span"": 233, ""end_span"": 235, ""type"": ""Chemical/Drug""}]"	train
Nephrotoxicity was assessed by measuring the concentrations of creatinine and urea in the plasma and reduced glutathione ( GSH) in the kidney cortex, and by light microscopic examination of kidney sections.	creatinine,63,73,Chemical/Drug	urea,78,82,Chemical/Drug	glutathione,109,120,Chemical/Drug	GSH,123,126,Chemical/Drug	"[{""token"": ""creatinine"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""glutathione"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Chemical/Drug""}, {""token"": ""GSH"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Chemical/Drug""}]"	train
Sub - chronic low dose gamma - vinyl GABA ( vigabatrin) inhibits cocaine - induced increases in nucleus accumbens dopamine.	gamma - vinyl GABA,23,41,Chemical/Drug	vigabatrin,44,54,Chemical/Drug	cocaine,65,72,Chemical/Drug	dopamine,114,122,Chemical/Drug	"[{""token"": ""gamma - vinyl GABA"", ""start_span"": 23, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""vigabatrin"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Chemical/Drug""}]"	train
OBJECTIVES: Given its preclinical success for treating substance abuse and the increased risk of visual field defects ( VFD) associated with cumulative lifetime exposure, we explored the effects of sub - chronic low dose GVG on cocaine - induced increases in nucleus accumbens ( NAcc) dopamine ( DA).	GVG,221,224,Chemical/Drug	cocaine,228,235,Chemical/Drug	dopamine,285,293,Chemical/Drug	DA,296,298,Chemical/Drug	"[{""token"": ""GVG"", ""start_span"": 221, ""end_span"": 224, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 285, ""end_span"": 293, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 296, ""end_span"": 298, ""type"": ""Chemical/Drug""}]"	train
When comparing all lithium treated versus non - lithium - treated groups, lithium caused a reduction in glomerular filtration rate ( GFR) without significant changes in effective renal plasma flow ( as determined by a marker secreted into the proximal tubules) or lithium clearance.	lithium,19,26,Chemical/Drug	lithium,48,55,Chemical/Drug	lithium,74,81,Chemical/Drug	lithium,264,271,Chemical/Drug	"[{""token"": ""lithium"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 264, ""end_span"": 271, ""type"": ""Chemical/Drug""}]"	train
Protection against amphetamine - induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist.	amphetamine,19,30,Chemical/Drug	dopamine,71,79,Chemical/Drug	LY274614,102,110,Chemical/Drug	amino acid,126,136,Chemical/Drug	"[{""token"": ""amphetamine"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""LY274614"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Chemical/Drug""}, {""token"": ""amino acid"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Chemical/Drug""}]"	train
LY274614, 3SR, 4aRS, 6SR, 8aRS - 6 - [ phosphonomethyl] decahydr oisoquinoline - 3 - carboxylic acid, has been described as a potent antagonist of the N - methyl - D - aspartate ( NMDA) subtype of glutamate receptor.	LY274614,0,8,Chemical/Drug	N - methyl - D - aspartate,151,177,Chemical/Drug	NMDA,180,184,Chemical/Drug	glutamate,197,206,Chemical/Drug	"[{""token"": ""LY274614"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""N - methyl - D - aspartate"", ""start_span"": 151, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Chemical/Drug""}]"	train
A 10 mg / kg dose of LY274614 was effective in antagonizing the depletion of dopamine in the striatum, when given as long as 8 hr prior to amphetamine but not when given 24 hr prior to amphetamine.	LY274614,21,29,Chemical/Drug	dopamine,77,85,Chemical/Drug	amphetamine,139,150,Chemical/Drug	amphetamine,185,196,Chemical/Drug	"[{""token"": ""LY274614"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 185, ""end_span"": 196, ""type"": ""Chemical/Drug""}]"	train
NO - induced migraine attack: strong increase in plasma calcitonin gene - related peptide ( CGRP) concentration and negative correlation with platelet serotonin release.	NO,0,2,Chemical/Drug	calcitonin gene - related peptide,56,89,Chemical/Drug	CGRP,92,96,Chemical/Drug	serotonin,151,160,Chemical/Drug	"[{""token"": ""NO"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Chemical/Drug""}, {""token"": ""calcitonin gene - related peptide"", ""start_span"": 56, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""CGRP"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Chemical/Drug""}]"	train
Tincture of Crataegus ( TCR), an alcoholic extract of the berries of hawthorn ( Crataegus oxycantha), is used in herbal and homeopathic medicine.	Tincture of Crataegus,0,21,Chemical/Drug	TCR,24,27,Chemical/Drug	alcoholic extract of the berries of hawthorn,33,77,Chemical/Drug	Crataegus oxycantha,80,99,Chemical/Drug	"[{""token"": ""Tincture of Crataegus"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""TCR"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""alcoholic extract of the berries of hawthorn"", ""start_span"": 33, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""Crataegus oxycantha"", ""start_span"": 80, ""end_span"": 99, ""type"": ""Chemical/Drug""}]"	train
TCR prevented the isoproterenol - induced decrease in antioxidant enzymes in the heart and increased the rate of ADP - stimulated oxygen uptake and respiratory coupling ratio.	TCR,0,3,Chemical/Drug	isoproterenol,18,31,Chemical/Drug	ADP,113,116,Chemical/Drug	oxygen,130,136,Chemical/Drug	"[{""token"": ""TCR"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical/Drug""}, {""token"": ""isoproterenol"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""ADP"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""oxygen"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Chemical/Drug""}]"	train
The rise in blood pressure became less marked when higher concentrations of sevoflurane or enflurane were administered and the blood pressure at convulsions decreased significantly in 1. 6% sevoflurane, and in 0. 8% and 1. 6% enflurane.	sevoflurane,76,87,Chemical/Drug	enflurane,91,100,Chemical/Drug	sevoflurane,190,201,Chemical/Drug	enflurane,226,235,Chemical/Drug	"[{""token"": ""sevoflurane"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""enflurane"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""sevoflurane"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Chemical/Drug""}, {""token"": ""enflurane"", ""start_span"": 226, ""end_span"": 235, ""type"": ""Chemical/Drug""}]"	train
Apamin, a selective blocker of calcium - dependent potassium channels, was administered intracerebroventricularly in rats anesthetized with 0. 8% sevoflurane to investigate the mechanism of the anticonvulsive effects.	Apamin,0,6,Chemical/Drug	calcium,31,38,Chemical/Drug	potassium,51,60,Chemical/Drug	sevoflurane,146,157,Chemical/Drug	"[{""token"": ""Apamin"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""sevoflurane"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Chemical/Drug""}]"	train
Both, Ro4368554 ( 3 and 10 mg / kg, intraperitoneally ( i. p.)) and metrifonate ( 10 mg / kg, p. o., respectively) reversed memory deficits induced by scopolamine and TRP depletion ( 10 mg / kg, i. p., and 3 mg / kg, p. o., respectively).	Ro4368554,6,15,Chemical/Drug	metrifonate,68,79,Chemical/Drug	scopolamine,151,162,Chemical/Drug	TRP,167,170,Chemical/Drug	"[{""token"": ""Ro4368554"", ""start_span"": 6, ""end_span"": 15, ""type"": ""Chemical/Drug""}, {""token"": ""metrifonate"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Chemical/Drug""}, {""token"": ""TRP"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Chemical/Drug""}]"	train
The effect of a 6 - week treatment with the calcium channel blocker nitrendipine or the angiotensin converting enzyme inhibitor enalapril on blood pressure, albuminuria, renal hemodynamics, and morphology of the nonclipped kidney was studied in rats with two - kidney, one clip renovascular hypertension.	calcium,44,51,Chemical/Drug	nitrendipine,68,80,Chemical/Drug	angiotensin,88,99,Chemical/Drug	enalapril,128,137,Chemical/Drug	"[{""token"": ""calcium"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""nitrendipine"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""angiotensin"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""enalapril"", ""start_span"": 128, ""end_span"": 137, ""type"": ""Chemical/Drug""}]"	train
Initial cardiopulmonary resuscitation and immediate treatment with adrenaline ( epinephrine), atropine and furosemide was successful.	adrenaline,67,77,Chemical/Drug	epinephrine,80,91,Chemical/Drug	atropine,94,102,Chemical/Drug	furosemide,107,117,Chemical/Drug	"[{""token"": ""adrenaline"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""atropine"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""furosemide"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Chemical/Drug""}]"	train
THP exhibited an antipsychotic - like profile by potentiating haloperidol - induced catalepsy, reducing amphetamine - induced hyperactivity and reducing apomorphine - induced climbing in mice.	THP,0,3,Chemical/Drug	haloperidol,62,73,Chemical/Drug	amphetamine,104,115,Chemical/Drug	apomorphine,153,164,Chemical/Drug	"[{""token"": ""THP"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 104, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""apomorphine"", ""start_span"": 153, ""end_span"": 164, ""type"": ""Chemical/Drug""}]"	train
Atorvastatin ( Ato) possesses pleiotropic properties that have been reported to improve endothelial function through increased availability of NO and reduced O2 - production in various forms of hypertension.	Atorvastatin,0,12,Chemical/Drug	Ato,15,18,Chemical/Drug	NO,143,145,Chemical/Drug	O2 -,158,162,Chemical/Drug	"[{""token"": ""Atorvastatin"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""Ato"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 143, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""O2 -"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	train
Aortic superoxide production was lower in the Dex + Ato group compared with the group treated with Dex alone ( P < 0. 0001).	superoxide,7,17,Chemical/Drug	Dex,46,49,Chemical/Drug	Ato,52,55,Chemical/Drug	Dex,99,102,Chemical/Drug	"[{""token"": ""superoxide"", ""start_span"": 7, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""Dex"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""Ato"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""Dex"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Chemical/Drug""}]"	train
Although these adverse effects occur in some patients, their occurrence could be minimised by knowledge of the molecular effects of sirolimus on the kidney, the use of sirolimus in appropriate patient populations, close monitoring of proteinuria and renal function, use of angiotensin - converting enzyme inhibitors or angiotensin II receptor blockers if proteinuria occurs and withdrawal if needed.	sirolimus,132,141,Chemical/Drug	sirolimus,168,177,Chemical/Drug	angiotensin,273,284,Chemical/Drug	angiotensin II,319,333,Chemical/Drug	"[{""token"": ""sirolimus"", ""start_span"": 132, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""sirolimus"", ""start_span"": 168, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""angiotensin"", ""start_span"": 273, ""end_span"": 284, ""type"": ""Chemical/Drug""}, {""token"": ""angiotensin II"", ""start_span"": 319, ""end_span"": 333, ""type"": ""Chemical/Drug""}]"	train
While contractions to carbachol and ATP were the same in inflamed and in control strips when related to a reference potassium response, isoprenaline - induced relaxations were smaller in inflamed strips.	carbachol,22,31,Chemical/Drug	ATP,36,39,Chemical/Drug	potassium,116,125,Chemical/Drug	isoprenaline,136,148,Chemical/Drug	"[{""token"": ""carbachol"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""isoprenaline"", ""start_span"": 136, ""end_span"": 148, ""type"": ""Chemical/Drug""}]"	train
As penicillin derivatives and amoxicillin alone are known to induce such types of lesions, the amoxicillin component, with or without a potentiating effect of clavulanic acid, might have a major role.	penicillin,3,13,Chemical/Drug	amoxicillin,30,41,Chemical/Drug	amoxicillin,95,106,Chemical/Drug	clavulanic acid,159,174,Chemical/Drug	"[{""token"": ""penicillin"", ""start_span"": 3, ""end_span"": 13, ""type"": ""Chemical/Drug""}, {""token"": ""amoxicillin"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""amoxicillin"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""clavulanic acid"", ""start_span"": 159, ""end_span"": 174, ""type"": ""Chemical/Drug""}]"	train
BACKGROUND: No direct comparisons exist of the renal tolerability of the low - osmolality contrast medium iopamidol with that of the iso - osmolality contrast medium iodixanol in high - risk patients.	contrast medium,90,105,Chemical/Drug	iopamidol,106,115,Chemical/Drug	contrast medium,150,165,Chemical/Drug	iodixanol,166,175,Chemical/Drug	"[{""token"": ""contrast medium"", ""start_span"": 90, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""iopamidol"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""contrast medium"", ""start_span"": 150, ""end_span"": 165, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 166, ""end_span"": 175, ""type"": ""Chemical/Drug""}]"	train
As the most potent dose ( 1 mg / kg) of lipopolysaccharide was administered two weeks, one day before or after the methamphetamine dosing regimen, methamphetamine - induced striatal dopamine and 3, 4 - dihydroxyphenylacetic acid depletions remained unaltered.	lipopolysaccharide,40,58,Chemical/Drug	methamphetamine,115,130,Chemical/Drug	methamphetamine,147,162,Chemical/Drug	dopamine,182,190,Chemical/Drug	"[{""token"": ""lipopolysaccharide"", ""start_span"": 40, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 147, ""end_span"": 162, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Chemical/Drug""}]"	train
While small prospective studies have not revealed any significant drug - drug interaction between warfarin and levofloxacin, several case reports have indicated that levofloxacin may significantly potentiate the anticoagulation effect of warfarin.	warfarin,98,106,Chemical/Drug	levofloxacin,111,123,Chemical/Drug	levofloxacin,166,178,Chemical/Drug	warfarin,238,246,Chemical/Drug	"[{""token"": ""warfarin"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""levofloxacin"", ""start_span"": 111, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""levofloxacin"", ""start_span"": 166, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""warfarin"", ""start_span"": 238, ""end_span"": 246, ""type"": ""Chemical/Drug""}]"	train
Serum samples were PCR amplified with HBV reverse transcriptase ( RT) primers, followed by direct sequencing across the tyrosine - methionine - aspartate - aspartate ( YMDD) motif of the major catalytic region in the C domain of the HBV RT enzyme.	tyrosine,120,128,Chemical/Drug	methionine,131,141,Chemical/Drug	aspartate,144,153,Chemical/Drug	aspartate,156,165,Chemical/Drug	"[{""token"": ""tyrosine"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""methionine"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 144, ""end_span"": 153, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 156, ""end_span"": 165, ""type"": ""Chemical/Drug""}]"	train
Briefly, cells were differentiated for 72 h with 100 nM PMA to obtain a macrophage - like phenotype in the presence or absence of 1 nM 17beta - estradiol ( E2), 100 nM progesterone or vehicle ( 0. 01% ethanol).	17beta - estradiol,135,153,Chemical/Drug	E2,156,158,Chemical/Drug	progesterone,168,180,Chemical/Drug	ethanol,201,208,Chemical/Drug	"[{""token"": ""17beta - estradiol"", ""start_span"": 135, ""end_span"": 153, ""type"": ""Chemical/Drug""}, {""token"": ""E2"", ""start_span"": 156, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""progesterone"", ""start_span"": 168, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""ethanol"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Chemical/Drug""}]"	train
Admission laboratory tests were as follows: alanine aminotransferase, 67 U / L ( reference range, 10 - 37 U / L); aspartate aminotransferase, 98 U / L ( 10 - 40 U / L); alkaline phosphatase, 513 U / L ( 0 - 270 U / L); gamma - glutamyltransferase, 32 U / L ( 7 - 49 U / L); amylase, 46 U / L ( 0 - 220 U / L); total bilirubin, 20. 1 mg / dL ( 0. 2 - 1. 0 mg / dL); direct bilirubin, 14. 8 mg / dL ( 0 - 0. 3 mg / dL); and albumin, 4. 7 mg / dL ( 3. 5 - 5. 4 mg / dL).	alanine,44,51,Chemical/Drug	aspartate,114,123,Chemical/Drug	bilirubin,316,325,Chemical/Drug	bilirubin,372,381,Chemical/Drug	"[{""token"": ""alanine"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""bilirubin"", ""start_span"": 316, ""end_span"": 325, ""type"": ""Chemical/Drug""}, {""token"": ""bilirubin"", ""start_span"": 372, ""end_span"": 381, ""type"": ""Chemical/Drug""}]"	train
METHODS: In this study, we evaluated the performance of dopamine beta - hydroxylase knockout ( Dbh - / -) mice, which lack norepinephrine ( NE), in the elevated plus maze ( EPM) to examine the contribution of noradrenergic signaling to cocaine - induced anxiety.	dopamine,56,64,Chemical/Drug	norepinephrine,123,137,Chemical/Drug	NE,140,142,Chemical/Drug	cocaine,236,243,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""norepinephrine"", ""start_span"": 123, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""NE"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Chemical/Drug""}]"	train
In experiments using specific adrenergic antagonists, we found that pretreatment with the beta - adrenergic receptor antagonist propranolol blocked cocaine - induced anxiety - like behavior in Dbh + / - and wild - type C57BL6 / J mice, while the alpha ( 1) antagonist prazosin and the alpha ( 2) antagonist yohimbine had no effect.	propranolol,128,139,Chemical/Drug	cocaine,148,155,Chemical/Drug	prazosin,268,276,Chemical/Drug	yohimbine,307,316,Chemical/Drug	"[{""token"": ""propranolol"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""prazosin"", ""start_span"": 268, ""end_span"": 276, ""type"": ""Chemical/Drug""}, {""token"": ""yohimbine"", ""start_span"": 307, ""end_span"": 316, ""type"": ""Chemical/Drug""}]"	train
METHOD: In a 16 - week multicenter, double - blind trial, 122 children with ADHD were randomly assigned to clonidine ( n = 31), methylphenidate ( n = 29), clonidine and methylphenidate ( n = 32), or placebo ( n = 30).	clonidine,107,116,Chemical/Drug	methylphenidate,128,143,Chemical/Drug	clonidine,155,164,Chemical/Drug	methylphenidate,169,184,Chemical/Drug	"[{""token"": ""clonidine"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""methylphenidate"", ""start_span"": 128, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""clonidine"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Chemical/Drug""}, {""token"": ""methylphenidate"", ""start_span"": 169, ""end_span"": 184, ""type"": ""Chemical/Drug""}]"	train
In addition, the role of dopamine receptors in mediating nicotine - induced locomotor stimulation was investigated by examining the effects of selective D1 and D2 dopamine receptor antagonists on activity induced by nicotine.	dopamine,25,33,Chemical/Drug	nicotine,57,65,Chemical/Drug	dopamine,163,171,Chemical/Drug	nicotine,216,224,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 216, ""end_span"": 224, ""type"": ""Chemical/Drug""}]"	train
Nicotine - induced hyperactivity was blocked by the selective D1 antagonist SCH 23390, the selective D2 antagonist raclopride and the D1 / D2 antagonist fluphenazine.	Nicotine,0,8,Chemical/Drug	SCH 23390,76,85,Chemical/Drug	raclopride,115,125,Chemical/Drug	fluphenazine,153,165,Chemical/Drug	"[{""token"": ""Nicotine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""SCH 23390"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""raclopride"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""fluphenazine"", ""start_span"": 153, ""end_span"": 165, ""type"": ""Chemical/Drug""}]"	train
Methamphetamine ( METH) damages dopamine ( DA) nerve endings by a process that has been linked to microglial activation but the signaling pathways that mediate this response have not yet been delineated.	Methamphetamine,0,15,Chemical/Drug	METH,18,22,Chemical/Drug	dopamine,32,40,Chemical/Drug	DA,43,45,Chemical/Drug	"[{""token"": ""Methamphetamine"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Chemical/Drug""}, {""token"": ""METH"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Chemical/Drug""}]"	train
Because the CNS damage caused by METH and MPTP is highly selective for the DA neuronal system in mouse models of neurotoxicity, we hypothesized that the CX3CR1 plays a role in METH - induced neurotoxicity and microglial activation.	METH,33,37,Chemical/Drug	MPTP,42,46,Chemical/Drug	DA,75,77,Chemical/Drug	METH,176,180,Chemical/Drug	"[{""token"": ""METH"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""MPTP"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 75, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""METH"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Chemical/Drug""}]"	train
VPU was more potent than VPA, exhibiting the median effective dose ( ED ( 50)) of 49 mg / kg in protecting rats against pilocarpine - induced seizure whereas the corresponding value for VPA was 322 mg / kg.	VPU,0,3,Chemical/Drug	VPA,25,28,Chemical/Drug	pilocarpine,120,131,Chemical/Drug	VPA,186,189,Chemical/Drug	"[{""token"": ""VPU"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical/Drug""}, {""token"": ""VPA"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""VPA"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Chemical/Drug""}]"	train
In addition, a statistically significant reduction was also observed on the level of GABA and glycine but less than a drastic reduction of glutamate and aspartate level.	GABA,85,89,Chemical/Drug	glycine,94,101,Chemical/Drug	glutamate,139,148,Chemical/Drug	aspartate,153,162,Chemical/Drug	"[{""token"": ""GABA"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""glycine"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 139, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 153, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	train
RESULTS: Omission of fentanyl did not reduce the overall incidence of postoperative nausea and vomiting, but did reduce the incidence of vomiting and / or moderate to severe nausea prior to discharge from 20% and 17% with fentanyl and fentanyl - dexamethasone, respectively, to 5% ( P = 0. 013).	fentanyl,21,29,Chemical/Drug	fentanyl,222,230,Chemical/Drug	fentanyl,235,243,Chemical/Drug	dexamethasone,246,259,Chemical/Drug	"[{""token"": ""fentanyl"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""fentanyl"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Chemical/Drug""}, {""token"": ""fentanyl"", ""start_span"": 235, ""end_span"": 243, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 246, ""end_span"": 259, ""type"": ""Chemical/Drug""}]"	train
Ezetimibe undergoes extensive glucuronidation by uridine diphosphate glucoronosyltransferases ( UGT) in the intestine and liver and may have inhibited the glucuronidation of simvastatin hydroxy acid, resulting in increased simvastatin exposure and subsequent hepatotoxicity.	Ezetimibe,0,9,Chemical/Drug	uridine diphosphate,49,68,Chemical/Drug	simvastatin hydroxy acid,174,198,Chemical/Drug	simvastatin,223,234,Chemical/Drug	"[{""token"": ""Ezetimibe"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""uridine diphosphate"", ""start_span"": 49, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""simvastatin hydroxy acid"", ""start_span"": 174, ""end_span"": 198, ""type"": ""Chemical/Drug""}, {""token"": ""simvastatin"", ""start_span"": 223, ""end_span"": 234, ""type"": ""Chemical/Drug""}]"	train
The present study was aimed to investigate the combined effects of green tea and vitamin E on heart weight, body weight, serum marker enzymes, lipid peroxidation, endogenous antioxidants and membrane bound ATPases in isoproterenol ( ISO) - induced myocardial infarction in rats.	green tea,67,76,Chemical/Drug	vitamin E,81,90,Chemical/Drug	isoproterenol,217,230,Chemical/Drug	ISO,233,236,Chemical/Drug	"[{""token"": ""green tea"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin E"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""isoproterenol"", ""start_span"": 217, ""end_span"": 230, ""type"": ""Chemical/Drug""}, {""token"": ""ISO"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Chemical/Drug""}]"	train
Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model.	Bradykinin,0,10,Chemical/Drug	nitric oxide,37,49,Chemical/Drug	vincristine,73,84,Chemical/Drug	streptozotocin,89,103,Chemical/Drug	"[{""token"": ""Bradykinin"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""nitric oxide"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""vincristine"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""streptozotocin"", ""start_span"": 89, ""end_span"": 103, ""type"": ""Chemical/Drug""}]"	train
It was also shown that both products of inducible NO synthase and neuronal NO synthase activation as well as bradykinin are involved in hyperalgesia produced by vincristine.	NO,50,52,Chemical/Drug	NO,75,77,Chemical/Drug	bradykinin,109,119,Chemical/Drug	vincristine,161,172,Chemical/Drug	"[{""token"": ""NO"", ""start_span"": 50, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 75, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""bradykinin"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""vincristine"", ""start_span"": 161, ""end_span"": 172, ""type"": ""Chemical/Drug""}]"	train
To address the potential confounding effects of the cannabis use of the ecstasy using group, a second analysis included 14 previously tested cannabis users ( Nestor, L., Roberts, G., Garavan, H., Hester, R., 2008. Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users. Neuroimage 40, 1328 - 1339).	cannabis,52,60,Chemical/Drug	ecstasy,72,79,Chemical/Drug	cannabis,141,149,Chemical/Drug	cannabis,312,320,Chemical/Drug	"[{""token"": ""cannabis"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""ecstasy"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""cannabis"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""cannabis"", ""start_span"": 312, ""end_span"": 320, ""type"": ""Chemical/Drug""}]"	train
However, the observation that antagonists of the glutamate N - methyl - D - aspartate ( NMDA) receptor produce schizophrenic - like symptoms in humans has led to the idea of a dysfunctioning of the glutamatergic system via its NMDA receptor.	glutamate,49,58,Chemical/Drug	N - methyl - D - aspartate,59,85,Chemical/Drug	NMDA,88,92,Chemical/Drug	NMDA,227,231,Chemical/Drug	"[{""token"": ""glutamate"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""N - methyl - D - aspartate"", ""start_span"": 59, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Chemical/Drug""}]"	train
This study aimed at investigating the potential antipsychotic - like properties of SSR103800, with a particular focus on models of hyperactivity, involving either drug challenge ( ie, amphetamine and MK - 801) or transgenic mice ( ie, NMDA Nr1 ( neo - / -) and DAT ( - / -)).	SSR103800,83,92,Chemical/Drug	amphetamine,184,195,Chemical/Drug	MK - 801,200,208,Chemical/Drug	NMDA,235,239,Chemical/Drug	"[{""token"": ""SSR103800"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Chemical/Drug""}, {""token"": ""MK - 801"", ""start_span"": 200, ""end_span"": 208, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Chemical/Drug""}]"	train
Results showed that SSR103800 ( 10 - 30 mg / kg p. o.) blocked hyperactivity induced by the non - competitive NMDA receptor antagonist, MK - 801 and partially reversed spontaneous hyperactivity of NMDA Nr1 ( neo - / -) mice.	SSR103800,20,29,Chemical/Drug	NMDA,110,114,Chemical/Drug	MK - 801,136,144,Chemical/Drug	NMDA,197,201,Chemical/Drug	"[{""token"": ""SSR103800"", ""start_span"": 20, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""MK - 801"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Chemical/Drug""}]"	train
Importantly, both classical ( haloperidol) and atypical ( olanzapine, clozapine and aripiprazole) antipsychotics were effective in all these models of hyperactivity.	haloperidol,30,41,Chemical/Drug	olanzapine,58,68,Chemical/Drug	clozapine,70,79,Chemical/Drug	aripiprazole,84,96,Chemical/Drug	"[{""token"": ""haloperidol"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""olanzapine"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""clozapine"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""aripiprazole"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Chemical/Drug""}]"	train
Other antibacterial agents that showed associations included erythromycins ( 2 defects), penicillins ( 1 defect), cephalosporins ( 1 defect), and quinolones ( 1 defect).	erythromycins,61,74,Chemical/Drug	penicillins,89,100,Chemical/Drug	cephalosporins,114,128,Chemical/Drug	quinolones,146,156,Chemical/Drug	"[{""token"": ""erythromycins"", ""start_span"": 61, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""penicillins"", ""start_span"": 89, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""cephalosporins"", ""start_span"": 114, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""quinolones"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Chemical/Drug""}]"	train
In all clones with combined immune escape and LAM resistance mutations, the nucleotide analogues adefovir and tenofovir remained effective in suppressing viral replication in vitro.	LAM,46,49,Chemical/Drug	nucleotide,76,86,Chemical/Drug	adefovir,97,105,Chemical/Drug	tenofovir,110,119,Chemical/Drug	"[{""token"": ""LAM"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""nucleotide"", ""start_span"": 76, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""adefovir"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""tenofovir"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Chemical/Drug""}]"	train
METHODS: Following induction of anesthesia by fentanyl ( 0. 15 mg kg ( - 1)) and propofol ( 2. 0 mg kg ( - 1)), 13 patients received phenylephrine ( 0. 1 mg iv) and 12 patients received ephedrine ( 10 mg iv) to restore mean arterial pressure ( MAP).	fentanyl,46,54,Chemical/Drug	propofol,81,89,Chemical/Drug	phenylephrine,133,146,Chemical/Drug	ephedrine,186,195,Chemical/Drug	"[{""token"": ""fentanyl"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""propofol"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""phenylephrine"", ""start_span"": 133, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""ephedrine"", ""start_span"": 186, ""end_span"": 195, ""type"": ""Chemical/Drug""}]"	train
OBJECTIVE: To determine the safety and efficacy of adjunctive bupropion sustained - release ( SR) on male sexual dysfunction ( SD) induced by a selective serotonin reuptake inhibitor ( SSRI), as SD is a common side - effect of SSRIs and the most effective treatments have yet to be determined.	bupropion,62,71,Chemical/Drug	selective serotonin reuptake inhibitor,144,182,Chemical/Drug	SSRI,185,189,Chemical/Drug	SSRIs,227,232,Chemical/Drug	"[{""token"": ""bupropion"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""selective serotonin reuptake inhibitor"", ""start_span"": 144, ""end_span"": 182, ""type"": ""Chemical/Drug""}, {""token"": ""SSRI"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Chemical/Drug""}, {""token"": ""SSRIs"", ""start_span"": 227, ""end_span"": 232, ""type"": ""Chemical/Drug""}]"	train
OBJECTIVE: to analyze aspects of TEE safety associated to the use of Midazolan ( MZ) and Flumazenil ( FL) and the influence of the clinical variables on the event rate.	Midazolan,69,78,Chemical/Drug	MZ,81,83,Chemical/Drug	Flumazenil,89,99,Chemical/Drug	FL,102,104,Chemical/Drug	"[{""token"": ""Midazolan"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""MZ"", ""start_span"": 81, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""Flumazenil"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""FL"", ""start_span"": 102, ""end_span"": 104, ""type"": ""Chemical/Drug""}]"	train
With last observations carried forward ( LOCF), mean Positive and Negative Syndrome Scale total score reductions from baseline to endpoint were significantly greater with asenapine at 5 mg BID ( - 16. 2) and haloperidol ( - 15. 4) than placebo ( - 10. 7; both P < 0. 05); using mixed model for repeated measures ( MMRM), changes at day 42 were significantly greater with asenapine at 5 and 10 mg BID ( - 21. 3 and - 19. 4, respectively) and haloperidol ( - 20. 0) than placebo ( - 14. 6; all P < 0. 05).	asenapine,171,180,Chemical/Drug	haloperidol,208,219,Chemical/Drug	asenapine,371,380,Chemical/Drug	haloperidol,441,452,Chemical/Drug	"[{""token"": ""asenapine"", ""start_span"": 171, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 208, ""end_span"": 219, ""type"": ""Chemical/Drug""}, {""token"": ""asenapine"", ""start_span"": 371, ""end_span"": 380, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 441, ""end_span"": 452, ""type"": ""Chemical/Drug""}]"	train
At the end of study period, serum phenobarbitone and carbamazepine, whole brain malondialdehyde and reduced glutathione levels were estimated.	phenobarbitone,34,48,Chemical/Drug	carbamazepine,53,66,Chemical/Drug	malondialdehyde,80,95,Chemical/Drug	glutathione,108,119,Chemical/Drug	"[{""token"": ""phenobarbitone"", ""start_span"": 34, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""carbamazepine"", ""start_span"": 53, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""malondialdehyde"", ""start_span"": 80, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""glutathione"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Chemical/Drug""}]"	train
Similarly, pre - test scopolamine partially reversed the scopolamine - induced amnesia, but not significantly; and pre - test cycloheximide failed to reverse the cycloheximide - induced amnesia.	scopolamine,22,33,Chemical/Drug	scopolamine,57,68,Chemical/Drug	cycloheximide,126,139,Chemical/Drug	cycloheximide,162,175,Chemical/Drug	"[{""token"": ""scopolamine"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""cycloheximide"", ""start_span"": 126, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""cycloheximide"", ""start_span"": 162, ""end_span"": 175, ""type"": ""Chemical/Drug""}]"	train
As naloxone and clonidine do not appear to interact with the same receptor site, the observed functional antagonism suggests the release of an endogenous opiate by clonidine or alpha - methyldopa and the possible role of the opiate in the central control of sympathetic tone.	naloxone,3,11,Chemical/Drug	clonidine,16,25,Chemical/Drug	clonidine,164,173,Chemical/Drug	alpha - methyldopa,177,195,Chemical/Drug	"[{""token"": ""naloxone"", ""start_span"": 3, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""clonidine"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""clonidine"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Chemical/Drug""}, {""token"": ""alpha - methyldopa"", ""start_span"": 177, ""end_span"": 195, ""type"": ""Chemical/Drug""}]"	train
In vitro, gamma - HCH, pentylenetetrazol and picrotoxin were shown to inhibit 3H - TBOB binding in mouse whole brain, with IC50 values of 4. 6, 404 and 9. 4 microM, respectively.	gamma - HCH,10,21,Chemical/Drug	pentylenetetrazol,23,40,Chemical/Drug	picrotoxin,45,55,Chemical/Drug	3H - TBOB,78,87,Chemical/Drug	"[{""token"": ""gamma - HCH"", ""start_span"": 10, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""pentylenetetrazol"", ""start_span"": 23, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""picrotoxin"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""3H - TBOB"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Chemical/Drug""}]"	train
The biochemical results of brain biogenic amines of BALB / C mouse strain suggest a probable decrease of catecholamine turnover rate and / or metabolism by monoamine oxidase and a resulting increase in O - methylation of norepinephrine which may account for a behavioral depression caused by amantadine in the BALB / C mice.	amines,42,48,Chemical/Drug	catecholamine,105,118,Chemical/Drug	norepinephrine,221,235,Chemical/Drug	amantadine,292,302,Chemical/Drug	"[{""token"": ""amines"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""catecholamine"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""norepinephrine"", ""start_span"": 221, ""end_span"": 235, ""type"": ""Chemical/Drug""}, {""token"": ""amantadine"", ""start_span"": 292, ""end_span"": 302, ""type"": ""Chemical/Drug""}]"	train
It is suggested that the effects of Captopril on the lungs may be attributable to a vasodilatory effect due to a reduction in the circulating level of Angiotension II and an increase in prostacyclin ( secondary to an increase in bradykinin).	Captopril,36,45,Chemical/Drug	Angiotension II,151,166,Chemical/Drug	prostacyclin,186,198,Chemical/Drug	bradykinin,229,239,Chemical/Drug	"[{""token"": ""Captopril"", ""start_span"": 36, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""Angiotension II"", ""start_span"": 151, ""end_span"": 166, ""type"": ""Chemical/Drug""}, {""token"": ""prostacyclin"", ""start_span"": 186, ""end_span"": 198, ""type"": ""Chemical/Drug""}, {""token"": ""bradykinin"", ""start_span"": 229, ""end_span"": 239, ""type"": ""Chemical/Drug""}]"	train
In conclusion, reductions in creatinine clearance and renal amphotericin B accumulation after chronic amphotericin B administration were enhanced by salt depletion and attenuated by sodium loading in rats.	creatinine,29,39,Chemical/Drug	amphotericin B,60,74,Chemical/Drug	amphotericin B,102,116,Chemical/Drug	sodium,182,188,Chemical/Drug	"[{""token"": ""creatinine"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""amphotericin B"", ""start_span"": 60, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""amphotericin B"", ""start_span"": 102, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""sodium"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Chemical/Drug""}]"	train
The cataleptogenic effect of THC was significantly reduced in rats treated with 6 - OHDA and in rats with lesions of the locus coeruleus but not in rats treated with desipramine and 6 - OHDA, as compared with control rats.	THC,29,32,Chemical/Drug	6 - OHDA,80,88,Chemical/Drug	desipramine,166,177,Chemical/Drug	6 - OHDA,182,190,Chemical/Drug	"[{""token"": ""THC"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Chemical/Drug""}]"	train
On the contrary, the cataleptogenic effect of haloperidol was significantly reduced in rats treated with desipramine and 6 - OHDA but not in rats treated with 6 - OHDA or in rats with lesions of the locus coeruleus.	haloperidol,46,57,Chemical/Drug	desipramine,105,116,Chemical/Drug	6 - OHDA,121,129,Chemical/Drug	6 - OHDA,159,167,Chemical/Drug	"[{""token"": ""haloperidol"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 159, ""end_span"": 167, ""type"": ""Chemical/Drug""}]"	train
Myopathy, associated in some cases with myoglobinuria, and in 2 cases with transient renal failure, has been rarely reported with lovastatin, especially in patients concomitantly treated with cyclosporin, gemfibrozil or niacin.	lovastatin,130,140,Chemical/Drug	cyclosporin,192,203,Chemical/Drug	gemfibrozil,205,216,Chemical/Drug	niacin,220,226,Chemical/Drug	"[{""token"": ""lovastatin"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""cyclosporin"", ""start_span"": 192, ""end_span"": 203, ""type"": ""Chemical/Drug""}, {""token"": ""gemfibrozil"", ""start_span"": 205, ""end_span"": 216, ""type"": ""Chemical/Drug""}, {""token"": ""niacin"", ""start_span"": 220, ""end_span"": 226, ""type"": ""Chemical/Drug""}]"	train
Use of verapamil in combination with carbamazepine should either be avoided or prescribed only with appropriate adjustment of the carbamazepine dose ( usually reduction of the carbamazepine dose by one half).	verapamil,7,16,Chemical/Drug	carbamazepine,37,50,Chemical/Drug	carbamazepine,130,143,Chemical/Drug	carbamazepine,176,189,Chemical/Drug	"[{""token"": ""verapamil"", ""start_span"": 7, ""end_span"": 16, ""type"": ""Chemical/Drug""}, {""token"": ""carbamazepine"", ""start_span"": 37, ""end_span"": 50, ""type"": ""Chemical/Drug""}, {""token"": ""carbamazepine"", ""start_span"": 130, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""carbamazepine"", ""start_span"": 176, ""end_span"": 189, ""type"": ""Chemical/Drug""}]"	train
Severe complications of antianginal drug therapy in a patient identified as a poor metabolizer of metoprolol, propafenone, diltiazem, and sparteine.	metoprolol,98,108,Chemical/Drug	propafenone,110,121,Chemical/Drug	diltiazem,123,132,Chemical/Drug	sparteine,138,147,Chemical/Drug	"[{""token"": ""metoprolol"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""propafenone"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Chemical/Drug""}, {""token"": ""sparteine"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Chemical/Drug""}]"	train
Flow and metabolism were measured 5 - 13 days after the subarachnoid haemorrhage by a modification of the classical Kety - Schmidt technique using xenon - 133 i. v. Anaesthesia was maintained with an inspired isoflurane concentration of 0. 75% ( plus 67% nitrous oxide in oxygen), during which CBF and CMRO2 were 34. 3 + / - 2. 1 ml / 100 g min - 1 and 2. 32 + / - 0. 16 ml / 100 g min - 1 at PaCO2 4. 1 + / - 0. 1 kPa ( mean + / - SEM).	xenon,147,152,Chemical/Drug	isoflurane,209,219,Chemical/Drug	nitrous oxide,255,268,Chemical/Drug	oxygen,272,278,Chemical/Drug	"[{""token"": ""xenon"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""isoflurane"", ""start_span"": 209, ""end_span"": 219, ""type"": ""Chemical/Drug""}, {""token"": ""nitrous oxide"", ""start_span"": 255, ""end_span"": 268, ""type"": ""Chemical/Drug""}, {""token"": ""oxygen"", ""start_span"": 272, ""end_span"": 278, ""type"": ""Chemical/Drug""}]"	train
A patient who allegedly consumed 100 tablets of an over - the - counter analgesic containing sodium acetylsalicylate, caffeine, and acetaminophen displayed no significant CNS stimulation despite the presence of 175 micrograms of caffeine per mL of serum.	sodium acetylsalicylate,93,116,Chemical/Drug	caffeine,118,126,Chemical/Drug	acetaminophen,132,145,Chemical/Drug	caffeine,229,237,Chemical/Drug	"[{""token"": ""sodium acetylsalicylate"", ""start_span"": 93, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""caffeine"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""caffeine"", ""start_span"": 229, ""end_span"": 237, ""type"": ""Chemical/Drug""}]"	train
Studies in DBA / 2J mice showed that: 1) pretreatment with acetaminophen ( 100 mg / kg) increased the interval between the administration of caffeine ( 300 to 450 mg / kg IP) and the onset of fatal convulsions by a factor of about two; and 2) pretreatment with acetaminophen ( 75 mg / kg) reduced the incidence of audiogenic seizures produced in the presence of caffeine ( 12. 5 to 75 mg / kg IP).	acetaminophen,59,72,Chemical/Drug	caffeine,141,149,Chemical/Drug	acetaminophen,261,274,Chemical/Drug	caffeine,362,370,Chemical/Drug	"[{""token"": ""acetaminophen"", ""start_span"": 59, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""caffeine"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 261, ""end_span"": 274, ""type"": ""Chemical/Drug""}, {""token"": ""caffeine"", ""start_span"": 362, ""end_span"": 370, ""type"": ""Chemical/Drug""}]"	train
Patients tapped faster after propranolol than diazepam and they were more sedated after diazepam than propranolol.	propranolol,29,40,Chemical/Drug	diazepam,46,54,Chemical/Drug	diazepam,88,96,Chemical/Drug	propranolol,102,113,Chemical/Drug	"[{""token"": ""propranolol"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical/Drug""}]"	train
The effect of a widely used organic solvent, polyethylene glycol 400 ( PEG 400), on the toxic action of an acute or chronic treatment with adriamycin ( ADR) was evaluated in mice.	polyethylene glycol 400,45,68,Chemical/Drug	PEG 400,71,78,Chemical/Drug	adriamycin,139,149,Chemical/Drug	ADR,152,155,Chemical/Drug	"[{""token"": ""polyethylene glycol 400"", ""start_span"": 45, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""PEG 400"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""adriamycin"", ""start_span"": 139, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""ADR"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Chemical/Drug""}]"	train
An autoradiographic study was performed on male F - 344 rats fed diet containing FANFT at a level of 0. 2% and / or aspirin at a level of 0. 5% to evaluate the effect of aspirin on the increased cell proliferation induced by FANFT in the forestomach and bladder.	FANFT,81,86,Chemical/Drug	aspirin,116,123,Chemical/Drug	aspirin,170,177,Chemical/Drug	FANFT,225,230,Chemical/Drug	"[{""token"": ""FANFT"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""FANFT"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Chemical/Drug""}]"	train
Intrarenal compared with intravenous infusion of noradrenaline caused higher plasma noradrenaline concentrations and a shift of the plasma noradrenaline concentration - blood pressure effect curve towards lower plasma noradrenaline levels.	noradrenaline,49,62,Chemical/Drug	noradrenaline,84,97,Chemical/Drug	noradrenaline,139,152,Chemical/Drug	noradrenaline,218,231,Chemical/Drug	"[{""token"": ""noradrenaline"", ""start_span"": 49, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""noradrenaline"", ""start_span"": 84, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""noradrenaline"", ""start_span"": 139, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""noradrenaline"", ""start_span"": 218, ""end_span"": 231, ""type"": ""Chemical/Drug""}]"	train
"The yield of severe cirrhosis of the liver ( defined as a shrunken finely nodular liver with micronodular histology, ascites greater than 30 ml, plasma albumin less than 2. 2 g / dl, splenomegaly 2 - 3 times normal, and testicular atrophy approximately half normal weight) after 12 doses of carbon tetrachloride given intragastrically in the phenobarbitone - primed rat was increased from 25% to 56% by giving the initial "" calibrating "" dose of carbon tetrachloride at the peak of the phenobarbitone - induced enlargement of the liver."	carbon tetrachloride,291,311,Chemical/Drug	phenobarbitone,342,356,Chemical/Drug	carbon tetrachloride,446,466,Chemical/Drug	phenobarbitone,486,500,Chemical/Drug	"[{""token"": ""carbon tetrachloride"", ""start_span"": 291, ""end_span"": 311, ""type"": ""Chemical/Drug""}, {""token"": ""phenobarbitone"", ""start_span"": 342, ""end_span"": 356, ""type"": ""Chemical/Drug""}, {""token"": ""carbon tetrachloride"", ""start_span"": 446, ""end_span"": 466, ""type"": ""Chemical/Drug""}, {""token"": ""phenobarbitone"", ""start_span"": 486, ""end_span"": 500, ""type"": ""Chemical/Drug""}]"	train
The role of the renin - - angiotensin system in the maintenance of blood pressure during halothane anesthesia and sodium nitroprusside ( SNP) - induced hypotension was evaluated.	angiotensin,26,37,Chemical/Drug	halothane,89,98,Chemical/Drug	sodium nitroprusside,114,134,Chemical/Drug	SNP,137,140,Chemical/Drug	"[{""token"": ""angiotensin"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""halothane"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""sodium nitroprusside"", ""start_span"": 114, ""end_span"": 134, ""type"": ""Chemical/Drug""}, {""token"": ""SNP"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Chemical/Drug""}]"	train
This study indicates that with stable halothane anesthesia, the partial recovery of blood pressure during SNP infusion and the post - SNP rebound of blood pressure can be completely blocked by saralasin.	halothane,38,47,Chemical/Drug	SNP,106,109,Chemical/Drug	SNP,134,137,Chemical/Drug	saralasin,193,202,Chemical/Drug	"[{""token"": ""halothane"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""SNP"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""SNP"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""saralasin"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Chemical/Drug""}]"	train
The effect of amiloride on lithium - induced polydipsia and polyuria and on the lithium concentration in the plasma, brain, kidney, thyroid and red blood cells was investigated in rats, chronically treated with LiCl.	amiloride,14,23,Chemical/Drug	lithium,27,34,Chemical/Drug	lithium,80,87,Chemical/Drug	LiCl,211,215,Chemical/Drug	"[{""token"": ""amiloride"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""LiCl"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Chemical/Drug""}]"	train
In all the experiments, the attenuation of the lithium - induced diabetes - insipidus - like syndrome by amiloride was accompanied by a reduction of the ratio between the lithium concentration in the renal medulla and its levels in the blood and an elevation in the plasma potassium level.	lithium,47,54,Chemical/Drug	amiloride,105,114,Chemical/Drug	lithium,171,178,Chemical/Drug	potassium,273,282,Chemical/Drug	"[{""token"": ""lithium"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""amiloride"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 273, ""end_span"": 282, ""type"": ""Chemical/Drug""}]"	train
It is concluded that acute amiloride administration to lithium - treated patients suffering from polydipsia and polyuria might relieve these patients but prolonged amiloride supplementation would result in elevated lithium levels and might be hazardous.	amiloride,27,36,Chemical/Drug	lithium,55,62,Chemical/Drug	amiloride,164,173,Chemical/Drug	lithium,215,222,Chemical/Drug	"[{""token"": ""amiloride"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""amiloride"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 215, ""end_span"": 222, ""type"": ""Chemical/Drug""}]"	train
A prospective, randomized study was conducted to evaluate the role of vitamin B12 and folinic acid supplementation in preventing zidovudine ( ZDV) - induced bone marrow suppression.	vitamin B12,70,81,Chemical/Drug	folinic acid,86,98,Chemical/Drug	zidovudine,129,139,Chemical/Drug	ZDV,142,145,Chemical/Drug	"[{""token"": ""vitamin B12"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""folinic acid"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 129, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""ZDV"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Chemical/Drug""}]"	train
Vitamin B12 and folinic acid supplementation of ZDV therapy does not seem useful in preventing or reducing ZDV - induced myelotoxicity in the overall treated population, although a beneficial effect in certain subgroups of patients cannot be excluded.	Vitamin B12,0,11,Chemical/Drug	folinic acid,16,28,Chemical/Drug	ZDV,48,51,Chemical/Drug	ZDV,107,110,Chemical/Drug	"[{""token"": ""Vitamin B12"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""folinic acid"", ""start_span"": 16, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""ZDV"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""ZDV"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Chemical/Drug""}]"	train
A 61 - year - old man was treated with combination chemotherapy incorporating cisplatinum, etoposide, high - dose 5 - fluorouracil ( 2, 250 mg / m2 / 24 hours) and folinic acid for an inoperable gastric adenocarcinoma.	cisplatinum,78,89,Chemical/Drug	etoposide,91,100,Chemical/Drug	5 - fluorouracil,114,130,Chemical/Drug	folinic acid,164,176,Chemical/Drug	"[{""token"": ""cisplatinum"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""etoposide"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""5 - fluorouracil"", ""start_span"": 114, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""folinic acid"", ""start_span"": 164, ""end_span"": 176, ""type"": ""Chemical/Drug""}]"	train
CONCLUSIONS: A comparison of frequency of adverse reactions to indocyanine green with the previously reported frequency of such reactions to fluorescein sodium indicated that indocyanine green is a safe as fluorescein for use in angiography.	indocyanine green,63,80,Chemical/Drug	fluorescein sodium,141,159,Chemical/Drug	indocyanine green,175,192,Chemical/Drug	fluorescein,206,217,Chemical/Drug	"[{""token"": ""indocyanine green"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""fluorescein sodium"", ""start_span"": 141, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""indocyanine green"", ""start_span"": 175, ""end_span"": 192, ""type"": ""Chemical/Drug""}, {""token"": ""fluorescein"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Chemical/Drug""}]"	train
A detailed clinical history, together with skin tests, RAST ( radioallergosorbent test), and controlled challenge tests, was used to establish whether patients allergic to beta - lactam antibiotics had selective immediate allergic responses to amoxicillin ( AX) or were cross - reacting with other penicillin derivatives.	beta - lactam,172,185,Chemical/Drug	amoxicillin,244,255,Chemical/Drug	AX,258,260,Chemical/Drug	penicillin,298,308,Chemical/Drug	"[{""token"": ""beta - lactam"", ""start_span"": 172, ""end_span"": 185, ""type"": ""Chemical/Drug""}, {""token"": ""amoxicillin"", ""start_span"": 244, ""end_span"": 255, ""type"": ""Chemical/Drug""}, {""token"": ""AX"", ""start_span"": 258, ""end_span"": 260, ""type"": ""Chemical/Drug""}, {""token"": ""penicillin"", ""start_span"": 298, ""end_span"": 308, ""type"": ""Chemical/Drug""}]"	train
The convulsant activity of bupivacaine was not significantly modified but calcium channel blockers decreased the time of latency to obtain bupivacaine - induced convulsions; this effect was less pronounced with bepridil.	bupivacaine,27,38,Chemical/Drug	calcium,74,81,Chemical/Drug	bupivacaine,139,150,Chemical/Drug	bepridil,211,219,Chemical/Drug	"[{""token"": ""bupivacaine"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""bupivacaine"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""bepridil"", ""start_span"": 211, ""end_span"": 219, ""type"": ""Chemical/Drug""}]"	train
A total of 38 consecutive patients who presented to our clinic with impotence received 0. 2 ml. of a combination of 3 drugs: 6 mg. papaverine, 100 micrograms. phentolamine and 10 micrograms. prostaglandin E1 with ( pH 7. 05) or without ( pH 4. 17) the addition of sodium bicarbonate ( 0. 03 mEq.).	papaverine,131,141,Chemical/Drug	phentolamine,159,171,Chemical/Drug	prostaglandin E1,191,207,Chemical/Drug	sodium bicarbonate,264,282,Chemical/Drug	"[{""token"": ""papaverine"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""phentolamine"", ""start_span"": 159, ""end_span"": 171, ""type"": ""Chemical/Drug""}, {""token"": ""prostaglandin E1"", ""start_span"": 191, ""end_span"": 207, ""type"": ""Chemical/Drug""}, {""token"": ""sodium bicarbonate"", ""start_span"": 264, ""end_span"": 282, ""type"": ""Chemical/Drug""}]"	train
The use and toxicity of didanosine ( ddI) in HIV antibody - positive individuals intolerant to zidovudine ( AZT)	didanosine,24,34,Chemical/Drug	ddI,37,40,Chemical/Drug	zidovudine,95,105,Chemical/Drug	AZT,108,111,Chemical/Drug	"[{""token"": ""didanosine"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""ddI"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Chemical/Drug""}]"	train
One hundred and fifty - one patients intolerant to zidovudine ( AZT) received didanosine ( ddI) to a maximum dose of 12. 5 mg / kg / day.	zidovudine,51,61,Chemical/Drug	AZT,64,67,Chemical/Drug	didanosine,78,88,Chemical/Drug	ddI,91,94,Chemical/Drug	"[{""token"": ""zidovudine"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""didanosine"", ""start_span"": 78, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""ddI"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Chemical/Drug""}]"	train
Preliminary results of an Eastern Cooperative Oncology Group study of single - agent paclitaxel ( Taxol; Bristol - Myers Squibb Company, Princeton, NJ) reported a 37% response rate in patients with head and neck cancer, and the paclitaxel / cisplatin combination has been used successfully and has significantly improved median response duration in ovarian cancer patients.	paclitaxel,85,95,Chemical/Drug	Taxol,98,103,Chemical/Drug	paclitaxel,228,238,Chemical/Drug	cisplatin,241,250,Chemical/Drug	"[{""token"": ""paclitaxel"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""Taxol"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""paclitaxel"", ""start_span"": 228, ""end_span"": 238, ""type"": ""Chemical/Drug""}, {""token"": ""cisplatin"", ""start_span"": 241, ""end_span"": 250, ""type"": ""Chemical/Drug""}]"	train
In addition, reflex bradycardia caused by injected norepinephrine was significantly enhanced by L - dopa, DL - Threo - dihydroxyphenylserine had no effect on blood pressure, heart rate or reflex responses to norepinephrine.	norepinephrine,51,65,Chemical/Drug	L - dopa,96,104,Chemical/Drug	DL - Threo - dihydroxyphenylserine,106,140,Chemical/Drug	norepinephrine,208,222,Chemical/Drug	"[{""token"": ""norepinephrine"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""L - dopa"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""DL - Threo - dihydroxyphenylserine"", ""start_span"": 106, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""norepinephrine"", ""start_span"": 208, ""end_span"": 222, ""type"": ""Chemical/Drug""}]"	train
In both cases, discontinuation of FK506 and treatment with plasma exchange, fresh frozen plasma replacement, corticosteroids, aspirin, and dipyridamole led to resolution of MAHA.	FK506,34,39,Chemical/Drug	corticosteroids,109,124,Chemical/Drug	aspirin,126,133,Chemical/Drug	dipyridamole,139,151,Chemical/Drug	"[{""token"": ""FK506"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""corticosteroids"", ""start_span"": 109, ""end_span"": 124, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Chemical/Drug""}, {""token"": ""dipyridamole"", ""start_span"": 139, ""end_span"": 151, ""type"": ""Chemical/Drug""}]"	train
We studied three calcium channel blockers of different structure, nifedipine, diltiazem, and verapamil, along with the new agent.	calcium,17,24,Chemical/Drug	nifedipine,66,76,Chemical/Drug	diltiazem,78,87,Chemical/Drug	verapamil,93,102,Chemical/Drug	"[{""token"": ""calcium"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""nifedipine"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""verapamil"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Chemical/Drug""}]"	train
Treatment of previously treated metastatic breast cancer by mitoxantrone and 48 - hour continuous infusion of high - dose 5 - FU and leucovorin ( MFL): low palliative benefit and high treatment - related toxicity.	mitoxantrone,60,72,Chemical/Drug	5 - FU,122,128,Chemical/Drug	leucovorin,133,143,Chemical/Drug	MFL,146,149,Chemical/Drug	"[{""token"": ""mitoxantrone"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""leucovorin"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""MFL"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Chemical/Drug""}]"	train
The expression of arginine vasopressin ( AVP) gene in the paraventricular ( PVN) and supraoptic nuclei ( SON) was investigated in rats with lithium ( Li) - induced polyuria, using in situ hybridization histochemistry and radioimmunoassay.	arginine vasopressin,18,38,Chemical/Drug	AVP,41,44,Chemical/Drug	lithium,140,147,Chemical/Drug	Li,150,152,Chemical/Drug	"[{""token"": ""arginine vasopressin"", ""start_span"": 18, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""AVP"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""Li"", ""start_span"": 150, ""end_span"": 152, ""type"": ""Chemical/Drug""}]"	train
TRI given repeatedly to rats increases the locomotor hyperactivity induced by d - amphetamine, quinpirole and ( +) - 7 - hydroxy - dipropyloaminotetralin ( dopamine D2 and D3 effects).	TRI,0,3,Chemical/Drug	d - amphetamine,78,93,Chemical/Drug	quinpirole,95,105,Chemical/Drug	dopamine,156,164,Chemical/Drug	"[{""token"": ""TRI"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical/Drug""}, {""token"": ""d - amphetamine"", ""start_span"": 78, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""quinpirole"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 156, ""end_span"": 164, ""type"": ""Chemical/Drug""}]"	train
Effects of acetylsalicylic acid, dipyridamole, and hydrocortisone on epinephrine - induced myocardial injury in dogs.	acetylsalicylic acid,11,31,Chemical/Drug	dipyridamole,33,45,Chemical/Drug	hydrocortisone,51,65,Chemical/Drug	epinephrine,69,80,Chemical/Drug	"[{""token"": ""acetylsalicylic acid"", ""start_span"": 11, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""dipyridamole"", ""start_span"": 33, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""hydrocortisone"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Chemical/Drug""}]"	train
Patients with aneurysmal subarachnoid hemorrhage ( SAH) were randomized to receive either ketoprofen, 100 mg, three times a day ( ketoprofen group, n = 9) or a weak NSAID, acetaminophen, 1 g, three times a day ( acetaminophen group, n = 9) starting immediately after the diagnosis of aneurysmal SAH.	ketoprofen,90,100,Chemical/Drug	ketoprofen,130,140,Chemical/Drug	acetaminophen,172,185,Chemical/Drug	acetaminophen,212,225,Chemical/Drug	"[{""token"": ""ketoprofen"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""ketoprofen"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 172, ""end_span"": 185, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 212, ""end_span"": 225, ""type"": ""Chemical/Drug""}]"	train
The indications for switch were chronic CsA or Tac nephrotoxicity ( 12), acute CsA or Tac toxicity ( 3), severe facial dysmorphism ( 2), posttransplant lymphoproliferative disorder ( PTLD) in remission ( 2), and hepatotoxicity in 1.	CsA,40,43,Chemical/Drug	Tac,47,50,Chemical/Drug	CsA,79,82,Chemical/Drug	Tac,86,89,Chemical/Drug	"[{""token"": ""CsA"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""Tac"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Chemical/Drug""}, {""token"": ""CsA"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""Tac"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Chemical/Drug""}]"	train
STUDY OBJECTIVE: To determine the effect of metoprolol on dobutamine stress testing with technetium - 99m sestamibi single - photon emission computed tomography imaging and ST - segment monitoring, and to assess the impact of intravenous glucagon on metoprolol ' s effects.	metoprolol,44,54,Chemical/Drug	dobutamine,58,68,Chemical/Drug	technetium - 99m sestamibi,89,115,Chemical/Drug	metoprolol,250,260,Chemical/Drug	"[{""token"": ""metoprolol"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""dobutamine"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""technetium - 99m sestamibi"", ""start_span"": 89, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""metoprolol"", ""start_span"": 250, ""end_span"": 260, ""type"": ""Chemical/Drug""}]"	train
Reduced cardiotoxicity and preserved antitumor efficacy of liposome - encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer.	doxorubicin,83,94,Chemical/Drug	cyclophosphamide,99,115,Chemical/Drug	doxorubicin,143,154,Chemical/Drug	cyclophosphamide,159,175,Chemical/Drug	"[{""token"": ""doxorubicin"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 99, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 159, ""end_span"": 175, ""type"": ""Chemical/Drug""}]"	train
PURPOSE: To determine whether Myocet ( liposome - encapsulated doxorubicin; The Liposome Company, Elan Corporation, Princeton, NJ) in combination with cyclophosphamide significantly reduces doxorubicin cardiotoxicity while providing comparable antitumor efficacy in first - line treatment of metastatic breast cancer ( MBC).	Myocet,30,36,Chemical/Drug	doxorubicin,63,74,Chemical/Drug	cyclophosphamide,151,167,Chemical/Drug	doxorubicin,190,201,Chemical/Drug	"[{""token"": ""Myocet"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 151, ""end_span"": 167, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Chemical/Drug""}]"	train
METHODS: To evaluate the potential mechanisms of AF promotion by Ca ( 2 +) channel blockers, we administered verapamil to morphine - chloralose anesthetized dogs.	Ca,65,67,Chemical/Drug	verapamil,109,118,Chemical/Drug	morphine,122,130,Chemical/Drug	chloralose,133,143,Chemical/Drug	"[{""token"": ""Ca"", ""start_span"": 65, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""verapamil"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""chloralose"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Chemical/Drug""}]"	train
Previous studies evaluated the tolerance of nimesulide and paracetamol in subjects with cutaneous, respiratory and anaphylactoid reactions induced by nonsteroidal anti - inflammatory drugs ( NSAIDs).	nimesulide,44,54,Chemical/Drug	paracetamol,59,70,Chemical/Drug	nonsteroidal anti - inflammatory drugs,150,188,Chemical/Drug	NSAIDs,191,197,Chemical/Drug	"[{""token"": ""nimesulide"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""paracetamol"", ""start_span"": 59, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""nonsteroidal anti - inflammatory drugs"", ""start_span"": 150, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""NSAIDs"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Chemical/Drug""}]"	train
DESIGN: This trial evaluated the effect of placebo, 0. 5% aqueous timolol ( timolol solution) and a 0. 5% timolol suspension that forms a gel on application to the conjunctiva ( timolol gellan) on the 24 - hour heart rate in patients currently being treated for glaucoma to quantify the reduction in mean heart rate.	timolol,66,73,Chemical/Drug	timolol,76,83,Chemical/Drug	timolol,106,113,Chemical/Drug	timolol,178,185,Chemical/Drug	"[{""token"": ""timolol"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""timolol"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""timolol"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""timolol"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Chemical/Drug""}]"	train
This hypothesis stems from findings that PREGS is a potent positive modulator of N - methyl - d - aspartate receptors ( NMDARs) and a negative modulator of gamma - aminobutyric acid ( A) receptors ( GABA ( A) Rs).	PREGS,41,46,Chemical/Drug	N - methyl - d - aspartate,81,107,Chemical/Drug	gamma - aminobutyric acid,156,181,Chemical/Drug	GABA,199,203,Chemical/Drug	"[{""token"": ""PREGS"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""N - methyl - d - aspartate"", ""start_span"": 81, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""gamma - aminobutyric acid"", ""start_span"": 156, ""end_span"": 181, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Chemical/Drug""}]"	train
In addition PJ34 significantly reduced the DOX - induced increase in the serum lactate dehydrogenase and creatine kinase activities but not metalloproteinase activation in the heart.	PJ34,12,16,Chemical/Drug	DOX,43,46,Chemical/Drug	lactate,79,86,Chemical/Drug	creatine,105,113,Chemical/Drug	"[{""token"": ""PJ34"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""lactate"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""creatine"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Chemical/Drug""}]"	train
RESULTS: Patients receiving concomitant AmB and spironolactone had significantly higher plasma potassium levels than those receiving AmB alone ( P = 0. 0027).	AmB,40,43,Chemical/Drug	spironolactone,48,62,Chemical/Drug	potassium,95,104,Chemical/Drug	AmB,133,136,Chemical/Drug	"[{""token"": ""AmB"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""spironolactone"", ""start_span"": 48, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 95, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""AmB"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Chemical/Drug""}]"	train
Those patients receiving AmB and spironolactone required significantly less potassium supplementation to maintain their plasma potassium within the normal range ( P = 0. 022).	AmB,25,28,Chemical/Drug	spironolactone,33,47,Chemical/Drug	potassium,76,85,Chemical/Drug	potassium,127,136,Chemical/Drug	"[{""token"": ""AmB"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""spironolactone"", ""start_span"": 33, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Chemical/Drug""}]"	train
Moreover, urinary potassium losses were significantly less in patients receiving AmB and spironolactone than those receiving AmB alone ( P = 0. 040).	potassium,18,27,Chemical/Drug	AmB,81,84,Chemical/Drug	spironolactone,89,103,Chemical/Drug	AmB,125,128,Chemical/Drug	"[{""token"": ""potassium"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""AmB"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""spironolactone"", ""start_span"": 89, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""AmB"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Chemical/Drug""}]"	train
CONCLUSION: This study showed that spironolactone can reduce potassium requirements and prevent hypokalemia by reducing urinary potassium loss in neutropenic patients on AmB treatment.	spironolactone,35,49,Chemical/Drug	potassium,61,70,Chemical/Drug	potassium,128,137,Chemical/Drug	AmB,170,173,Chemical/Drug	"[{""token"": ""spironolactone"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 128, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""AmB"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Chemical/Drug""}]"	train
After premedication with diazepam, glycopyrrolate and local anaesthesia, and induction with standard doses of ketamine, a maintenance dose of 10 - 20 microg / kg / min of ketamine proved safe and effective.	diazepam,25,33,Chemical/Drug	glycopyrrolate,35,49,Chemical/Drug	ketamine,110,118,Chemical/Drug	ketamine,171,179,Chemical/Drug	"[{""token"": ""diazepam"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""glycopyrrolate"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 171, ""end_span"": 179, ""type"": ""Chemical/Drug""}]"	train
Low - molecular - weight heparin ( LMWH) offers theoretical advantages over UH, but is not currently considered in clinical guidelines as an alternative to UH in patients with prosthetic valves.	Low - molecular - weight heparin,0,32,Chemical/Drug	LMWH,35,39,Chemical/Drug	UH,76,78,Chemical/Drug	UH,156,158,Chemical/Drug	"[{""token"": ""Low - molecular - weight heparin"", ""start_span"": 0, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""LMWH"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""UH"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""UH"", ""start_span"": 156, ""end_span"": 158, ""type"": ""Chemical/Drug""}]"	train
Group PS, the control group, received normal saline and succinylcholine 1. 5 mg x kg ( - 1); Group LS, lidocaine 1. 5 mg x kg ( - 1) and succinylcholine 1. 5 mg x kg ( - 1); Group PR, normal saline and rocuronium 0. 6 mg x kg ( - 1).	succinylcholine,56,71,Chemical/Drug	lidocaine,103,112,Chemical/Drug	succinylcholine,137,152,Chemical/Drug	rocuronium,202,212,Chemical/Drug	"[{""token"": ""succinylcholine"", ""start_span"": 56, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""lidocaine"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""succinylcholine"", ""start_span"": 137, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""rocuronium"", ""start_span"": 202, ""end_span"": 212, ""type"": ""Chemical/Drug""}]"	train
Two of the 64 patients in the iodixanol group ( 3 percent) had an increase in the creatinine concentration of 0. 5 mg per deciliter or more, as compared with 17 of the 65 patients in the iohexol group ( 26 percent) ( P = 0. 002; odds ratio for such an increase in the iodixanol group, 0. 09 [ 95 percent confidence interval, 0. 02 to 0. 41]).	iodixanol,30,39,Chemical/Drug	creatinine,82,92,Chemical/Drug	iohexol,187,194,Chemical/Drug	iodixanol,268,277,Chemical/Drug	"[{""token"": ""iodixanol"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 268, ""end_span"": 277, ""type"": ""Chemical/Drug""}]"	train
The pressor responses and bradycardia to the alpha 1 - agonist cirazoline ( 0. 6 and 2 micrograms kg - 1 i. v.), the alpha 2 - agonist Abbott - 53693 ( 1 and 3 micrograms kg - 1 i. v.), and noradrenaline ( 0. 1 and 1. 0 micrograms kg - 1 i. v.) were determined in conscious SHR with and without chronic prazosin pretreatment.	cirazoline,63,73,Chemical/Drug	Abbott - 53693,135,149,Chemical/Drug	noradrenaline,190,203,Chemical/Drug	prazosin,303,311,Chemical/Drug	"[{""token"": ""cirazoline"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""Abbott - 53693"", ""start_span"": 135, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""noradrenaline"", ""start_span"": 190, ""end_span"": 203, ""type"": ""Chemical/Drug""}, {""token"": ""prazosin"", ""start_span"": 303, ""end_span"": 311, ""type"": ""Chemical/Drug""}]"	train
One, two or three doses of mesna were replaced with dexamethasone alone or with dexamethasone plus mesna.	mesna,27,32,Chemical/Drug	dexamethasone,52,65,Chemical/Drug	dexamethasone,80,93,Chemical/Drug	mesna,99,104,Chemical/Drug	"[{""token"": ""mesna"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 52, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 80, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""mesna"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Chemical/Drug""}]"	train
The combinations of loreclezole ( 2. 5 mg / kg) with valproate, clonazepam, or carbamazepine ( applied at their subprotective doses) also exhibited antiseizure effect in this test.	loreclezole,20,31,Chemical/Drug	valproate,53,62,Chemical/Drug	clonazepam,64,74,Chemical/Drug	carbamazepine,79,92,Chemical/Drug	"[{""token"": ""loreclezole"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""valproate"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""clonazepam"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""carbamazepine"", ""start_span"": 79, ""end_span"": 92, ""type"": ""Chemical/Drug""}]"	train
Nineteen sexually dysfunctional women receiving either fluoxetine, sertraline, or paroxetine participated in an eight - week, double - blind, placebo - controlled, cross - over study of the effects of ephedrine ( 50 mg) on self - report measures of sexual desire, arousal, orgasm, and sexual satisfaction.	fluoxetine,55,65,Chemical/Drug	sertraline,67,77,Chemical/Drug	paroxetine,82,92,Chemical/Drug	ephedrine,201,210,Chemical/Drug	"[{""token"": ""fluoxetine"", ""start_span"": 55, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""sertraline"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""paroxetine"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""ephedrine"", ""start_span"": 201, ""end_span"": 210, ""type"": ""Chemical/Drug""}]"	train
The incidence of cardiovascular thrombotic events ( cardiac, cerebrovascular and peripheral vascular, or arterial thrombotic) was determined by analyzing pooled valdecoxib ( 10 - 80 mg daily), nonselective NSAID ( diclofenac 75 mg bid, ibuprofen 800 mg tid, or naproxen 500 mg bid) and placebo data from 10 randomized osteoarthritis and rheumatoid arthritis trials that were 6 - 52 weeks in duration.	valdecoxib,161,171,Chemical/Drug	diclofenac,214,224,Chemical/Drug	ibuprofen,236,245,Chemical/Drug	naproxen,261,269,Chemical/Drug	"[{""token"": ""valdecoxib"", ""start_span"": 161, ""end_span"": 171, ""type"": ""Chemical/Drug""}, {""token"": ""diclofenac"", ""start_span"": 214, ""end_span"": 224, ""type"": ""Chemical/Drug""}, {""token"": ""ibuprofen"", ""start_span"": 236, ""end_span"": 245, ""type"": ""Chemical/Drug""}, {""token"": ""naproxen"", ""start_span"": 261, ""end_span"": 269, ""type"": ""Chemical/Drug""}]"	train
RESULTS: After adjustment for cardiovascular disease risk factors, type of diabetes medication used, duration of diabetes, and intakes of folate, vitamin E, and beta - carotene, the adjusted relative risks of total cardiovascular disease mortality were 1. 0, 0. 97, 1. 11, 1. 47, and 1. 84 ( P for trend < 0. 01) across quintiles of total vitamin C intake from food and supplements.	folate,138,144,Chemical/Drug	vitamin E,146,155,Chemical/Drug	beta - carotene,161,176,Chemical/Drug	vitamin C,339,348,Chemical/Drug	"[{""token"": ""folate"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin E"", ""start_span"": 146, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""beta - carotene"", ""start_span"": 161, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin C"", ""start_span"": 339, ""end_span"": 348, ""type"": ""Chemical/Drug""}]"	train
To examine the relationship between quantitative stimulant drug levels, catecholamines, and psychotic symptoms, nineteen patients in a psychiatric emergency service with a diagnosis of amphetamine - or cocaine - induced psychosis were interviewed, and plasma and urine were collected for quantitative assays of stimulant drug and catecholamine metabolite levels.	catecholamines,72,86,Chemical/Drug	amphetamine,185,196,Chemical/Drug	cocaine,202,209,Chemical/Drug	catecholamine,330,343,Chemical/Drug	"[{""token"": ""catecholamines"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 185, ""end_span"": 196, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Chemical/Drug""}, {""token"": ""catecholamine"", ""start_span"": 330, ""end_span"": 343, ""type"": ""Chemical/Drug""}]"	train
Oxidative stress was assessed by determining plasma and liver levels of 15 - F ( 2t) - IsoP, lipid hydroperoxides ( LPO), and thiobarbituric acid reactive substances ( TBARs).	lipid hydroperoxides,93,113,Chemical/Drug	LPO,116,119,Chemical/Drug	thiobarbituric acid reactive substances,126,165,Chemical/Drug	TBARs,168,173,Chemical/Drug	"[{""token"": ""lipid hydroperoxides"", ""start_span"": 93, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""LPO"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""thiobarbituric acid reactive substances"", ""start_span"": 126, ""end_span"": 165, ""type"": ""Chemical/Drug""}, {""token"": ""TBARs"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Chemical/Drug""}]"	train
Dexrazoxane protects against myelosuppression from the DNA cleavage - enhancing drugs etoposide and daunorubicin but not doxorubicin.	Dexrazoxane,0,11,Chemical/Drug	etoposide,86,95,Chemical/Drug	daunorubicin,100,112,Chemical/Drug	doxorubicin,121,132,Chemical/Drug	"[{""token"": ""Dexrazoxane"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""etoposide"", ""start_span"": 86, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""daunorubicin"", ""start_span"": 100, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Chemical/Drug""}]"	train
Likewise, in vivo, B6D2F1 mice were treated with etoposide, daunorubicin, and doxorubicin, with or without dexrazoxane over a wide range of doses: posttreatment, a full hematologic evaluation was done.	etoposide,49,58,Chemical/Drug	daunorubicin,60,72,Chemical/Drug	doxorubicin,78,89,Chemical/Drug	dexrazoxane,107,118,Chemical/Drug	"[{""token"": ""etoposide"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""daunorubicin"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""dexrazoxane"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Chemical/Drug""}]"	train
Corticosteroids ( dexamethasone and methylprednisolone), benzodiazepines ( midazolam) and general anaesthesia have been the specific agents mentioned most frequently in the literature as being associated with the development of hiccups.	dexamethasone,18,31,Chemical/Drug	methylprednisolone,36,54,Chemical/Drug	benzodiazepines,57,72,Chemical/Drug	midazolam,75,84,Chemical/Drug	"[{""token"": ""dexamethasone"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""methylprednisolone"", ""start_span"": 36, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""benzodiazepines"", ""start_span"": 57, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""midazolam"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Chemical/Drug""}]"	train
In contrast, a significant decline in glomerular filtration rate was found after the introduction of suprofen to the kidney perfused with uric acid; no changes were found with suprofen in the absence of uric acid.	suprofen,101,109,Chemical/Drug	uric acid,138,147,Chemical/Drug	suprofen,176,184,Chemical/Drug	uric acid,203,212,Chemical/Drug	"[{""token"": ""suprofen"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""uric acid"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""suprofen"", ""start_span"": 176, ""end_span"": 184, ""type"": ""Chemical/Drug""}, {""token"": ""uric acid"", ""start_span"": 203, ""end_span"": 212, ""type"": ""Chemical/Drug""}]"	train
Because 5 - HT transporters play a key element in the regulation of synaptic 5 - HT transmission it may be important to control for the potential covariance effect of a polymorphism in the 5 - HT transporter promoter gene region ( 5 - HTTLPR) when studying the effects of MDMA as well as cognitive functioning.	5 - HT,8,14,Chemical/Drug	5 - HT,77,83,Chemical/Drug	5 - HT,189,195,Chemical/Drug	MDMA,272,276,Chemical/Drug	"[{""token"": ""5 - HT"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 189, ""end_span"": 195, ""type"": ""Chemical/Drug""}, {""token"": ""MDMA"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Chemical/Drug""}]"	train
Co - administration of lidocaine, bupivacaine or tricaine with desipramine reversed this effect.	lidocaine,23,32,Chemical/Drug	bupivacaine,34,45,Chemical/Drug	tricaine,49,57,Chemical/Drug	desipramine,63,74,Chemical/Drug	"[{""token"": ""lidocaine"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""bupivacaine"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""tricaine"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical/Drug""}]"	train
The rat received either alpha - TC ( 20 mg / kg) intraperitoneally for 3 days and 30 min prior to MA administration or DFO ( 50 mg / kg) subcutaneously 30 min before MA administration.	alpha - TC,24,34,Chemical/Drug	MA,98,100,Chemical/Drug	DFO,119,122,Chemical/Drug	MA,166,168,Chemical/Drug	"[{""token"": ""alpha - TC"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""MA"", ""start_span"": 98, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""DFO"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Chemical/Drug""}, {""token"": ""MA"", ""start_span"": 166, ""end_span"": 168, ""type"": ""Chemical/Drug""}]"	train
Dopamine antagonist fluphenazine, D - 1 antagonist SCH 23390 or D - 2 antagonist sulpiride induced catalepsy.	Dopamine,0,8,Chemical/Drug	fluphenazine,20,32,Chemical/Drug	SCH 23390,51,60,Chemical/Drug	sulpiride,81,90,Chemical/Drug	"[{""token"": ""Dopamine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""fluphenazine"", ""start_span"": 20, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""SCH 23390"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""sulpiride"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Chemical/Drug""}]"	train
Digitalis arrhythmia, which is suppressed by Na channel blockers, was induced by intermittent intravenous ( i. v.) injection of ouabain in pentobarbital - anesthetized dogs.	Digitalis,0,9,Chemical/Drug	Na,45,47,Chemical/Drug	ouabain,128,135,Chemical/Drug	pentobarbital,139,152,Chemical/Drug	"[{""token"": ""Digitalis"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 45, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""ouabain"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Chemical/Drug""}, {""token"": ""pentobarbital"", ""start_span"": 139, ""end_span"": 152, ""type"": ""Chemical/Drug""}]"	train
Lithium was associated with a significantly higher incidence ( p < 0. 05) of tremor ( 18. 4%) than quetiapine ( 5. 6%); cerebellar tremor, which is a known adverse effect of lithium, may have contributed to the elevated rate of tremor in patients receiving lithium therapy.	Lithium,0,7,Chemical/Drug	quetiapine,99,109,Chemical/Drug	lithium,174,181,Chemical/Drug	lithium,257,264,Chemical/Drug	"[{""token"": ""Lithium"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""quetiapine"", ""start_span"": 99, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 257, ""end_span"": 264, ""type"": ""Chemical/Drug""}]"	train
The goal of this study was to assess the interactive effects of chronic anabolic androgenic steroid ( AAS) exposure and brain serotonin ( 5 - hydroxytryptamine, 5 - HT) depletion on behavior of pubertal male rats.	steroid,92,99,Chemical/Drug	serotonin,126,135,Chemical/Drug	5 - hydroxytryptamine,138,159,Chemical/Drug	5 - HT,161,167,Chemical/Drug	"[{""token"": ""steroid"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Chemical/Drug""}, {""token"": ""5 - hydroxytryptamine"", ""start_span"": 138, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Chemical/Drug""}]"	train
Chronic T treatment significantly decreased 5 - HT and 5 - HIAA in certain brain areas, but to a much lesser extent than PCPA.	T,8,9,Chemical/Drug	5 - HT,44,50,Chemical/Drug	5 - HIAA,55,63,Chemical/Drug	PCPA,121,125,Chemical/Drug	"[{""token"": ""T"", ""start_span"": 8, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HIAA"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""PCPA"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Chemical/Drug""}]"	train
Radiolabeled metaiodobenzylguanidine ( MIBG), an analog of norepinephrine ( NE), serves as an index of adrenergic neuron integrity and function.	Radiolabeled metaiodobenzylguanidine,0,36,Chemical/Drug	MIBG,39,43,Chemical/Drug	norepinephrine,59,73,Chemical/Drug	NE,76,78,Chemical/Drug	"[{""token"": ""Radiolabeled metaiodobenzylguanidine"", ""start_span"": 0, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""MIBG"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""norepinephrine"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""NE"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Chemical/Drug""}]"	train
RESULTS: We identified 27 reports of toxic leukoencephalopathy in patients treated with methotrexate ( intrathecal, systemic), 5 - fluorouracil and its derivative carmofur, and capecitabine.	methotrexate,88,100,Chemical/Drug	5 - fluorouracil,127,143,Chemical/Drug	carmofur,163,171,Chemical/Drug	capecitabine,177,189,Chemical/Drug	"[{""token"": ""methotrexate"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""5 - fluorouracil"", ""start_span"": 127, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""carmofur"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Chemical/Drug""}, {""token"": ""capecitabine"", ""start_span"": 177, ""end_span"": 189, ""type"": ""Chemical/Drug""}]"	train
Remifentanil - related complications were assessed during the remifentanil infusion, and pain caused by propofol was evaluated using a four - point scale during the propofol infusion.	Remifentanil,0,12,Chemical/Drug	remifentanil,62,74,Chemical/Drug	propofol,104,112,Chemical/Drug	propofol,165,173,Chemical/Drug	"[{""token"": ""Remifentanil"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""remifentanil"", ""start_span"": 62, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""propofol"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""propofol"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Chemical/Drug""}]"	train
CONCLUSIONS: During induction of anaesthesia with TCI of propofol and remifentanil, a significant reduction in propofol infusion pain was achieved without significant complications by prior administration of remifentanil at a target Ce of 4 ng ml ( - 1).	propofol,57,65,Chemical/Drug	remifentanil,70,82,Chemical/Drug	propofol,111,119,Chemical/Drug	remifentanil,208,220,Chemical/Drug	"[{""token"": ""propofol"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""remifentanil"", ""start_span"": 70, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""propofol"", ""start_span"": 111, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""remifentanil"", ""start_span"": 208, ""end_span"": 220, ""type"": ""Chemical/Drug""}]"	train
Four binary comparisons were made: WT control versus CYP treatment ( 48 h), VIP ( - / -) control versus CYP treatment ( 48 h), WT control versus VIP ( - / -) control, and WT with CYP treatment ( 48 h) versus VIP ( - / -) with CYP treatment ( 48 h).	CYP,53,56,Chemical/Drug	CYP,104,107,Chemical/Drug	CYP,179,182,Chemical/Drug	CYP,226,229,Chemical/Drug	"[{""token"": ""CYP"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""CYP"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""CYP"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Chemical/Drug""}, {""token"": ""CYP"", ""start_span"": 226, ""end_span"": 229, ""type"": ""Chemical/Drug""}]"	train
Thirty patients were treated with three 21 - day cycles of bortezomib 1. 3 mg / m ( 2) on days 1, 4, 8, and 11 plus dexamethasone 40 mg on the day of bortezomib injection and the day after plus cyclophosphamide at 900, 1, 200, or 1, 500 mg / m ( 2) on day 1.	bortezomib,59,69,Chemical/Drug	dexamethasone,116,129,Chemical/Drug	bortezomib,150,160,Chemical/Drug	cyclophosphamide,194,210,Chemical/Drug	"[{""token"": ""bortezomib"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 116, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""bortezomib"", ""start_span"": 150, ""end_span"": 160, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 194, ""end_span"": 210, ""type"": ""Chemical/Drug""}]"	train
Similarly, the total protein abundance of the Na - K - 2Cl cotransporter ( NKCC2) in the medulla but not in the cortex of the + / + mice was significantly reduced by lithium treatment.	Na,46,48,Chemical/Drug	K,51,52,Chemical/Drug	2Cl,55,58,Chemical/Drug	lithium,166,173,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 51, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""2Cl"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Chemical/Drug""}]"	train
Specific dopamine - 1, ( DA1) and dopamine - 2 ( DA2) receptor agonists are now under clinical investigation.	dopamine,9,17,Chemical/Drug	DA1,25,28,Chemical/Drug	dopamine,34,42,Chemical/Drug	DA2,49,52,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""DA1"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""DA2"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Chemical/Drug""}]"	train
Systemic aortic blood pressure and renal blood flow were measured continuously with a carotid arterial catheter and an electromagnetic flow probe respectively, in order to compare the cardiovascular and renal vascular effects of fenoldopam and sodium nitroprusside in ten dogs under halothane general anaesthesia.	fenoldopam,229,239,Chemical/Drug	sodium,244,250,Chemical/Drug	nitroprusside,251,264,Chemical/Drug	halothane,283,292,Chemical/Drug	"[{""token"": ""fenoldopam"", ""start_span"": 229, ""end_span"": 239, ""type"": ""Chemical/Drug""}, {""token"": ""sodium"", ""start_span"": 244, ""end_span"": 250, ""type"": ""Chemical/Drug""}, {""token"": ""nitroprusside"", ""start_span"": 251, ""end_span"": 264, ""type"": ""Chemical/Drug""}, {""token"": ""halothane"", ""start_span"": 283, ""end_span"": 292, ""type"": ""Chemical/Drug""}]"	train
An activated moiety, i. e. N - acylimidazole derivative of etodolac ( EAI), was condensed with the polysaccharide polymer dextran of different molecular weights ( 40000, 60000, 110000 and 200000).	N - acylimidazole,27,44,Chemical/Drug	etodolac,59,67,Chemical/Drug	EAI,70,73,Chemical/Drug	dextran,122,129,Chemical/Drug	"[{""token"": ""N - acylimidazole"", ""start_span"": 27, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""etodolac"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""EAI"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""dextran"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Chemical/Drug""}]"	train
[ Ca ( 2 +)] ( i) overload induced by aconitine or ouabain was reduced in isolated myocytes pretreated with pilocarpine.	Ca,2,4,Chemical/Drug	aconitine,38,47,Chemical/Drug	ouabain,51,58,Chemical/Drug	pilocarpine,108,119,Chemical/Drug	"[{""token"": ""Ca"", ""start_span"": 2, ""end_span"": 4, ""type"": ""Chemical/Drug""}, {""token"": ""aconitine"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""ouabain"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Chemical/Drug""}]"	train
Moreover, M ( 3) - muscarinic acetylcholine receptor ( mAChR) antagonist 4 - DAMP ( 4 - diphenylacetoxy - N - methylpiperidine - methiodide) partially abolished the beneficial effects of pilocarpine.	acetylcholine,30,43,Chemical/Drug	4 - DAMP,73,81,Chemical/Drug	4 - diphenylacetoxy - N - methylpiperidine - methiodide,84,139,Chemical/Drug	pilocarpine,187,198,Chemical/Drug	"[{""token"": ""acetylcholine"", ""start_span"": 30, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""4 - DAMP"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""4 - diphenylacetoxy - N - methylpiperidine - methiodide"", ""start_span"": 84, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 187, ""end_span"": 198, ""type"": ""Chemical/Drug""}]"	train
We tested the hypothesis that nimodipine ( NIMO) administered at the onset of nitroglycerin ( NTG) - induced hypotension would preserve long - term associative memory.	nimodipine,30,40,Chemical/Drug	NIMO,43,47,Chemical/Drug	nitroglycerin,78,91,Chemical/Drug	NTG,94,97,Chemical/Drug	"[{""token"": ""nimodipine"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""NIMO"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""nitroglycerin"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""NTG"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Chemical/Drug""}]"	train
AMN082 ( 2. 5 and 5 mg / kg) reduces apomorphine - induced rotations in unilateral 6 - hydroxydopamine ( 6 - OHDA) - lesioned rats.	AMN082,0,6,Chemical/Drug	apomorphine,37,48,Chemical/Drug	6 - hydroxydopamine,83,102,Chemical/Drug	6 - OHDA,105,113,Chemical/Drug	"[{""token"": ""AMN082"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical/Drug""}, {""token"": ""apomorphine"", ""start_span"": 37, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""6 - hydroxydopamine"", ""start_span"": 83, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Chemical/Drug""}]"	train
Cessation of sorafenib and administration of Ca - channel blocker and nitrates ameliorated his symptoms, but relapse occurred after resumption of sorafenib.	sorafenib,13,22,Chemical/Drug	Ca,45,47,Chemical/Drug	nitrates,70,78,Chemical/Drug	sorafenib,146,155,Chemical/Drug	"[{""token"": ""sorafenib"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 45, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""nitrates"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""sorafenib"", ""start_span"": 146, ""end_span"": 155, ""type"": ""Chemical/Drug""}]"	train
The toxic effects of tacrine - loaded poly - L - lactid acid nanoparticles ( 5mg / kg), a saline solution of tacrine ( 5mg / kg) and an empty colloidal nanoparticle suspension were compared following i. p. administration in LiCl - pre - treated Wistar rats.	tacrine,21,28,Chemical/Drug	poly - L - lactid acid,38,60,Chemical/Drug	tacrine,109,116,Chemical/Drug	LiCl,224,228,Chemical/Drug	"[{""token"": ""tacrine"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""poly - L - lactid acid"", ""start_span"": 38, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""tacrine"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""LiCl"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Chemical/Drug""}]"	train
Aventyl ( nortriptyline) and Elavil ( amitriptyline) each produced left bundle branch block in a 73 year old woman.	Aventyl,0,7,Chemical/Drug	nortriptyline,10,23,Chemical/Drug	Elavil,29,35,Chemical/Drug	amitriptyline,38,51,Chemical/Drug	"[{""token"": ""Aventyl"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""nortriptyline"", ""start_span"": 10, ""end_span"": 23, ""type"": ""Chemical/Drug""}, {""token"": ""Elavil"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Chemical/Drug""}, {""token"": ""amitriptyline"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Chemical/Drug""}]"	train
Anesthesia was maintained with fentanyl, nitrous oxide, oxygen, and isoflurane.	fentanyl,31,39,Chemical/Drug	nitrous oxide,41,54,Chemical/Drug	oxygen,56,62,Chemical/Drug	isoflurane,68,78,Chemical/Drug	"[{""token"": ""fentanyl"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""nitrous oxide"", ""start_span"": 41, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""oxygen"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""isoflurane"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Chemical/Drug""}]"	train
Coenzyme Q10 significantly reduced blood urea nitrogen and serum creatinine levels which were increased by cisplatin.	Coenzyme Q10,0,12,Chemical/Drug	blood urea nitrogen,35,54,Chemical/Drug	creatinine,65,75,Chemical/Drug	cisplatin,107,116,Chemical/Drug	"[{""token"": ""Coenzyme Q10"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""blood urea nitrogen"", ""start_span"": 35, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""cisplatin"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Chemical/Drug""}]"	train
Here we show that the recently reported ability of L - dihydroxyphenylalanine to reverse the protective effect of alpha - methyl - para - tyrosine on METH - induced DA neurotoxicity is also confounded by drug effects on body temperature.	L - dihydroxyphenylalanine,51,77,Chemical/Drug	alpha - methyl - para - tyrosine,114,146,Chemical/Drug	METH,150,154,Chemical/Drug	DA,165,167,Chemical/Drug	"[{""token"": ""L - dihydroxyphenylalanine"", ""start_span"": 51, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""alpha - methyl - para - tyrosine"", ""start_span"": 114, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""METH"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 165, ""end_span"": 167, ""type"": ""Chemical/Drug""}]"	train
The condition is treated with intravenous thyroxine ( T4) or intravenous tri - iodo - thyronine ( T3).	thyroxine,42,51,Chemical/Drug	T4,54,56,Chemical/Drug	tri - iodo - thyronine,73,95,Chemical/Drug	T3,98,100,Chemical/Drug	"[{""token"": ""thyroxine"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""T4"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""tri - iodo - thyronine"", ""start_span"": 73, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""T3"", ""start_span"": 98, ""end_span"": 100, ""type"": ""Chemical/Drug""}]"	train
METHODS: Male adult Wistar rats ( n = 90 and 260 - 290 g) were divided into 1, control; 2 and 3, crocins ( 15 and 30 mg / kg); 4, STZ; 5 and 6, STZ + crocins ( 15 and 30 mg / kg) groups.	crocins,97,104,Chemical/Drug	STZ,130,133,Chemical/Drug	STZ,144,147,Chemical/Drug	crocins,150,157,Chemical/Drug	"[{""token"": ""crocins"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""STZ"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Chemical/Drug""}, {""token"": ""STZ"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""crocins"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Chemical/Drug""}]"	train
Increased extracellular concentrations of uridine ( Urd) have been reported to reduce, in vitro, azidothymidine ( AZT) - induced inhibition of human granulocyte - macrophage progenitor cells without impairment of its antihuman immunodeficiency virus ( HIV) activity.	uridine,42,49,Chemical/Drug	Urd,52,55,Chemical/Drug	azidothymidine,97,111,Chemical/Drug	AZT,114,117,Chemical/Drug	"[{""token"": ""uridine"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""Urd"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""azidothymidine"", ""start_span"": 97, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Chemical/Drug""}]"	train
Because of the clinical toxicities associated with chronic Urd administration, the ability of benzylacyclouridine ( BAU) to effect, in vivo, AZT - induced anemia and leukopenia was assessed.	Urd,59,62,Chemical/Drug	benzylacyclouridine,94,113,Chemical/Drug	BAU,116,119,Chemical/Drug	AZT,141,144,Chemical/Drug	"[{""token"": ""Urd"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""benzylacyclouridine"", ""start_span"": 94, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""BAU"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Chemical/Drug""}]"	train
In mice rendered anemic and leukopenic by the administration of AZT for 28 days in drinking water ( 1. 5 mg / mL), the continued administration of AZT plus daily BAU ( 300 mg / kg, orally) partially reversed AZT - induced anemia and leukopenia ( P less than. 05), increased peripheral reticulocytes ( to 4. 9%, P less than. 01), increased cellularity in the marrow, and improved megaloblastosis.	AZT,64,67,Chemical/Drug	AZT,147,150,Chemical/Drug	BAU,162,165,Chemical/Drug	AZT,208,211,Chemical/Drug	"[{""token"": ""AZT"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""BAU"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Chemical/Drug""}, {""token"": ""AZT"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Chemical/Drug""}]"	train
Further, 5, 7 - DHT lesion of serotonin nerves travelling in the median forebrain bundle, one of the main ascending pathways from the B3 serotonin cells, did not affect the fall in blood pressure associated with a midline B3 serotonin methyldopa injection.	serotonin,30,39,Chemical/Drug	serotonin,137,146,Chemical/Drug	serotonin,225,234,Chemical/Drug	methyldopa,235,245,Chemical/Drug	"[{""token"": ""serotonin"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin"", ""start_span"": 225, ""end_span"": 234, ""type"": ""Chemical/Drug""}, {""token"": ""methyldopa"", ""start_span"": 235, ""end_span"": 245, ""type"": ""Chemical/Drug""}]"	train
The incidence of ischemic episodes per patient per hour was 0. 05 + / - 0. 02 prior to 5 - FU infusion v 0. 13 + / - 0. 03 during 5 - FU infusion ( P less than. 001); the duration of ECG changes was 0. 6 + / - 0. 3 minutes per patient per hour before 5 - FU v 1. 9 + / - 0. 5 minutes per patient per hour during 5 - FU ( P less than. 01).	5 - FU,87,93,Chemical/Drug	5 - FU,130,136,Chemical/Drug	5 - FU,251,257,Chemical/Drug	5 - FU,312,318,Chemical/Drug	"[{""token"": ""5 - FU"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 251, ""end_span"": 257, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 312, ""end_span"": 318, ""type"": ""Chemical/Drug""}]"	train
This program consists of double screenings of pregnant women and prophylactic treatment to the infants born to both hepatitis B surface antigen ( HBsAg) and hepatitis B e antigen ( HBeAg) positive mothers.	hepatitis B surface antigen,116,143,Chemical/Drug	HBsAg,146,151,Chemical/Drug	hepatitis B e antigen,157,178,Chemical/Drug	HBeAg,181,186,Chemical/Drug	"[{""token"": ""hepatitis B surface antigen"", ""start_span"": 116, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""HBsAg"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""hepatitis B e antigen"", ""start_span"": 157, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""HBeAg"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Chemical/Drug""}]"	train
The protection from gentamicin nephrotoxicity was studied in non - diabetic rats with chronic solute diuresis induced by blockage of tubular glucose reabsorption with phlorizin ( P).	gentamicin,20,30,Chemical/Drug	glucose,141,148,Chemical/Drug	phlorizin,167,176,Chemical/Drug	P,179,180,Chemical/Drug	"[{""token"": ""gentamicin"", ""start_span"": 20, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 141, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""phlorizin"", ""start_span"": 167, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""P"", ""start_span"": 179, ""end_span"": 180, ""type"": ""Chemical/Drug""}]"	train
There was mutual potentiation between sub - effective doses of ketamine and morphine, but sub - effective doses of ketamine partly antagonized fully - effective doses of morphine.	ketamine,63,71,Chemical/Drug	morphine,76,84,Chemical/Drug	ketamine,115,123,Chemical/Drug	morphine,170,178,Chemical/Drug	"[{""token"": ""ketamine"", ""start_span"": 63, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 170, ""end_span"": 178, ""type"": ""Chemical/Drug""}]"	train
Rats, tolerant to ketamine - dominant combinations, were cross - tolerant to both drugs, while those tolerant to morphine - dominant combinations were cross - tolerant to morphine but showed either no cross - tolerance or an augmented response to ketamine.	ketamine,18,26,Chemical/Drug	morphine,113,121,Chemical/Drug	morphine,171,179,Chemical/Drug	ketamine,247,255,Chemical/Drug	"[{""token"": ""ketamine"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 171, ""end_span"": 179, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Chemical/Drug""}]"	train
50 mg / kg, i. v. thiopental produced respiratory arrest with further increase in GABA and decrease in glutamate again in cortex and brain stem without affecting any of the amino acids studied in four regions of rat brain.	thiopental,18,28,Chemical/Drug	GABA,82,86,Chemical/Drug	glutamate,103,112,Chemical/Drug	amino acids,173,184,Chemical/Drug	"[{""token"": ""thiopental"", ""start_span"": 18, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""amino acids"", ""start_span"": 173, ""end_span"": 184, ""type"": ""Chemical/Drug""}]"	train
The data indicate that diazepam acts through the benzodiazepine - GABA - chloride channel macromolecular complex within the central nervous system to facilitate reflex bradycardia mediated through baroreceptor reflexes in response to an acute increase in arterial pressure.	diazepam,23,31,Chemical/Drug	benzodiazepine,49,63,Chemical/Drug	GABA,66,70,Chemical/Drug	chloride,73,81,Chemical/Drug	"[{""token"": ""diazepam"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""benzodiazepine"", ""start_span"": 49, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""chloride"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Chemical/Drug""}]"	train
In the normal - sodium group the highest mean potassium deficit was 176 mmol on day 9, after which some potassium was regained; in the low - sodium group the highest deficit was 276 mmol on day 13.	sodium,16,22,Chemical/Drug	potassium,46,55,Chemical/Drug	potassium,104,113,Chemical/Drug	sodium,141,147,Chemical/Drug	"[{""token"": ""sodium"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""sodium"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Chemical/Drug""}]"	train
The normal - sodium group showed an immediate but temporary rise of the renin and aldosterone levels; in the low - sodium group renin and aldosterone increased more slowly but remained elevated.	sodium,13,19,Chemical/Drug	aldosterone,82,93,Chemical/Drug	sodium,115,121,Chemical/Drug	aldosterone,138,149,Chemical/Drug	"[{""token"": ""sodium"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""aldosterone"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""sodium"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""aldosterone"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Chemical/Drug""}]"	train
A series of aryl - piperazine analogues of buspirone and other 5 - hydroxytryptaminergic agonists were tested for their ability to reverse haloperidol induced catalepsy.	aryl - piperazine,12,29,Chemical/Drug	buspirone,43,52,Chemical/Drug	5 - hydroxytryptaminergic agonists,63,97,Chemical/Drug	haloperidol,139,150,Chemical/Drug	"[{""token"": ""aryl - piperazine"", ""start_span"": 12, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""buspirone"", ""start_span"": 43, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""5 - hydroxytryptaminergic agonists"", ""start_span"": 63, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Chemical/Drug""}]"	train
A strong association has been found between nephritis and dermatitis due to Tiopronin ( a D - Penicillamine like compound) and class I antigens B35 - Cw4, and between dermatitis due to gold thiosulphate and B35.	Tiopronin,76,85,Chemical/Drug	D - Penicillamine,90,107,Chemical/Drug	gold,185,189,Chemical/Drug	thiosulphate,190,202,Chemical/Drug	"[{""token"": ""Tiopronin"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""D - Penicillamine"", ""start_span"": 90, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""gold"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Chemical/Drug""}, {""token"": ""thiosulphate"", ""start_span"": 190, ""end_span"": 202, ""type"": ""Chemical/Drug""}]"	train
The potential modifying effect of retinyl acetate ( RA) on butylated hydroxyanisole ( BHA) - induced rat forestomach tumorigenesis was examined.	retinyl acetate,34,49,Chemical/Drug	RA,52,54,Chemical/Drug	butylated hydroxyanisole,59,83,Chemical/Drug	BHA,86,89,Chemical/Drug	"[{""token"": ""retinyl acetate"", ""start_span"": 34, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""RA"", ""start_span"": 52, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""butylated hydroxyanisole"", ""start_span"": 59, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""BHA"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Chemical/Drug""}]"	train
We observed no changes in nicotine - induced locomotor response, striatal L - [ 3H] nicotine and [ 3H] spiperone binding in the animals pretreated with nicotine for 1 day.	nicotine,26,34,Chemical/Drug	nicotine,84,92,Chemical/Drug	spiperone,103,112,Chemical/Drug	nicotine,152,160,Chemical/Drug	"[{""token"": ""nicotine"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""spiperone"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Chemical/Drug""}]"	train
These results suggest that chronic nicotine - treated rats develop locomotor hyperactivity in response to nicotine initially due to increases of both the density of nicotinic receptors and DA concentration, followed by inducing DA receptor supersensitivity in the striatum.	nicotine,35,43,Chemical/Drug	nicotine,106,114,Chemical/Drug	DA,189,191,Chemical/Drug	DA,228,230,Chemical/Drug	"[{""token"": ""nicotine"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 228, ""end_span"": 230, ""type"": ""Chemical/Drug""}]"	train
Ototoxicity occurred in four ( 9. 5%) of 42 netilmicin and piperacillin and in 12 ( 22%) of 54 tobramycin and piperacillin - treated patients.	netilmicin,44,54,Chemical/Drug	piperacillin,59,71,Chemical/Drug	tobramycin,95,105,Chemical/Drug	piperacillin,110,122,Chemical/Drug	"[{""token"": ""netilmicin"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 59, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""tobramycin"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 110, ""end_span"": 122, ""type"": ""Chemical/Drug""}]"	train
Of those evaluated with posttherapy audiograms, three of four netilmicin and piperacillin - treated patients had auditory thresholds return to baseline compared with one of nine tobramycin and piperacillin - treated patients.	netilmicin,62,72,Chemical/Drug	piperacillin,77,89,Chemical/Drug	tobramycin,178,188,Chemical/Drug	piperacillin,193,205,Chemical/Drug	"[{""token"": ""netilmicin"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""tobramycin"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 193, ""end_span"": 205, ""type"": ""Chemical/Drug""}]"	train
The number of greater than or equal to 15 - dB increases in auditory threshold as a proportion of total greater than or equal to 15 - dB changes ( increases and decreases) was significantly lower in netilmicin and piperacillin - vs tobramycin and piperacillin - treated patients ( 18 of 78 vs 67 of 115).	netilmicin,199,209,Chemical/Drug	piperacillin,214,226,Chemical/Drug	tobramycin,232,242,Chemical/Drug	piperacillin,247,259,Chemical/Drug	"[{""token"": ""netilmicin"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 214, ""end_span"": 226, ""type"": ""Chemical/Drug""}, {""token"": ""tobramycin"", ""start_span"": 232, ""end_span"": 242, ""type"": ""Chemical/Drug""}, {""token"": ""piperacillin"", ""start_span"": 247, ""end_span"": 259, ""type"": ""Chemical/Drug""}]"	train
Aspirin or salicylate ingestion had occurred in only one of the 20 cases ( 5%), and paracetamol ( acetaminophen) had been administered in only six of the cases ( 30%).	Aspirin,0,7,Chemical/Drug	salicylate,11,21,Chemical/Drug	paracetamol,84,95,Chemical/Drug	acetaminophen,98,111,Chemical/Drug	"[{""token"": ""Aspirin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""salicylate"", ""start_span"": 11, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""paracetamol"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 98, ""end_span"": 111, ""type"": ""Chemical/Drug""}]"	train
Thus, myocardial electrical excitability was measured in patients with mild essential hypertension and known coronary artery disease after 8 weeks of treatment with a potassium - conserving diuretic ( amiloride) and a similar period on a potassium - losing diuretic ( chlorthalidone) in a randomised study.	potassium,167,176,Chemical/Drug	amiloride,201,210,Chemical/Drug	potassium,238,247,Chemical/Drug	chlorthalidone,268,282,Chemical/Drug	"[{""token"": ""potassium"", ""start_span"": 167, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""amiloride"", ""start_span"": 201, ""end_span"": 210, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 238, ""end_span"": 247, ""type"": ""Chemical/Drug""}, {""token"": ""chlorthalidone"", ""start_span"": 268, ""end_span"": 282, ""type"": ""Chemical/Drug""}]"	train
We studied a thiamine - dependent enzyme, transketolase, from fibroblasts of a diabetic patient who developed Wernicke ' s encephalopathy when treated with tolazamide, in order to delineate if this patient also had transketolase abnormality [ high Km for thiamine pyrophosphate ( TPP)], as previously reported in postalcoholic Wernicke - Korsakoff syndrome.	thiamine,13,21,Chemical/Drug	tolazamide,156,166,Chemical/Drug	thiamine pyrophosphate,255,277,Chemical/Drug	TPP,280,283,Chemical/Drug	"[{""token"": ""thiamine"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""tolazamide"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Chemical/Drug""}, {""token"": ""thiamine pyrophosphate"", ""start_span"": 255, ""end_span"": 277, ""type"": ""Chemical/Drug""}, {""token"": ""TPP"", ""start_span"": 280, ""end_span"": 283, ""type"": ""Chemical/Drug""}]"	train
The present work has been planned in order to elucidate the effect of phenobarbital ( PB: 15 mg per rat of ingested dose) on carcinogenesis when it is administered simultaneously with diethylnitrosamine ( DEN: 10 mg / kg / day).	phenobarbital,70,83,Chemical/Drug	PB,86,88,Chemical/Drug	diethylnitrosamine,184,202,Chemical/Drug	DEN,205,208,Chemical/Drug	"[{""token"": ""phenobarbital"", ""start_span"": 70, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""PB"", ""start_span"": 86, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""diethylnitrosamine"", ""start_span"": 184, ""end_span"": 202, ""type"": ""Chemical/Drug""}, {""token"": ""DEN"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Chemical/Drug""}]"	train
Tri - ortho - tolyl phosphate ( TOTP), 360 mg / kg, po, and 0, 0 ' - diisopropyl phosphorofluoridate ( DFP), 1 mg / kg sc, were administered to adult White Leghorn chickens 24 hr after they were placed on diets containing 0 to 300 ppm corticosterone.	Tri - ortho - tolyl phosphate,0,29,Chemical/Drug	TOTP,32,36,Chemical/Drug	DFP,103,106,Chemical/Drug	corticosterone,235,249,Chemical/Drug	"[{""token"": ""Tri - ortho - tolyl phosphate"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""TOTP"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""DFP"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""corticosterone"", ""start_span"": 235, ""end_span"": 249, ""type"": ""Chemical/Drug""}]"	train
Although low concentrations ( less than or equal to 50 ppm) of corticosterone had beneficial effects on TOTP - induced neuropathy, greater than or equal to 200 ppm exacerbated clinical signs in chickens given either TOTP or DFP.	corticosterone,63,77,Chemical/Drug	TOTP,104,108,Chemical/Drug	TOTP,216,220,Chemical/Drug	DFP,224,227,Chemical/Drug	"[{""token"": ""corticosterone"", ""start_span"": 63, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""TOTP"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""TOTP"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Chemical/Drug""}, {""token"": ""DFP"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Chemical/Drug""}]"	train
Local anesthetics that are commonly used in ophthalmic surgery ( 0. 75% bupivacaine hydrochloride, 2. 0% mepivacaine hydrochloride, and 2. 0% lidocaine hydrochloride plus 1: 100, 000 epinephrine) were injected into the retrobulbar area of rat eyes.	bupivacaine hydrochloride,72,97,Chemical/Drug	mepivacaine hydrochloride,105,130,Chemical/Drug	lidocaine hydrochloride,142,165,Chemical/Drug	epinephrine,183,194,Chemical/Drug	"[{""token"": ""bupivacaine hydrochloride"", ""start_span"": 72, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""mepivacaine hydrochloride"", ""start_span"": 105, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""lidocaine hydrochloride"", ""start_span"": 142, ""end_span"": 165, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 183, ""end_span"": 194, ""type"": ""Chemical/Drug""}]"	train
Tiapride, a substituted benzamide derivative closely related to metoclopramide, reduced levodopa - induced peak dose involuntary movements in 16 patients with idiopathic Parkinson ' s disease.	Tiapride,0,8,Chemical/Drug	benzamide,24,33,Chemical/Drug	metoclopramide,64,78,Chemical/Drug	levodopa,88,96,Chemical/Drug	"[{""token"": ""Tiapride"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""benzamide"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""metoclopramide"", ""start_span"": 64, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""levodopa"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Chemical/Drug""}]"	train
Mean serum potassium level fell, and urea and uric acid levels rose, in men and women taking bendrofluazide.	potassium,11,20,Chemical/Drug	urea,37,41,Chemical/Drug	uric acid,46,55,Chemical/Drug	bendrofluazide,93,107,Chemical/Drug	"[{""token"": ""potassium"", ""start_span"": 11, ""end_span"": 20, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""uric acid"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""bendrofluazide"", ""start_span"": 93, ""end_span"": 107, ""type"": ""Chemical/Drug""}]"	train
In the propranolol group, serum potassium and uric acid levels rose in both sexes, but the urea level rose significantly in women only.	propranolol,7,18,Chemical/Drug	potassium,32,41,Chemical/Drug	uric acid,46,55,Chemical/Drug	urea,91,95,Chemical/Drug	"[{""token"": ""propranolol"", ""start_span"": 7, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 32, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""uric acid"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Chemical/Drug""}]"	train
However, ranitidine was threefold more potent than cimetidine both in acute inhibition studies and in the median maintenance dose needed ( 1. 2 g per day for ranitidine and 3. 6 g per day for cimetidine).	ranitidine,9,19,Chemical/Drug	cimetidine,51,61,Chemical/Drug	ranitidine,158,168,Chemical/Drug	cimetidine,192,202,Chemical/Drug	"[{""token"": ""ranitidine"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""cimetidine"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""ranitidine"", ""start_span"": 158, ""end_span"": 168, ""type"": ""Chemical/Drug""}, {""token"": ""cimetidine"", ""start_span"": 192, ""end_span"": 202, ""type"": ""Chemical/Drug""}]"	train
Captopril had little or no demonstrable effects on serum electrolyte concentrations, excretion of urine, sodium and potassium, endogenous creatinine clearance, body weight, and food and water consumption.	Captopril,0,9,Chemical/Drug	sodium,105,111,Chemical/Drug	potassium,116,125,Chemical/Drug	creatinine,138,148,Chemical/Drug	"[{""token"": ""Captopril"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""sodium"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Chemical/Drug""}]"	train
Ketamine was more potent in the hypophysectomized chick and the circadian rhythm noted in the intact chick was absent; furthermore, melatonin did not augment the ketamine DOC whereas dopamine continued to do so.	Ketamine,0,8,Chemical/Drug	melatonin,132,141,Chemical/Drug	ketamine,162,170,Chemical/Drug	dopamine,183,191,Chemical/Drug	"[{""token"": ""Ketamine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""melatonin"", ""start_span"": 132, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Chemical/Drug""}]"	train
This study was undertaken to investigate the links between the long - term administration of digoxin therapy and sexual behavior, and the effect of digoxin on plasma levels of estradiol, testosterone, and LH.	digoxin,93,100,Chemical/Drug	digoxin,148,155,Chemical/Drug	estradiol,176,185,Chemical/Drug	testosterone,187,199,Chemical/Drug	"[{""token"": ""digoxin"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""digoxin"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""estradiol"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Chemical/Drug""}, {""token"": ""testosterone"", ""start_span"": 187, ""end_span"": 199, ""type"": ""Chemical/Drug""}]"	train
Twelve healthy volunteers were assigned to take BPT / CLZ in the following schedule; BPT: 40 micrograms at day 1 and 120 micrograms t. i. d. from day 7 to 14, CLZ: 200 mg t. i. d. from day 3 to 14.	BPT,48,51,Chemical/Drug	CLZ,54,57,Chemical/Drug	BPT,85,88,Chemical/Drug	CLZ,159,162,Chemical/Drug	"[{""token"": ""BPT"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""CLZ"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""BPT"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""CLZ"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	train
Intraventricular infusion of dopamine sufficient to raise the brain dopamine to the same extent did not prevent the ammonia coma nor affect the blood and brain ammonia concentrations.	dopamine,29,37,Chemical/Drug	dopamine,68,76,Chemical/Drug	ammonia,116,123,Chemical/Drug	ammonia,160,167,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""ammonia"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""ammonia"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Chemical/Drug""}]"	train
Thus, the reduction in blood and brain ammonia and the prevention of ammonia coma after L - dopa, can be accounted for by the peripheral effect of dopamine on renal function rather than its central action.	ammonia,39,46,Chemical/Drug	ammonia,69,76,Chemical/Drug	L - dopa,88,96,Chemical/Drug	dopamine,147,155,Chemical/Drug	"[{""token"": ""ammonia"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""ammonia"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""L - dopa"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 147, ""end_span"": 155, ""type"": ""Chemical/Drug""}]"	train
This supports and extends previous evidence for a mechanism by which enflurane and / or isoflurane could produce a hypersensitivity condition similar to that of halothane hepatitis either alone or subsequent to halothane administration.	enflurane,69,78,Chemical/Drug	isoflurane,88,98,Chemical/Drug	halothane,161,170,Chemical/Drug	halothane,211,220,Chemical/Drug	"[{""token"": ""enflurane"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""isoflurane"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""halothane"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Chemical/Drug""}, {""token"": ""halothane"", ""start_span"": 211, ""end_span"": 220, ""type"": ""Chemical/Drug""}]"	train
Increased plasma malondialdehyde was also recorded in two other groups of animals subjected to the same experimental model, one receiving 20 mg / kg b. w. of the cyclooxygenase inhibitor acetylsalicylate intravenously immediately before ischemia, the other receiving 650 micrograms / kg b. w. of the hypotensive drug nitroprusside at a flow rate of 103 microliters / min intravenously during ischemia, although in this latter group malondialdehyde was significantly higher.	malondialdehyde,17,32,Chemical/Drug	acetylsalicylate,187,203,Chemical/Drug	nitroprusside,317,330,Chemical/Drug	malondialdehyde,432,447,Chemical/Drug	"[{""token"": ""malondialdehyde"", ""start_span"": 17, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""acetylsalicylate"", ""start_span"": 187, ""end_span"": 203, ""type"": ""Chemical/Drug""}, {""token"": ""nitroprusside"", ""start_span"": 317, ""end_span"": 330, ""type"": ""Chemical/Drug""}, {""token"": ""malondialdehyde"", ""start_span"": 432, ""end_span"": 447, ""type"": ""Chemical/Drug""}]"	train
We conducted a double - blind, randomized phase II study to evaluate the safety and activity of combination therapy with N - butyl - deoxynojirimycin ( SC - 48334) ( an alpha - glucosidase I inhibitor) and zidovudine versus zidovudine alone.	N - butyl - deoxynojirimycin,121,149,Chemical/Drug	SC - 48334,152,162,Chemical/Drug	zidovudine,206,216,Chemical/Drug	zidovudine,224,234,Chemical/Drug	"[{""token"": ""N - butyl - deoxynojirimycin"", ""start_span"": 121, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""SC - 48334"", ""start_span"": 152, ""end_span"": 162, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 206, ""end_span"": 216, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 224, ""end_span"": 234, ""type"": ""Chemical/Drug""}]"	train
Patients with 200 to 500 CD4 cells / mm3 who tolerated < or = 12 weeks of prior zidovudine therapy received SC - 48334 ( 1000 mg every 8 h) and zidovudine ( 100 mg every 8 h) or zidovudine and placebo.	zidovudine,80,90,Chemical/Drug	SC - 48334,108,118,Chemical/Drug	zidovudine,144,154,Chemical/Drug	zidovudine,178,188,Chemical/Drug	"[{""token"": ""zidovudine"", ""start_span"": 80, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""SC - 48334"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""zidovudine"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Chemical/Drug""}]"	train
The oxytocin should be given only in Ringers lactate or, alternately, in Ringers lactate and a 5 per cent dextrose and water solutions.	oxytocin,4,12,Chemical/Drug	lactate,45,52,Chemical/Drug	lactate,81,88,Chemical/Drug	dextrose,106,114,Chemical/Drug	"[{""token"": ""oxytocin"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""lactate"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""lactate"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""dextrose"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Chemical/Drug""}]"	train
RESULTS: Among women, lovastatin ( 20 to 80 mg / d) produced sustained ( 12 - to 48 - week), dose - related changes ( P < 0. 001): decreases in LDL cholesterol ( 24% to 40%) and triglycerides ( 9% to 18%), and increases in HDL cholesterol ( 6. 7% to 8. 6%).	lovastatin,22,32,Chemical/Drug	cholesterol,148,159,Chemical/Drug	triglycerides,178,191,Chemical/Drug	cholesterol,227,238,Chemical/Drug	"[{""token"": ""lovastatin"", ""start_span"": 22, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""triglycerides"", ""start_span"": 178, ""end_span"": 191, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 227, ""end_span"": 238, ""type"": ""Chemical/Drug""}]"	train
In a phase I study to determine the maximum tolerated dose of paclitaxel ( Taxol; Bristol - Myers Squibb Company, Princeton, NJ) given as a 3 - hour infusion in combination with carboplatin administered every 21 days to women with advanced ovarian cancer, paclitaxel doses were escalated as follows: level 1, 135 mg / m2; level 2, 160 mg / m2; level 3, 185 mg / m2; and level 4, 210 mg / m2.	paclitaxel,62,72,Chemical/Drug	Taxol,75,80,Chemical/Drug	carboplatin,178,189,Chemical/Drug	paclitaxel,256,266,Chemical/Drug	"[{""token"": ""paclitaxel"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""Taxol"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""carboplatin"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Chemical/Drug""}, {""token"": ""paclitaxel"", ""start_span"": 256, ""end_span"": 266, ""type"": ""Chemical/Drug""}]"	train
Therefore, 60 male rats were randomly assigned to receive daily injection of saline ( C), methylprednisolone ( M), or triamcinolone ( T) 80 mg / kg / d for 5 d.	methylprednisolone,90,108,Chemical/Drug	M,111,112,Chemical/Drug	triamcinolone,118,131,Chemical/Drug	T,134,135,Chemical/Drug	"[{""token"": ""methylprednisolone"", ""start_span"": 90, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""M"", ""start_span"": 111, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""triamcinolone"", ""start_span"": 118, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""T"", ""start_span"": 134, ""end_span"": 135, ""type"": ""Chemical/Drug""}]"	train
Recently, we demonstrated the hepatoprotective effects of nicotinic acid amide, a selective inhibitor of poly ( ADP - ribose) polymerase ( PARP; EC 2. 4. 2. 30) on mice suffering from acetaminophen ( AAP) - hepatitis, suggesting that the AAP - induced liver injury involves a step which depends on adenoribosylation.	nicotinic acid amide,58,78,Chemical/Drug	acetaminophen,184,197,Chemical/Drug	AAP,200,203,Chemical/Drug	AAP,238,241,Chemical/Drug	"[{""token"": ""nicotinic acid amide"", ""start_span"": 58, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""acetaminophen"", ""start_span"": 184, ""end_span"": 197, ""type"": ""Chemical/Drug""}, {""token"": ""AAP"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Chemical/Drug""}, {""token"": ""AAP"", ""start_span"": 238, ""end_span"": 241, ""type"": ""Chemical/Drug""}]"	train
Liver injuries were quantified as serum activities of glutamate - oxaloacetate transaminase ( GOT) and glutamate - pyruvate transaminase ( GPT).	glutamate,54,63,Chemical/Drug	oxaloacetate,66,78,Chemical/Drug	glutamate,103,112,Chemical/Drug	pyruvate,115,123,Chemical/Drug	"[{""token"": ""glutamate"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""oxaloacetate"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""pyruvate"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Chemical/Drug""}]"	train
Our results provide evidence that the AAP - induced hepatitis and its exacerbation by ethanol can either be reduced by end - product inhibition of PARP by NAA or by dietary depletion of the enzyme ' s substrate NAD.	AAP,38,41,Chemical/Drug	ethanol,86,93,Chemical/Drug	NAA,155,158,Chemical/Drug	NAD,211,214,Chemical/Drug	"[{""token"": ""AAP"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""ethanol"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""NAA"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""NAD"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Chemical/Drug""}]"	train
A phase I clinical study of the antipurine antifolate lometrexol ( DDATHF) given with oral folic acid.	antipurine,32,42,Chemical/Drug	lometrexol,54,64,Chemical/Drug	DDATHF,67,73,Chemical/Drug	folic acid,91,101,Chemical/Drug	"[{""token"": ""antipurine"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""lometrexol"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""DDATHF"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""folic acid"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Chemical/Drug""}]"	train
This observation prompted a Phase I clinical study of lometrexol given with folic acid supplementation which has confirmed that the toxicity of lometrexol can be markedly reduced by folic acid supplementation.	lometrexol,54,64,Chemical/Drug	folic acid,76,86,Chemical/Drug	lometrexol,144,154,Chemical/Drug	folic acid,182,192,Chemical/Drug	"[{""token"": ""lometrexol"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""folic acid"", ""start_span"": 76, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""lometrexol"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""folic acid"", ""start_span"": 182, ""end_span"": 192, ""type"": ""Chemical/Drug""}]"	train
Superoxide and hydrogen peroxide production in neutrophils stimulated with formyl - methionyl - leucyl - phenylalanine ( fMLP) from a further 18 ALF patients was unaffected compared with control neutrophils.	Superoxide,0,10,Chemical/Drug	hydrogen peroxide,15,32,Chemical/Drug	formyl - methionyl - leucyl - phenylalanine,75,118,Chemical/Drug	fMLP,121,125,Chemical/Drug	"[{""token"": ""Superoxide"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""hydrogen peroxide"", ""start_span"": 15, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""formyl - methionyl - leucyl - phenylalanine"", ""start_span"": 75, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""fMLP"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Chemical/Drug""}]"	train
Our findings do suggest that CS - mediated protection is dependent on the action of the intact anionic CS molecule ( non - hydrolyzable CSE was as protective as CS), whose mechanism has yet to be defined.	CS,29,31,Chemical/Drug	CS,103,105,Chemical/Drug	CSE,136,139,Chemical/Drug	CS,161,163,Chemical/Drug	"[{""token"": ""CS"", ""start_span"": 29, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""CS"", ""start_span"": 103, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""CSE"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""CS"", ""start_span"": 161, ""end_span"": 163, ""type"": ""Chemical/Drug""}]"	train
Therefore, the effects of carteolol, a beta - adrenoceptor antagonist, on haloperidol - induced catalepsy in rats were behaviorally studied and compared with those of propranolol and biperiden, a muscarinic receptor antagonist.	carteolol,26,35,Chemical/Drug	haloperidol,74,85,Chemical/Drug	propranolol,167,178,Chemical/Drug	biperiden,183,192,Chemical/Drug	"[{""token"": ""carteolol"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""biperiden"", ""start_span"": 183, ""end_span"": 192, ""type"": ""Chemical/Drug""}]"	train
Carteolol, as well as propranolol and biperiden, inhibited the haloperidol - induced catalepsy.	Carteolol,0,9,Chemical/Drug	propranolol,22,33,Chemical/Drug	biperiden,38,47,Chemical/Drug	haloperidol,63,74,Chemical/Drug	"[{""token"": ""Carteolol"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""biperiden"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical/Drug""}]"	train
The effects of NIK - 247 on cholinesterase, scopolamine - induced amnesia and spontaneous movement were examined and compared with those of the well - known cholinesterase inhibitors tacrine and E - 2020.	NIK - 247,15,24,Chemical/Drug	scopolamine,44,55,Chemical/Drug	tacrine,183,190,Chemical/Drug	E - 2020,195,203,Chemical/Drug	"[{""token"": ""NIK - 247"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 44, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""tacrine"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""E - 2020"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Chemical/Drug""}]"	train
We therefore conducted the present acute dose - response study in four 1 - methyl - 4 - phenyl - 1, 2, 3, 6 - tetrahydropyridine ( MPTP) - exposed cynomolgus monkeys primed to exhibit levodopa - induced dyskinesias to evaluate the locomotor and dyskinetic effects on challenge with four doses ( from 0. 03 to 1. 0 mg / kg) of A - 86929 ( [ -] - [ 5aR, 11bS] - 4, 5, 5a, 6, 7, 11b - hexahydro - 2 - propyl - 3 - thia - 5 - + + + azacyclopent - 1 - ena [ c] phenathrene - 9 - 10 - diol), a selective and full DA D1 - like receptor agonist with an intermediate duration of action.	MPTP,131,135,Chemical/Drug	levodopa,184,192,Chemical/Drug	A - 86929,326,335,Chemical/Drug	DA,507,509,Chemical/Drug	"[{""token"": ""MPTP"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Chemical/Drug""}, {""token"": ""levodopa"", ""start_span"": 184, ""end_span"": 192, ""type"": ""Chemical/Drug""}, {""token"": ""A - 86929"", ""start_span"": 326, ""end_span"": 335, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 507, ""end_span"": 509, ""type"": ""Chemical/Drug""}]"	train
METHOD: Sphincter of Oddi spasm was induced by prostigmine - morphine administration ( 0. 5 mg prostigmine intramuscularly and 10 mg morphine subcutaneously) and visualized by quantitative hepatobiliary scintigraphy.	prostigmine,47,58,Chemical/Drug	morphine,61,69,Chemical/Drug	prostigmine,95,106,Chemical/Drug	morphine,133,141,Chemical/Drug	"[{""token"": ""prostigmine"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""prostigmine"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Chemical/Drug""}]"	train
Glyceryl trinitrate infusion completely normalized the prostigmine - morphine - induced alterations in these quantitative parameters ( TmaX over the LP: 11. 33 + / - 1. 13; over the HH: 18. 88 + / - 1. 48; and over the CBD: 36. 22 + / - 1. 92; and T1 / 2 over the LP: 28. 21 + / - 1. 83; over the HH: 33. 42 + / - 3. 10; and over the CBD: 41. 66 + / - 6. 33), suggesting an effective sphincter - relaxing effect of glyceryl trinitrate.	Glyceryl trinitrate,0,19,Chemical/Drug	prostigmine,55,66,Chemical/Drug	morphine,69,77,Chemical/Drug	glyceryl trinitrate,415,434,Chemical/Drug	"[{""token"": ""Glyceryl trinitrate"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""prostigmine"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""glyceryl trinitrate"", ""start_span"": 415, ""end_span"": 434, ""type"": ""Chemical/Drug""}]"	train
BACKGROUND: The most striking of carboplatin ' s advantages ( CBDCA) over cisplatin ( CDDP) is its markedly reduced rate of neurotoxic effects.	carboplatin,33,44,Chemical/Drug	CBDCA,62,67,Chemical/Drug	cisplatin,74,83,Chemical/Drug	CDDP,86,90,Chemical/Drug	"[{""token"": ""carboplatin"", ""start_span"": 33, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""CBDCA"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""cisplatin"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""CDDP"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Chemical/Drug""}]"	train
In cisapride - treated diarrhoea - predominant patients the mean contraction amplitude was higher ( 29. 3 + / - 3. 2 versus 24. 9 + / - 2. 6 mm Hg, cisapride versus placebo ( P < 0. 001); pretreatment, 25. 7 + / - 6. 0 mm Hg), the mean contraction duration longer ( 3. 4 + / - 0. 2 versus 3. 0 + / - 0. 2 sec, cisapride versus placebo ( P < 0. 001); pretreatment, 3. 1 + / - 0. 5 sec), and the mean contraction frequency lower ( 2. 0 + / - 0. 2 versus 2. 5 + / - 0. 4 cont. / min, cisapride versus placebo ( P < 0. 001); pretreatment, 2. 5 + / - 1. 1 cont. / min] than patients treated with placebo.	cisapride,3,12,Chemical/Drug	cisapride,148,157,Chemical/Drug	cisapride,310,319,Chemical/Drug	cisapride,481,490,Chemical/Drug	"[{""token"": ""cisapride"", ""start_span"": 3, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 148, ""end_span"": 157, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 310, ""end_span"": 319, ""type"": ""Chemical/Drug""}, {""token"": ""cisapride"", ""start_span"": 481, ""end_span"": 490, ""type"": ""Chemical/Drug""}]"	train
